word,frequency,log frequency
the,5506,8.613593685702552
of,5480,8.608860379942062
and,4369,8.382289428951436
in,3093,8.03689677268507
to,2530,7.835974581721566
a,1738,7.460490305825338
with,1680,7.426549072397305
for,1217,7.104144092987527
is,1171,7.065613363597717
patients,1068,6.97354301952014
The,987,6.894670039433482
was,846,6.740519359606223
were,725,6.586171654854675
that,714,6.570882962339584
asthma,643,6.466144724237619
as,625,6.437751649736401
are,582,6.366470447731438
by,578,6.359573868672378
on,563,6.333279628139691
stroke,562,6.331501849893691
be,516,6.246106765481563
influenza,482,6.1779441140506
or,478,6.169610732491456
from,469,6.150602768446279
infarction,439,6.0844994130751715
an,438,6.082218910376446
myocardial,421,6.042632833682381
acute,397,5.983936280687191
this,391,5.968707559985366
have,355,5.872117789475416
disease,351,5.860786223465865
In,337,5.820082930352362
risk,334,5.811140992976701
COVID-19,320,5.768320995793772
SARS-CoV-2,320,5.768320995793772
at,319,5.765191102784844
study,298,5.697093486505405
has,295,5.68697535633982
clinical,292,5.676753802268282
than,292,5.676753802268282
A,280,5.634789603169249
after,279,5.631211781821365
We,269,5.594711379601839
been,265,5.579729825986222
not,262,5.568344503761097
treatment,260,5.560681631015528
between,249,5.517452896464707
which,247,5.5093883366279774
pandemic,246,5.5053315359323625
This,244,5.497168225293202
can,224,5.4116460518550396
severe,222,5.402677381872279
virus,222,5.402677381872279
had,217,5.37989735354046
these,216,5.375278407684165
may,215,5.3706380281276624
infection,215,5.3706380281276624
more,209,5.342334251964811
but,206,5.327876168789581
mortality,196,5.278114659230517
during,195,5.272999558563747
we,193,5.262690188904886
2,190,5.247024072160486
children,186,5.225746673713202
cases,185,5.220355825078324
associated,183,5.209486152841421
health,180,5.19295685089021
used,177,5.176149732573829
factors,173,5.153291594497779
respiratory,166,5.111987788356544
Background,165,5.10594547390058
years,163,5.093750200806762
therapy,160,5.075173815233827
studies,158,5.062595033026967
who,155,5.043425116919247
control,155,5.043425116919247
all,154,5.0369526024136295
high,154,5.0369526024136295
it,154,5.0369526024136295
coronary,154,5.0369526024136295
coronavirus,153,5.030437921392435
group,152,5.0238805208462765
also,150,5.0106352940962555
age,149,5.003946305945459
management,148,4.997212273764115
their,148,4.997212273764115
most,146,4.983606621708336
data,145,4.976733742420574
vaccine,144,4.969813299576001
other,143,4.962844630259907
results,143,4.962844630259907
use,140,4.941642422609304
care,139,4.9344739331306915
its,139,4.9344739331306915
patient,136,4.912654885736052
review,136,4.912654885736052
no,133,4.890349128221754
symptoms,131,4.875197323201151
such,131,4.875197323201151
diagnosis,129,4.859812404361672
using,127,4.844187086458591
first,123,4.812184355372417
1,123,4.812184355372417
time,122,4.804021044733257
both,120,4.787491742782046
left,119,4.77912349311153
early,118,4.770684624465665
3,117,4.762173934797756
different,116,4.7535901911063645
viral,116,4.7535901911063645
To,115,4.74493212836325
showed,115,4.74493212836325
new,115,4.74493212836325
significant,115,4.74493212836325
against,114,4.736198448394496
less,114,4.736198448394496
one,113,4.727387818712341
two,112,4.718498871295094
rate,111,4.709530201312334
among,111,4.709530201312334
only,110,4.700480365792417
increased,110,4.700480365792417
ischemic,110,4.700480365792417
those,109,4.6913478822291435
case,108,4.68213122712422
higher,108,4.68213122712422
potential,108,4.68213122712422
population,108,4.68213122712422
should,107,4.672828834461906
including,107,4.672828834461906
role,106,4.663439094112067
vaccination,105,4.653960350157523
compared,103,4.634728988229636
significantly,102,4.624972813284271
well,102,4.624972813284271
development,102,4.624972813284271
AMI,101,4.61512051684126
strokes,99,4.59511985013459
there,98,4.584967478670572
response,98,4.584967478670572
ventricular,98,4.584967478670572
heart,98,4.584967478670572
days,98,4.584967478670572
groups,97,4.574710978503383
However,97,4.574710978503383
syndrome,97,4.574710978503383
effective,96,4.564348191467836
blood,95,4.553876891600541
important,94,4.543294782270004
outcomes,93,4.532599493153256
about,92,4.5217885770490405
effects,91,4.51085950651685
viruses,91,4.51085950651685
when,91,4.51085950651685
within,90,4.499809670330265
present,90,4.499809670330265
found,90,4.499809670330265
death,89,4.48863636973214
-,88,4.477336814478207
95,88,4.477336814478207
function,88,4.477336814478207
cells,88,4.477336814478207
cardiac,86,4.454347296253507
over,86,4.454347296253507
artery,85,4.442651256490317
test,84,4.430816798843313
due,84,4.430816798843313
could,84,4.430816798843313
current,83,4.418840607796598
changes,83,4.418840607796598
infections,83,4.418840607796598
cause,82,4.406719247264253
diagnostic,82,4.406719247264253
major,82,4.406719247264253
human,81,4.394449154672439
It,81,4.394449154672439
testing,80,4.382026634673881
rates,80,4.382026634673881
hospital,79,4.3694478524670215
into,79,4.3694478524670215
positive,79,4.3694478524670215
available,78,4.356708826689592
common,78,4.356708826689592
immune,78,4.356708826689592
CI,76,4.330733340286331
analysis,76,4.330733340286331
MI,76,4.330733340286331
cell,75,4.31748811353631
2019,75,4.31748811353631
individuals,75,4.31748811353631
chronic,74,4.30406509320417
therapeutic,74,4.30406509320417
medical,74,4.30406509320417
2009,74,4.30406509320417
vaccines,73,4.290459441148391
public,73,4.290459441148391
will,72,4.276666119016055
lower,72,4.276666119016055
system,71,4.2626798770413155
mean,71,4.2626798770413155
without,71,4.2626798770413155
onset,71,4.2626798770413155
level,71,4.2626798770413155
number,70,4.248495242049359
levels,70,4.248495242049359
specific,70,4.248495242049359
flow,69,4.23410650459726
These,69,4.23410650459726
prevention,69,4.23410650459726
p,69,4.23410650459726
evidence,69,4.23410650459726
year,69,4.23410650459726
complications,68,4.219507705176107
period,68,4.219507705176107
tests,68,4.219507705176107
H1N1,68,4.219507705176107
our,68,4.219507705176107
possible,68,4.219507705176107
identify,67,4.204692619390966
some,67,4.204692619390966
performed,67,4.204692619390966
strategies,67,4.204692619390966
There,67,4.204692619390966
whether,67,4.204692619390966
three,67,4.204692619390966
effect,67,4.204692619390966
findings,67,4.204692619390966
observed,66,4.189654742026425
measures,66,4.189654742026425
morbidity,66,4.189654742026425
impact,65,4.174387269895637
they,65,4.174387269895637
information,65,4.174387269895637
4,64,4.1588830833596715
Objective,64,4.1588830833596715
evaluate,64,4.1588830833596715
several,64,4.1588830833596715
confirmed,64,4.1588830833596715
determine,63,4.143134726391533
novel,63,4.143134726391533
related,63,4.143134726391533
increase,63,4.143134726391533
reported,63,4.143134726391533
6,63,4.143134726391533
based,63,4.143134726391533
inflammation,63,4.143134726391533
through,63,4.143134726391533
exercise,63,4.143134726391533
subjects,62,4.127134385045092
total,62,4.127134385045092
association,62,4.127134385045092
provide,62,4.127134385045092
pressure,62,4.127134385045092
global,62,4.127134385045092
months,62,4.127134385045092
diseases,62,4.127134385045092
Although,61,4.110873864173311
caused,61,4.110873864173311
10,61,4.110873864173311
severity,61,4.110873864173311
transmission,61,4.110873864173311
following,60,4.0943445622221
adults,60,4.0943445622221
emergency,60,4.0943445622221
airway,59,4.07753744390572
imaging,59,4.07753744390572
outcome,59,4.07753744390572
samples,59,4.07753744390572
bronchial,59,4.07753744390572
size,58,4.060443010546419
low,58,4.060443010546419
developed,58,4.060443010546419
type,58,4.060443010546419
differences,58,4.060443010546419
incidence,58,4.060443010546419
P,57,4.04305126783455
interventions,57,4.04305126783455
agents,57,4.04305126783455
method,56,4.02535169073515
5,56,4.02535169073515
Asthma,56,4.02535169073515
many,56,4.02535169073515
rapid,56,4.02535169073515
need,55,4.007333185232471
spread,55,4.007333185232471
activity,55,4.007333185232471
suggest,55,4.007333185232471
detection,55,4.007333185232471
identified,55,4.007333185232471
better,55,4.007333185232471
each,54,3.9889840465642745
antibodies,54,3.9889840465642745
prevalence,54,3.9889840465642745
events,54,3.9889840465642745
assessment,54,3.9889840465642745
deaths,54,3.9889840465642745
outbreak,54,3.9889840465642745
life,53,3.970291913552122
treated,53,3.970291913552122
cardiovascular,53,3.970291913552122
people,53,3.970291913552122
aim,53,3.970291913552122
failure,53,3.970291913552122
improve,53,3.970291913552122
drugs,52,3.9512437185814275
models,52,3.9512437185814275
still,52,3.9512437185814275
understanding,52,3.9512437185814275
infarct,51,3.9318256327243257
report,51,3.9318256327243257
sensitivity,51,3.9318256327243257
research,51,3.9318256327243257
20,51,3.9318256327243257
greater,51,3.9318256327243257
surveillance,51,3.9318256327243257
mechanisms,51,3.9318256327243257
trials,51,3.9318256327243257
value,51,3.9318256327243257
antiviral,51,3.9318256327243257
primary,50,3.912023005428146
if,50,3.912023005428146
assessed,50,3.912023005428146
recent,50,3.912023005428146
assess,50,3.912023005428146
known,50,3.912023005428146
countries,49,3.8918202981106265
often,49,3.8918202981106265
efficacy,49,3.8918202981106265
million,49,3.8918202981106265
shown,49,3.8918202981106265
large,49,3.8918202981106265
admission,49,3.8918202981106265
guidelines,48,3.871201010907891
considered,48,3.871201010907891
brain,48,3.871201010907891
included,48,3.871201010907891
purpose,48,3.871201010907891
would,48,3.871201010907891
likely,47,3.8501476017100584
similar,47,3.8501476017100584
recovery,47,3.8501476017100584
asthmatic,47,3.8501476017100584
responses,47,3.8501476017100584
assays,47,3.8501476017100584
score,47,3.8501476017100584
n,47,3.8501476017100584
approach,47,3.8501476017100584
characteristics,46,3.828641396489095
main,46,3.828641396489095
methods,46,3.828641396489095
B,46,3.828641396489095
presence,46,3.828641396489095
increasing,46,3.828641396489095
effectiveness,46,3.828641396489095
demonstrated,46,3.828641396489095
general,46,3.828641396489095
hours,45,3.8066624897703196
social,45,3.8066624897703196
protein,45,3.8066624897703196
model,45,3.8066624897703196
being,45,3.8066624897703196
illness,45,3.8066624897703196
long-term,45,3.8066624897703196
2020,45,3.8066624897703196
knowledge,45,3.8066624897703196
occurred,45,3.8066624897703196
Stroke,45,3.8066624897703196
reduced,45,3.8066624897703196
because,45,3.8066624897703196
conditions,45,3.8066624897703196
intervention,44,3.784189633918261
normal,44,3.784189633918261
respectively,44,3.784189633918261
studied,44,3.784189633918261
exposure,44,3.784189633918261
women,44,3.784189633918261
further,44,3.784189633918261
future,44,3.784189633918261
limited,44,3.784189633918261
reduce,44,3.784189633918261
cerebral,43,3.7612001156935624
work,43,3.7612001156935624
practice,43,3.7612001156935624
12,43,3.7612001156935624
phase,43,3.7612001156935624
functional,43,3.7612001156935624
pulmonary,43,3.7612001156935624
very,43,3.7612001156935624
before,42,3.7376696182833684
estimated,42,3.7376696182833684
status,42,3.7376696182833684
appropriate,42,3.7376696182833684
improved,42,3.7376696182833684
tested,42,3.7376696182833684
Our,42,3.7376696182833684
any,42,3.7376696182833684
how,42,3.7376696182833684
pneumonia,41,3.713572066704308
did,41,3.713572066704308
out,41,3.713572066704308
highly,41,3.713572066704308
assay,41,3.713572066704308
remains,41,3.713572066704308
them,41,3.713572066704308
ischemia,41,3.713572066704308
improvement,41,3.713572066704308
host,41,3.713572066704308
inflammatory,40,3.6888794541139363
RNA,40,3.6888794541139363
young,40,3.6888794541139363
strains,40,3.6888794541139363
support,40,3.6888794541139363
describe,40,3.6888794541139363
various,40,3.6888794541139363
evaluated,40,3.6888794541139363
attack,40,3.6888794541139363
15,40,3.6888794541139363
United,40,3.6888794541139363
range,40,3.6888794541139363
ST,40,3.6888794541139363
under,40,3.6888794541139363
aimed,39,3.6635616461296463
All,39,3.6635616461296463
IgG,39,3.6635616461296463
education,39,3.6635616461296463
seasonal,39,3.6635616461296463
leading,38,3.6375861597263857
essential,38,3.6375861597263857
antibody,38,3.6375861597263857
factor,38,3.6375861597263857
develop,38,3.6375861597263857
causes,38,3.6375861597263857
initial,38,3.6375861597263857
examined,38,3.6375861597263857
reperfusion,38,3.6375861597263857
result,38,3.6375861597263857
admitted,38,3.6375861597263857
help,38,3.6375861597263857
anterior,38,3.6375861597263857
proportion,38,3.6375861597263857
hospitals,38,3.6375861597263857
50,38,3.6375861597263857
however,38,3.6375861597263857
evaluation,38,3.6375861597263857
whereas,37,3.6109179126442243
include,37,3.6109179126442243
mild,37,3.6109179126442243
four,37,3.6109179126442243
worldwide,37,3.6109179126442243
lung,37,3.6109179126442243
States,36,3.58351893845611
motor,36,3.58351893845611
14,36,3.58351893845611
addition,36,3.58351893845611
criteria,36,3.58351893845611
relationship,36,3.58351893845611
described,36,3.58351893845611
process,36,3.58351893845611
required,36,3.58351893845611
established,36,3.58351893845611
quality,36,3.58351893845611
might,35,3.5553480614894135
investigated,35,3.5553480614894135
infected,35,3.5553480614894135
history,35,3.5553480614894135
world,35,3.5553480614894135
literature,35,3.5553480614894135
article,35,3.5553480614894135
course,35,3.5553480614894135
0001,35,3.5553480614894135
Health,35,3.5553480614894135
prognosis,35,3.5553480614894135
either,35,3.5553480614894135
up,35,3.5553480614894135
OR,35,3.5553480614894135
RT-PCR,35,3.5553480614894135
detected,35,3.5553480614894135
especially,35,3.5553480614894135
values,35,3.5553480614894135
unit,35,3.5553480614894135
defined,34,3.5263605246161616
obtained,34,3.5263605246161616
Influenza,34,3.5263605246161616
vs,34,3.5263605246161616
30,34,3.5263605246161616
presented,34,3.5263605246161616
drug,34,3.5263605246161616
S,34,3.5263605246161616
peak,34,3.5263605246161616
day,34,3.5263605246161616
surgery,34,3.5263605246161616
survival,34,3.5263605246161616
features,34,3.5263605246161616
objective,34,3.5263605246161616
late,34,3.5263605246161616
physical,34,3.5263605246161616
Patients,33,3.4965075614664802
pathogenesis,33,3.4965075614664802
direct,33,3.4965075614664802
negative,33,3.4965075614664802
accuracy,33,3.4965075614664802
weeks,33,3.4965075614664802
particularly,33,3.4965075614664802
Thus,33,3.4965075614664802
24,33,3.4965075614664802
order,33,3.4965075614664802
program,33,3.4965075614664802
across,33,3.4965075614664802
made,33,3.4965075614664802
even,33,3.4965075614664802
16,33,3.4965075614664802
conducted,33,3.4965075614664802
myocardium,33,3.4965075614664802
follow-up,32,3.4657359027997265
genetic,32,3.4657359027997265
needed,32,3.4657359027997265
genes,32,3.4657359027997265
strategy,32,3.4657359027997265
childhood,32,3.4657359027997265
angiography,32,3.4657359027997265
critical,32,3.4657359027997265
volume,32,3.4657359027997265
Here,32,3.4657359027997265
systems,32,3.4657359027997265
season,32,3.4657359027997265
healthcare,32,3.4657359027997265
useful,32,3.4657359027997265
since,32,3.4657359027997265
estimate,32,3.4657359027997265
individual,32,3.4657359027997265
vascular,32,3.4657359027997265
areas,32,3.4657359027997265
previous,31,3.4339872044851463
allergic,31,3.4339872044851463
according,31,3.4339872044851463
followed,31,3.4339872044851463
so,31,3.4339872044851463
serum,31,3.4339872044851463
additional,31,3.4339872044851463
During,31,3.4339872044851463
target,31,3.4339872044851463
Introduction,31,3.4339872044851463
wall,31,3.4339872044851463
After,31,3.4339872044851463
discussed,31,3.4339872044851463
gene,31,3.4339872044851463
right,31,3.4339872044851463
five,31,3.4339872044851463
stress,31,3.4339872044851463
binding,31,3.4339872044851463
protective,31,3.4339872044851463
same,31,3.4339872044851463
index,31,3.4339872044851463
change,31,3.4339872044851463
multiple,31,3.4339872044851463
recommendations,31,3.4339872044851463
while,31,3.4339872044851463
indicated,31,3.4339872044851463
thrombolysis,31,3.4339872044851463
condition,30,3.4011973816621555
As,30,3.4011973816621555
optimal,30,3.4011973816621555
monitoring,30,3.4011973816621555
acid,30,3.4011973816621555
benefit,30,3.4011973816621555
hypertension,30,3.4011973816621555
authors,30,3.4011973816621555
provides,30,3.4011973816621555
persons,30,3.4011973816621555
school,30,3.4011973816621555
strain,30,3.4011973816621555
impairment,30,3.4011973816621555
elevation,30,3.4011973816621555
mechanical,30,3.4011973816621555
importance,30,3.4011973816621555
11,30,3.4011973816621555
laboratory,30,3.4011973816621555
although,30,3.4011973816621555
investigate,30,3.4011973816621555
shock,30,3.4011973816621555
complex,30,3.4011973816621555
per,30,3.4011973816621555
reduction,30,3.4011973816621555
medication,29,3.367295829986474
plasma,29,3.367295829986474
specificity,29,3.367295829986474
indicate,29,3.367295829986474
hospitalization,29,3.367295829986474
injury,29,3.367295829986474
China,29,3.367295829986474
leads,29,3.367295829986474
Of,29,3.367295829986474
died,29,3.367295829986474
wave,29,3.367295829986474
25,29,3.367295829986474
few,29,3.367295829986474
regions,29,3.367295829986474
asthmatics,29,3.367295829986474
determined,29,3.367295829986474
flu,29,3.367295829986474
times,29,3.367295829986474
chest,29,3.367295829986474
Objectives,29,3.367295829986474
disorders,29,3.367295829986474
symptom,29,3.367295829986474
secondary,28,3.332204510175204
routine,28,3.332204510175204
oral,28,3.332204510175204
affected,28,3.332204510175204
reaction,28,3.332204510175204
must,28,3.332204510175204
currently,28,3.332204510175204
inhibitors,28,3.332204510175204
aged,28,3.332204510175204
intravenous,28,3.332204510175204
detect,28,3.332204510175204
standard,28,3.332204510175204
relative,28,3.332204510175204
epidemic,28,3.332204510175204
recently,28,3.332204510175204
Since,28,3.332204510175204
angioplasty,28,3.332204510175204
influence,28,3.332204510175204
potentially,28,3.332204510175204
h,28,3.332204510175204
mechanism,28,3.332204510175204
infectious,28,3.332204510175204
measured,27,3.295836866004329
protection,27,3.295836866004329
combination,27,3.295836866004329
Furthermore,27,3.295836866004329
signs,27,3.295836866004329
variants,27,3.295836866004329
difference,27,3.295836866004329
atrial,27,3.295836866004329
discuss,27,3.295836866004329
perioperative,27,3.295836866004329
local,27,3.295836866004329
show,27,3.295836866004329
8,27,3.295836866004329
revealed,27,3.295836866004329
given,27,3.295836866004329
lesions,27,3.295836866004329
tissue,27,3.295836866004329
tool,27,3.295836866004329
RBD,27,3.295836866004329
controlled,27,3.295836866004329
prevent,27,3.295836866004329
second,27,3.295836866004329
CT,27,3.295836866004329
yet,27,3.295836866004329
7,26,3.258096538021482
setting,26,3.258096538021482
New,26,3.258096538021482
occlusion,26,3.258096538021482
comprehensive,26,3.258096538021482
interval,26,3.258096538021482
US,26,3.258096538021482
burden,26,3.258096538021482
received,26,3.258096538021482
decreased,26,3.258096538021482
epidemics,26,3.258096538021482
STEMI,26,3.258096538021482
pain,26,3.258096538021482
daily,26,3.258096538021482
baseline,26,3.258096538021482
moderate,26,3.258096538021482
approaches,26,3.258096538021482
attention,26,3.258096538021482
correlation,26,3.258096538021482
lack,26,3.258096538021482
MRI,26,3.258096538021482
underlying,26,3.258096538021482
then,26,3.258096538021482
neurological,26,3.258096538021482
cognitive,26,3.258096538021482
arteries,25,3.2188758248682006
expiratory,25,3.2188758248682006
performance,25,3.2188758248682006
Two,25,3.2188758248682006
antigenic,25,3.2188758248682006
area,25,3.2188758248682006
characterized,25,3.2188758248682006
diabetes,25,3.2188758248682006
difficult,25,3.2188758248682006
body,25,3.2188758248682006
providing,25,3.2188758248682006
damage,25,3.2188758248682006
frequently,25,3.2188758248682006
ability,25,3.2188758248682006
screening,25,3.2188758248682006
symptomatic,25,3.2188758248682006
remodeling,25,3.2188758248682006
national,25,3.2188758248682006
paper,25,3.2188758248682006
therapies,25,3.2188758248682006
percutaneous,25,3.2188758248682006
No,25,3.2188758248682006
benefits,25,3.2188758248682006
form,25,3.2188758248682006
occurrence,25,3.2188758248682006
regarding,25,3.2188758248682006
rehabilitation,24,3.1780538303479458
suggested,24,3.1780538303479458
now,24,3.1780538303479458
corticosteroids,24,3.1780538303479458
scores,24,3.1780538303479458
thrombolytic,24,3.1780538303479458
site,24,3.1780538303479458
around,24,3.1780538303479458
65,24,3.1780538303479458
angina,24,3.1780538303479458
rare,24,3.1780538303479458
emerging,24,3.1780538303479458
PCR,24,3.1780538303479458
perfusion,24,3.1780538303479458
One,24,3.1780538303479458
versus,24,3.1780538303479458
17,24,3.1780538303479458
successful,24,3.1780538303479458
immunity,24,3.1780538303479458
ACE2,24,3.1780538303479458
treatments,24,3.1780538303479458
19,24,3.1780538303479458
swine,24,3.1780538303479458
recorded,24,3.1780538303479458
fibrillation,24,3.1780538303479458
recognition,24,3.1780538303479458
relatively,24,3.1780538303479458
persistent,24,3.1780538303479458
stem,24,3.1780538303479458
home,24,3.1780538303479458
UK,24,3.1780538303479458
correlated,24,3.1780538303479458
recommended,24,3.1780538303479458
obstruction,24,3.1780538303479458
National,24,3.1780538303479458
specimens,24,3.1780538303479458
contribute,24,3.1780538303479458
genome,24,3.1780538303479458
reviewed,23,3.1354942159291497
thrombosis,23,3.1354942159291497
decrease,23,3.1354942159291497
provided,23,3.1354942159291497
selected,23,3.1354942159291497
taken,23,3.1354942159291497
With,23,3.1354942159291497
clinically,23,3.1354942159291497
confidence,23,3.1354942159291497
andor,23,3.1354942159291497
predict,23,3.1354942159291497
isolation,23,3.1354942159291497
rapidly,23,3.1354942159291497
Purpose,23,3.1354942159291497
lead,23,3.1354942159291497
Therefore,23,3.1354942159291497
transient,23,3.1354942159291497
sudden,23,3.1354942159291497
community,23,3.1354942159291497
long,23,3.1354942159291497
suspected,23,3.1354942159291497
small,23,3.1354942159291497
expression,23,3.1354942159291497
subsequent,23,3.1354942159291497
airways,23,3.1354942159291497
On,23,3.1354942159291497
focus,23,3.1354942159291497
conclusion,23,3.1354942159291497
inhaled,23,3.1354942159291497
economic,23,3.1354942159291497
necessary,23,3.1354942159291497
examine,22,3.091042453358316
recurrent,22,3.091042453358316
via,22,3.091042453358316
parameters,22,3.091042453358316
mass,22,3.091042453358316
infarcted,22,3.091042453358316
older,22,3.091042453358316
21,22,3.091042453358316
discharge,22,3.091042453358316
100,22,3.091042453358316
oseltamivir,22,3.091042453358316
remain,22,3.091042453358316
biological,22,3.091042453358316
prior,22,3.091042453358316
identification,22,3.091042453358316
unknown,22,3.091042453358316
occupational,22,3.091042453358316
poor,22,3.091042453358316
An,22,3.091042453358316
induced,22,3.091042453358316
60,22,3.091042453358316
problem,22,3.091042453358316
neutralizing,22,3.091042453358316
dysfunction,22,3.091042453358316
segment,22,3.091042453358316
vector,22,3.091042453358316
epidemiology,22,3.091042453358316
design,22,3.091042453358316
basis,22,3.091042453358316
adult,22,3.091042453358316
complication,22,3.091042453358316
epidemiological,22,3.091042453358316
practices,22,3.091042453358316
AH1N1,22,3.091042453358316
collected,22,3.091042453358316
ventilation,22,3.091042453358316
access,22,3.091042453358316
isolated,22,3.091042453358316
regression,22,3.091042453358316
enzyme,22,3.091042453358316
widely,22,3.091042453358316
90,22,3.091042453358316
dynamics,21,3.044522437723423
old,21,3.044522437723423
populations,21,3.044522437723423
alternative,21,3.044522437723423
bypass,21,3.044522437723423
costs,21,3.044522437723423
physicians,21,3.044522437723423
environmental,21,3.044522437723423
occur,21,3.044522437723423
do,21,3.044522437723423
published,21,3.044522437723423
cardiogenic,21,3.044522437723423
ventricle,21,3.044522437723423
sensitive,21,3.044522437723423
H3N2,21,3.044522437723423
systematic,21,3.044522437723423
Despite,21,3.044522437723423
where,21,3.044522437723423
retrospective,21,3.044522437723423
previously,21,3.044522437723423
dose,21,3.044522437723423
frequency,21,3.044522437723423
thus,21,3.044522437723423
systemic,21,3.044522437723423
progression,21,3.044522437723423
challenge,21,3.044522437723423
little,21,3.044522437723423
controls,21,3.044522437723423
001,21,3.044522437723423
particular,21,3.044522437723423
week,21,3.044522437723423
AH1N1pdm09,21,3.044522437723423
sites,21,3.044522437723423
exacerbations,21,3.044522437723423
depression,21,3.044522437723423
end,21,3.044522437723423
mutations,21,3.044522437723423
diagnosed,21,3.044522437723423
carotid,21,3.044522437723423
action,21,3.044522437723423
COPD,21,3.044522437723423
past,21,3.044522437723423
seasons,21,3.044522437723423
least,21,3.044522437723423
annual,21,3.044522437723423
preventing,21,3.044522437723423
stenosis,21,3.044522437723423
identifying,20,2.995732273553991
approximately,20,2.995732273553991
arterial,20,2.995732273553991
activities,20,2.995732273553991
types,20,2.995732273553991
ie,20,2.995732273553991
settings,20,2.995732273553991
48,20,2.995732273553991
survey,20,2.995732273553991
emergence,20,2.995732273553991
December,20,2.995732273553991
echocardiography,20,2.995732273553991
proteins,20,2.995732273553991
intensive,20,2.995732273553991
last,20,2.995732273553991
variety,20,2.995732273553991
part,20,2.995732273553991
9,20,2.995732273553991
commonly,20,2.995732273553991
motion,20,2.995732273553991
best,20,2.995732273553991
active,20,2.995732273553991
procedures,20,2.995732273553991
highest,20,2.995732273553991
unclear,20,2.995732273553991
pregnant,20,2.995732273553991
frequent,20,2.995732273553991
aspects,20,2.995732273553991
environment,20,2.995732273553991
hospitalized,20,2.995732273553991
become,20,2.995732273553991
overall,20,2.995732273553991
Group,20,2.995732273553991
having,20,2.995732273553991
average,20,2.995732273553991
quantitative,20,2.995732273553991
key,20,2.995732273553991
classification,20,2.995732273553991
disability,20,2.995732273553991
13,20,2.995732273553991
deficits,20,2.995732273553991
smoking,20,2.995732273553991
problems,20,2.995732273553991
cohort,20,2.995732273553991
centers,20,2.995732273553991
younger,20,2.995732273553991
documented,20,2.995732273553991
air,20,2.995732273553991
half,20,2.995732273553991
admissions,20,2.995732273553991
ECG,20,2.995732273553991
molecular,20,2.995732273553991
directly,19,2.9444389791664403
analyses,19,2.9444389791664403
Data,19,2.9444389791664403
distribution,19,2.9444389791664403
sample,19,2.9444389791664403
ejection,19,2.9444389791664403
comparison,19,2.9444389791664403
much,19,2.9444389791664403
cerebrovascular,19,2.9444389791664403
whom,19,2.9444389791664403
resulting,19,2.9444389791664403
delay,19,2.9444389791664403
real-time,19,2.9444389791664403
compounds,19,2.9444389791664403
mainly,19,2.9444389791664403
estimates,19,2.9444389791664403
predicted,19,2.9444389791664403
responsible,19,2.9444389791664403
adverse,19,2.9444389791664403
stage,19,2.9444389791664403
primarily,19,2.9444389791664403
At,19,2.9444389791664403
trial,19,2.9444389791664403
safety,19,2.9444389791664403
extent,19,2.9444389791664403
implemented,19,2.9444389791664403
term,19,2.9444389791664403
application,19,2.9444389791664403
designed,19,2.9444389791664403
animal,19,2.9444389791664403
led,19,2.9444389791664403
inferior,19,2.9444389791664403
allergy,19,2.9444389791664403
Coronavirus,19,2.9444389791664403
together,19,2.9444389791664403
reports,19,2.9444389791664403
majority,19,2.9444389791664403
timely,19,2.9444389791664403
training,19,2.9444389791664403
spike,19,2.9444389791664403
concern,19,2.9444389791664403
behavior,19,2.9444389791664403
others,19,2.9444389791664403
outbreaks,19,2.9444389791664403
NIHSS,19,2.9444389791664403
efforts,19,2.9444389791664403
investigation,19,2.9444389791664403
experience,19,2.9444389791664403
receive,19,2.9444389791664403
40,19,2.9444389791664403
emerged,19,2.9444389791664403
six,19,2.9444389791664403
receptor,19,2.9444389791664403
variables,19,2.9444389791664403
clear,19,2.9444389791664403
percent,18,2.8903717578961645
contact,18,2.8903717578961645
ischaemic,18,2.8903717578961645
despite,18,2.8903717578961645
disorder,18,2.8903717578961645
involved,18,2.8903717578961645
Disease,18,2.8903717578961645
processes,18,2.8903717578961645
increases,18,2.8903717578961645
fraction,18,2.8903717578961645
minutes,18,2.8903717578961645
presentation,18,2.8903717578961645
elderly,18,2.8903717578961645
Test,18,2.8903717578961645
abnormal,18,2.8903717578961645
almost,18,2.8903717578961645
series,18,2.8903717578961645
abnormalities,18,2.8903717578961645
seen,18,2.8903717578961645
ratio,18,2.8903717578961645
reducing,18,2.8903717578961645
experienced,18,2.8903717578961645
candidates,18,2.8903717578961645
humans,18,2.8903717578961645
consumption,18,2.8903717578961645
scientific,18,2.8903717578961645
analyzed,18,2.8903717578961645
ranged,18,2.8903717578961645
atherosclerosis,18,2.8903717578961645
Most,18,2.8903717578961645
South,18,2.8903717578961645
resulted,18,2.8903717578961645
asymptomatic,18,2.8903717578961645
pathophysiology,18,2.8903717578961645
understand,18,2.8903717578961645
mutation,18,2.8903717578961645
nature,18,2.8903717578961645
require,18,2.8903717578961645
applied,18,2.8903717578961645
promising,18,2.8903717578961645
Myocardial,18,2.8903717578961645
technique,18,2.8903717578961645
male,18,2.8903717578961645
combined,17,2.833213344056216
vitro,17,2.833213344056216
nucleic,17,2.833213344056216
urgent,17,2.833213344056216
rise,17,2.833213344056216
susceptible,17,2.833213344056216
Wuhan,17,2.833213344056216
interest,17,2.833213344056216
pandemics,17,2.833213344056216
convalescent,17,2.833213344056216
Several,17,2.833213344056216
underwent,17,2.833213344056216
36,17,2.833213344056216
independent,17,2.833213344056216
cellular,17,2.833213344056216
immunization,17,2.833213344056216
waves,17,2.833213344056216
allow,17,2.833213344056216
examination,17,2.833213344056216
load,17,2.833213344056216
surgical,17,2.833213344056216
goal,17,2.833213344056216
way,17,2.833213344056216
structural,17,2.833213344056216
April,17,2.833213344056216
play,17,2.833213344056216
compare,17,2.833213344056216
infarctions,17,2.833213344056216
targets,17,2.833213344056216
Using,17,2.833213344056216
awareness,17,2.833213344056216
dementia,17,2.833213344056216
later,17,2.833213344056216
usually,17,2.833213344056216
simple,17,2.833213344056216
serious,17,2.833213344056216
QRS,17,2.833213344056216
event,17,2.833213344056216
concentration,17,2.833213344056216
hospitalizations,17,2.833213344056216
affect,17,2.833213344056216
Q,17,2.833213344056216
28,17,2.833213344056216
FeNO,17,2.833213344056216
prediction,17,2.833213344056216
complicated,17,2.833213344056216
sought,17,2.833213344056216
antivirals,17,2.833213344056216
80,17,2.833213344056216
point,17,2.833213344056216
rats,17,2.833213344056216
modified,17,2.833213344056216
administration,16,2.772588722239781
sequencing,16,2.772588722239781
challenges,16,2.772588722239781
marked,16,2.772588722239781
adherence,16,2.772588722239781
sex,16,2.772588722239781
progress,16,2.772588722239781
shows,16,2.772588722239781
I,16,2.772588722239781
mg,16,2.772588722239781
activation,16,2.772588722239781
consecutive,16,2.772588722239781
impaired,16,2.772588722239781
attacks,16,2.772588722239781
tomography,16,2.772588722239781
questions,16,2.772588722239781
TIA,16,2.772588722239781
prophylaxis,16,2.772588722239781
T,16,2.772588722239781
search,16,2.772588722239781
varied,16,2.772588722239781
programs,16,2.772588722239781
18,16,2.772588722239781
questionnaire,16,2.772588722239781
high-risk,16,2.772588722239781
biomarkers,16,2.772588722239781
state,16,2.772588722239781
Further,16,2.772588722239781
World,16,2.772588722239781
single,16,2.772588722239781
reliable,16,2.772588722239781
eg,16,2.772588722239781
central,16,2.772588722239781
significance,16,2.772588722239781
proposed,16,2.772588722239781
excess,16,2.772588722239781
predictive,16,2.772588722239781
38,16,2.772588722239781
developing,16,2.772588722239781
participants,16,2.772588722239781
measurements,16,2.772588722239781
cost,16,2.772588722239781
fully,16,2.772588722239781
variability,16,2.772588722239781
conventional,16,2.772588722239781
produced,16,2.772588722239781
family,16,2.772588722239781
international,16,2.772588722239781
corresponding,16,2.772588722239781
tools,16,2.772588722239781
pregnancy,16,2.772588722239781
suitable,16,2.772588722239781
inform,16,2.772588722239781
structure,16,2.772588722239781
medicine,16,2.772588722239781
expected,16,2.772588722239781
good,15,2.70805020110221
Because,15,2.70805020110221
existing,15,2.70805020110221
special,15,2.70805020110221
intracranial,15,2.70805020110221
psychological,15,2.70805020110221
degree,15,2.70805020110221
techniques,15,2.70805020110221
survivors,15,2.70805020110221
pathology,15,2.70805020110221
activator,15,2.70805020110221
II,15,2.70805020110221
axis,15,2.70805020110221
calculated,15,2.70805020110221
structures,15,2.70805020110221
means,15,2.70805020110221
relevant,15,2.70805020110221
upon,15,2.70805020110221
seems,15,2.70805020110221
pediatric,15,2.70805020110221
concerns,15,2.70805020110221
episodes,15,2.70805020110221
curves,15,2.70805020110221
Among,15,2.70805020110221
presenting,15,2.70805020110221
achieved,15,2.70805020110221
accurate,15,2.70805020110221
29,15,2.70805020110221
beliefs,15,2.70805020110221
variant,15,2.70805020110221
prognostic,15,2.70805020110221
explore,15,2.70805020110221
31,15,2.70805020110221
They,15,2.70805020110221
plans,15,2.70805020110221
urban,15,2.70805020110221
nasopharyngeal,15,2.70805020110221
date,15,2.70805020110221
intensity,15,2.70805020110221
2010,15,2.70805020110221
seven,15,2.70805020110221
longer,15,2.70805020110221
cytokines,15,2.70805020110221
needs,15,2.70805020110221
child,15,2.70805020110221
More,15,2.70805020110221
region,15,2.70805020110221
relation,15,2.70805020110221
vaccinated,15,2.70805020110221
includes,15,2.70805020110221
variation,15,2.70805020110221
antigen,15,2.70805020110221
safe,15,2.70805020110221
aims,15,2.70805020110221
century,15,2.70805020110221
reverse,15,2.70805020110221
Recent,15,2.70805020110221
cumulative,15,2.70805020110221
introduction,15,2.70805020110221
March,15,2.70805020110221
resistance,15,2.70805020110221
r,15,2.70805020110221
nine,14,2.6390573296152584
LV,14,2.6390573296152584
physician,14,2.6390573296152584
isolates,14,2.6390573296152584
variations,14,2.6390573296152584
ms,14,2.6390573296152584
plasminogen,14,2.6390573296152584
consequences,14,2.6390573296152584
PEFR,14,2.6390573296152584
duration,14,2.6390573296152584
IAV,14,2.6390573296152584
experimental,14,2.6390573296152584
threat,14,2.6390573296152584
aortic,14,2.6390573296152584
what,14,2.6390573296152584
fatal,14,2.6390573296152584
larger,14,2.6390573296152584
carried,14,2.6390573296152584
analyze,14,2.6390573296152584
35,14,2.6390573296152584
influenced,14,2.6390573296152584
fever,14,2.6390573296152584
fusion,14,2.6390573296152584
insights,14,2.6390573296152584
inhalation,14,2.6390573296152584
hypothesis,14,2.6390573296152584
patterns,14,2.6390573296152584
regional,14,2.6390573296152584
initiation,14,2.6390573296152584
median,14,2.6390573296152584
May,14,2.6390573296152584
FEV1,14,2.6390573296152584
monitor,14,2.6390573296152584
SARS-CoV,14,2.6390573296152584
Medical,14,2.6390573296152584
saliva,14,2.6390573296152584
pattern,14,2.6390573296152584
states,14,2.6390573296152584
hand,14,2.6390573296152584
repair,14,2.6390573296152584
availability,14,2.6390573296152584
spontaneous,14,2.6390573296152584
entry,14,2.6390573296152584
establish,14,2.6390573296152584
minor,14,2.6390573296152584
prospective,14,2.6390573296152584
release,14,2.6390573296152584
whole,14,2.6390573296152584
administered,14,2.6390573296152584
While,14,2.6390573296152584
33,14,2.6390573296152584
next,14,2.6390573296152584
measure,14,2.6390573296152584
students,14,2.6390573296152584
absence,14,2.6390573296152584
consistent,14,2.6390573296152584
toward,14,2.6390573296152584
coronaviruses,14,2.6390573296152584
surface,14,2.6390573296152584
Clinical,14,2.6390573296152584
coronavirus-2,14,2.6390573296152584
lacunar,14,2.6390573296152584
focused,14,2.6390573296152584
susceptibility,14,2.6390573296152584
circulating,14,2.6390573296152584
demonstrate,14,2.6390573296152584
reviews,14,2.6390573296152584
closely,14,2.6390573296152584
follow,14,2.6390573296152584
70,14,2.6390573296152584
address,14,2.6390573296152584
millions,14,2.6390573296152584
operation,14,2.6390573296152584
PEF,14,2.6390573296152584
23,14,2.6390573296152584
lesion,14,2.6390573296152584
prevalent,14,2.6390573296152584
side,14,2.6390573296152584
mice,14,2.6390573296152584
immediate,14,2.6390573296152584
circulation,14,2.6390573296152584
American,14,2.6390573296152584
recognized,14,2.6390573296152584
plan,14,2.6390573296152584
complete,14,2.6390573296152584
airflow,14,2.6390573296152584
For,14,2.6390573296152584
growth,14,2.6390573296152584
targeting,14,2.6390573296152584
wide,14,2.6390573296152584
elevated,14,2.6390573296152584
chain,14,2.6390573296152584
communication,14,2.6390573296152584
ill,14,2.6390573296152584
CAM,14,2.6390573296152584
avian,14,2.6390573296152584
proven,13,2.5649493574615367
appear,13,2.5649493574615367
location,13,2.5649493574615367
man,13,2.5649493574615367
transplantation,13,2.5649493574615367
agent,13,2.5649493574615367
AF,13,2.5649493574615367
services,13,2.5649493574615367
close,13,2.5649493574615367
appears,13,2.5649493574615367
75,13,2.5649493574615367
investigations,13,2.5649493574615367
reference,13,2.5649493574615367
aphasia,13,2.5649493574615367
allows,13,2.5649493574615367
odds,13,2.5649493574615367
percentage,13,2.5649493574615367
achieve,13,2.5649493574615367
growing,13,2.5649493574615367
Scale,13,2.5649493574615367
32,13,2.5649493574615367
capacity,13,2.5649493574615367
contrast,13,2.5649493574615367
increasingly,13,2.5649493574615367
domain,13,2.5649493574615367
2019-nCoV,13,2.5649493574615367
Coronary,13,2.5649493574615367
facilities,13,2.5649493574615367
men,13,2.5649493574615367
ARDS,13,2.5649493574615367
guide,13,2.5649493574615367
live,13,2.5649493574615367
005,13,2.5649493574615367
substantial,13,2.5649493574615367
whose,13,2.5649493574615367
ST-segment,13,2.5649493574615367
Control,13,2.5649493574615367
Prevention,13,2.5649493574615367
treating,13,2.5649493574615367
evolution,13,2.5649493574615367
markers,13,2.5649493574615367
Overall,13,2.5649493574615367
delivery,13,2.5649493574615367
coverage,13,2.5649493574615367
EVT,13,2.5649493574615367
enrolled,13,2.5649493574615367
visits,13,2.5649493574615367
magnetic,13,2.5649493574615367
oxygen,13,2.5649493574615367
Due,13,2.5649493574615367
ED,13,2.5649493574615367
stable,13,2.5649493574615367
treat,13,2.5649493574615367
fall,13,2.5649493574615367
dust,13,2.5649493574615367
intervals,13,2.5649493574615367
atopic,13,2.5649493574615367
improving,13,2.5649493574615367
records,13,2.5649493574615367
European,13,2.5649493574615367
implementation,13,2.5649493574615367
until,13,2.5649493574615367
Results,13,2.5649493574615367
stages,13,2.5649493574615367
resources,13,2.5649493574615367
noted,13,2.5649493574615367
0,13,2.5649493574615367
unstable,13,2.5649493574615367
consider,13,2.5649493574615367
heterogeneity,13,2.5649493574615367
terms,13,2.5649493574615367
behavioral,13,2.5649493574615367
view,13,2.5649493574615367
functions,13,2.5649493574615367
continued,13,2.5649493574615367
meta-analysis,13,2.5649493574615367
expressed,13,2.5649493574615367
participation,13,2.5649493574615367
resonance,13,2.5649493574615367
declared,13,2.5649493574615367
IL-6,13,2.5649493574615367
26,13,2.5649493574615367
professionals,13,2.5649493574615367
±,13,2.5649493574615367
therefore,13,2.5649493574615367
cutoff,13,2.5649493574615367
requires,13,2.5649493574615367
variable,13,2.5649493574615367
Acute,13,2.5649493574615367
field,13,2.5649493574615367
short-term,13,2.5649493574615367
42,13,2.5649493574615367
vivo,13,2.5649493574615367
WHO,12,2.4849066497880004
VE,12,2.4849066497880004
situation,12,2.4849066497880004
facilitate,12,2.4849066497880004
describes,12,2.4849066497880004
MR,12,2.4849066497880004
preparedness,12,2.4849066497880004
network,12,2.4849066497880004
formation,12,2.4849066497880004
June,12,2.4849066497880004
250,12,2.4849066497880004
objectives,12,2.4849066497880004
probably,12,2.4849066497880004
in-hospital,12,2.4849066497880004
echo,12,2.4849066497880004
Emergency,12,2.4849066497880004
infarct-related,12,2.4849066497880004
H1N1pdm09,12,2.4849066497880004
mental,12,2.4849066497880004
characteristic,12,2.4849066497880004
critically,12,2.4849066497880004
candidate,12,2.4849066497880004
amount,12,2.4849066497880004
programme,12,2.4849066497880004
suggests,12,2.4849066497880004
adjusted,12,2.4849066497880004
concentrations,12,2.4849066497880004
peripheral,12,2.4849066497880004
finding,12,2.4849066497880004
agreement,12,2.4849066497880004
his,12,2.4849066497880004
Three,12,2.4849066497880004
crucial,12,2.4849066497880004
every,12,2.4849066497880004
UEMI,12,2.4849066497880004
exacerbation,12,2.4849066497880004
interactions,12,2.4849066497880004
Chinese,12,2.4849066497880004
understood,12,2.4849066497880004
taking,12,2.4849066497880004
able,12,2.4849066497880004
rather,12,2.4849066497880004
maximum,12,2.4849066497880004
progressive,12,2.4849066497880004
swab,12,2.4849066497880004
already,12,2.4849066497880004
lungs,12,2.4849066497880004
deep,12,2.4849066497880004
newly,12,2.4849066497880004
animals,12,2.4849066497880004
block,12,2.4849066497880004
extensive,12,2.4849066497880004
If,12,2.4849066497880004
interaction,12,2.4849066497880004
January,12,2.4849066497880004
t-PA,12,2.4849066497880004
large-scale,12,2.4849066497880004
HDAC1,12,2.4849066497880004
propose,12,2.4849066497880004
Current,12,2.4849066497880004
HA,12,2.4849066497880004
regard,12,2.4849066497880004
unique,12,2.4849066497880004
receiving,12,2.4849066497880004
staff,12,2.4849066497880004
Severe,12,2.4849066497880004
Respiratory,12,2.4849066497880004
discharged,12,2.4849066497880004
22,12,2.4849066497880004
another,12,2.4849066497880004
pathways,12,2.4849066497880004
service,12,2.4849066497880004
vital,12,2.4849066497880004
summarize,12,2.4849066497880004
density,12,2.4849066497880004
posterior,12,2.4849066497880004
2021,12,2.4849066497880004
balloon,12,2.4849066497880004
February,12,2.4849066497880004
beneficial,12,2.4849066497880004
allergen,12,2.4849066497880004
III,12,2.4849066497880004
movements,12,2.4849066497880004
circadian,12,2.4849066497880004
recurrence,12,2.4849066497880004
validated,12,2.4849066497880004
poorly,12,2.4849066497880004
maximal,12,2.4849066497880004
sputum,12,2.4849066497880004
wheezing,12,2.4849066497880004
except,12,2.4849066497880004
Mb,12,2.4849066497880004
confirm,12,2.4849066497880004
vessel,12,2.4849066497880004
medications,12,2.4849066497880004
systolic,11,2.3978952727983707
protease,11,2.3978952727983707
room,11,2.3978952727983707
thrombectomy,11,2.3978952727983707
decades,11,2.3978952727983707
polymerase,11,2.3978952727983707
sequence,11,2.3978952727983707
CK,11,2.3978952727983707
Both,11,2.3978952727983707
articles,11,2.3978952727983707
suggesting,11,2.3978952727983707
delays,11,2.3978952727983707
source,11,2.3978952727983707
assessing,11,2.3978952727983707
72,11,2.3978952727983707
itself,11,2.3978952727983707
logistic,11,2.3978952727983707
computed,11,2.3978952727983707
SARS-CoV2,11,2.3978952727983707
occurring,11,2.3978952727983707
magnitude,11,2.3978952727983707
standardized,11,2.3978952727983707
determining,11,2.3978952727983707
changing,11,2.3978952727983707
short,11,2.3978952727983707
predominant,11,2.3978952727983707
healthy,11,2.3978952727983707
cycle,11,2.3978952727983707
infarcts,11,2.3978952727983707
choice,11,2.3978952727983707
detecting,11,2.3978952727983707
line,11,2.3978952727983707
subtypes,11,2.3978952727983707
opportunity,11,2.3978952727983707
relapse,11,2.3978952727983707
policy,11,2.3978952727983707
make,11,2.3978952727983707
female,11,2.3978952727983707
thrombotic,11,2.3978952727983707
min,11,2.3978952727983707
membrane,11,2.3978952727983707
genomes,11,2.3978952727983707
subtype,11,2.3978952727983707
none,11,2.3978952727983707
acceptable,11,2.3978952727983707
planning,11,2.3978952727983707
branch,11,2.3978952727983707
randomized,11,2.3978952727983707
predicting,11,2.3978952727983707
passive,11,2.3978952727983707
renal,11,2.3978952727983707
class,11,2.3978952727983707
30-day,11,2.3978952727983707
improves,11,2.3978952727983707
undergoing,11,2.3978952727983707
guidance,11,2.3978952727983707
defects,11,2.3978952727983707
Zealand,11,2.3978952727983707
initiated,11,2.3978952727983707
project,11,2.3978952727983707
strongly,11,2.3978952727983707
When,11,2.3978952727983707
requiring,11,2.3978952727983707
remaining,11,2.3978952727983707
emotional,11,2.3978952727983707
CFR,11,2.3978952727983707
stratification,11,2.3978952727983707
targeted,11,2.3978952727983707
behaviors,11,2.3978952727983707
detailed,11,2.3978952727983707
comparing,11,2.3978952727983707
does,11,2.3978952727983707
component,11,2.3978952727983707
generally,11,2.3978952727983707
N,11,2.3978952727983707
predictors,11,2.3978952727983707
sentinel,11,2.3978952727983707
reperfused,11,2.3978952727983707
independently,11,2.3978952727983707
prescribed,11,2.3978952727983707
effectively,11,2.3978952727983707
ranging,11,2.3978952727983707
set,11,2.3978952727983707
context,11,2.3978952727983707
tract,11,2.3978952727983707
transport,11,2.3978952727983707
upper,11,2.3978952727983707
involving,11,2.3978952727983707
life-threatening,11,2.3978952727983707
implications,11,2.3978952727983707
embolism,11,2.3978952727983707
causing,11,2.3978952727983707
H5N1,11,2.3978952727983707
numbers,11,2.3978952727983707
preventive,11,2.3978952727983707
determination,11,2.3978952727983707
Compared,11,2.3978952727983707
comparable,11,2.3978952727983707
scale,11,2.3978952727983707
delayed,11,2.3978952727983707
continues,11,2.3978952727983707
technologies,11,2.3978952727983707
plays,11,2.3978952727983707
depending,11,2.3978952727983707
2011,11,2.3978952727983707
advances,11,2.3978952727983707
department,11,2.3978952727983707
thrombus,11,2.3978952727983707
eight,11,2.3978952727983707
Organization,11,2.3978952727983707
Japan,11,2.3978952727983707
ILI,11,2.3978952727983707
validity,11,2.3978952727983707
ST-elevation,11,2.3978952727983707
sequences,11,2.3978952727983707
above,11,2.3978952727983707
diastolic,11,2.3978952727983707
beta,11,2.3978952727983707
parents,11,2.3978952727983707
affecting,11,2.3978952727983707
forms,11,2.3978952727983707
providers,10,2.302585092994046
magnesium,10,2.302585092994046
learning,10,2.302585092994046
Italy,10,2.302585092994046
comparative,10,2.302585092994046
communities,10,2.302585092994046
conclude,10,2.302585092994046
Korea,10,2.302585092994046
beginning,10,2.302585092994046
adequate,10,2.302585092994046
positivity,10,2.302585092994046
affects,10,2.302585092994046
possibly,10,2.302585092994046
technology,10,2.302585092994046
globally,10,2.302585092994046
imported,10,2.302585092994046
repeated,10,2.302585092994046
44,10,2.302585092994046
base,10,2.302585092994046
necrosis,10,2.302585092994046
Auckland,10,2.302585092994046
1918,10,2.302585092994046
By,10,2.302585092994046
earlier,10,2.302585092994046
uncontrolled,10,2.302585092994046
physiological,10,2.302585092994046
equal,10,2.302585092994046
dominant,10,2.302585092994046
practitioners,10,2.302585092994046
D614G,10,2.302585092994046
2015,10,2.302585092994046
evaluating,10,2.302585092994046
like,10,2.302585092994046
crisis,10,2.302585092994046
limitations,10,2.302585092994046
ages,10,2.302585092994046
placebo,10,2.302585092994046
adaptation,10,2.302585092994046
anticoagulants,10,2.302585092994046
August,10,2.302585092994046
Also,10,2.302585092994046
thereby,10,2.302585092994046
Moreover,10,2.302585092994046
throughout,10,2.302585092994046
pranlukast,10,2.302585092994046
ventriculography,10,2.302585092994046
immunoglobulin,10,2.302585092994046
cytokine,10,2.302585092994046
species,10,2.302585092994046
selection,10,2.302585092994046
potentials,10,2.302585092994046
eligible,10,2.302585092994046
45,10,2.302585092994046
threshold,10,2.302585092994046
risks,10,2.302585092994046
resistant,10,2.302585092994046
histamine,10,2.302585092994046
obstructive,10,2.302585092994046
country,10,2.302585092994046
C,10,2.302585092994046
emphasis,10,2.302585092994046
sources,10,2.302585092994046
great,10,2.302585092994046
Management,10,2.302585092994046
serve,10,2.302585092994046
fact,10,2.302585092994046
teaching,10,2.302585092994046
PCI,10,2.302585092994046
exposed,10,2.302585092994046
assist,10,2.302585092994046
influences,10,2.302585092994046
clearance,10,2.302585092994046
priority,10,2.302585092994046
efficient,10,2.302585092994046
billion,10,2.302585092994046
Canada,10,2.302585092994046
points,10,2.302585092994046
periods,10,2.302585092994046
presents,10,2.302585092994046
specifically,10,2.302585092994046
transcription,10,2.302585092994046
device,10,2.302585092994046
residents,10,2.302585092994046
reduces,10,2.302585092994046
rupture,10,2.302585092994046
oxide,10,2.302585092994046
intrinsic,10,2.302585092994046
relevance,10,2.302585092994046
serological,10,2.302585092994046
genomic,10,2.302585092994046
seizures,10,2.302585092994046
third,10,2.302585092994046
RI,10,2.302585092994046
efficiency,10,2.302585092994046
regulatory,10,2.302585092994046
pathological,10,2.302585092994046
neuraminidase,10,2.302585092994046
etiology,10,2.302585092994046
successfully,10,2.302585092994046
production,10,2.302585092994046
CoV,10,2.302585092994046
sleep,10,2.302585092994046
offers,10,2.302585092994046
widespread,10,2.302585092994046
PTCA,10,2.302585092994046
woman,10,2.302585092994046
indications,10,2.302585092994046
serial,10,2.302585092994046
possibility,10,2.302585092994046
favorable,10,2.302585092994046
drift,10,2.302585092994046
occurs,10,2.302585092994046
always,10,2.302585092994046
done,10,2.302585092994046
completely,10,2.302585092994046
derived,10,2.302585092994046
options,10,2.302585092994046
summarizes,10,2.302585092994046
characterization,10,2.302585092994046
offer,10,2.302585092994046
step,10,2.302585092994046
completed,10,2.302585092994046
201112,10,2.302585092994046
profile,10,2.302585092994046
explored,10,2.302585092994046
MoCA,10,2.302585092994046
educational,10,2.302585092994046
fatality,10,2.302585092994046
therapeutics,10,2.302585092994046
decline,10,2.302585092994046
curve,10,2.302585092994046
55,10,2.302585092994046
aggressive,10,2.302585092994046
invasive,10,2.302585092994046
noninvasive,10,2.302585092994046
recommend,10,2.302585092994046
skin,10,2.302585092994046
manner,10,2.302585092994046
indirect,10,2.302585092994046
53,10,2.302585092994046
goals,10,2.302585092994046
nitric,10,2.302585092994046
cysteine,9,2.1972245773362196
weight,9,2.1972245773362196
explain,9,2.1972245773362196
27,9,2.1972245773362196
question,9,2.1972245773362196
CDC,9,2.1972245773362196
hyperventilation,9,2.1972245773362196
71,9,2.1972245773362196
lowest,9,2.1972245773362196
reporting,9,2.1972245773362196
accounted,9,2.1972245773362196
Herein,9,2.1972245773362196
46,9,2.1972245773362196
September,9,2.1972245773362196
Future,9,2.1972245773362196
cancer,9,2.1972245773362196
sickle,9,2.1972245773362196
AH3N2,9,2.1972245773362196
shedding,9,2.1972245773362196
59,9,2.1972245773362196
race,9,2.1972245773362196
congestive,9,2.1972245773362196
schools,9,2.1972245773362196
immunisation,9,2.1972245773362196
pectoris,9,2.1972245773362196
speed,9,2.1972245773362196
speech,9,2.1972245773362196
toxicity,9,2.1972245773362196
concluded,9,2.1972245773362196
statin,9,2.1972245773362196
arrhythmias,9,2.1972245773362196
limitation,9,2.1972245773362196
members,9,2.1972245773362196
inhibition,9,2.1972245773362196
pooled,9,2.1972245773362196
99,9,2.1972245773362196
distress,9,2.1972245773362196
declined,9,2.1972245773362196
classified,9,2.1972245773362196
prompt,9,2.1972245773362196
Within,9,2.1972245773362196
loss,9,2.1972245773362196
responsiveness,9,2.1972245773362196
traditional,9,2.1972245773362196
sST2,9,2.1972245773362196
creatine,9,2.1972245773362196
viable,9,2.1972245773362196
Finally,9,2.1972245773362196
Aims,9,2.1972245773362196
slightly,9,2.1972245773362196
organs,9,2.1972245773362196
list,9,2.1972245773362196
considerable,9,2.1972245773362196
workers,9,2.1972245773362196
mellitus,9,2.1972245773362196
syndromes,9,2.1972245773362196
distancing,9,2.1972245773362196
blue,9,2.1972245773362196
involves,9,2.1972245773362196
likelihood,9,2.1972245773362196
trend,9,2.1972245773362196
anti-SARS-CoV-2,9,2.1972245773362196
disease-2019,9,2.1972245773362196
campaign,9,2.1972245773362196
37,9,2.1972245773362196
polymorphisms,9,2.1972245773362196
vessels,9,2.1972245773362196
manifestations,9,2.1972245773362196
IgM,9,2.1972245773362196
clarify,9,2.1972245773362196
HCP,9,2.1972245773362196
basic,9,2.1972245773362196
62,9,2.1972245773362196
discovered,9,2.1972245773362196
stenting,9,2.1972245773362196
Study,9,2.1972245773362196
immediately,9,2.1972245773362196
PC,9,2.1972245773362196
components,9,2.1972245773362196
specialist,9,2.1972245773362196
easily,9,2.1972245773362196
statistical,9,2.1972245773362196
replication,9,2.1972245773362196
serology,9,2.1972245773362196
gain,9,2.1972245773362196
maternal,9,2.1972245773362196
media,9,2.1972245773362196
IV,9,2.1972245773362196
peptide,9,2.1972245773362196
concerning,9,2.1972245773362196
consensus,9,2.1972245773362196
EIA,9,2.1972245773362196
fewer,9,2.1972245773362196
image,9,2.1972245773362196
respect,9,2.1972245773362196
mm,9,2.1972245773362196
Hg,9,2.1972245773362196
unchanged,9,2.1972245773362196
automated,9,2.1972245773362196
utility,9,2.1972245773362196
56,9,2.1972245773362196
movement,9,2.1972245773362196
pathogenic,9,2.1972245773362196
prehospital,9,2.1972245773362196
circulatory,9,2.1972245773362196
collection,9,2.1972245773362196
hemodynamic,9,2.1972245773362196
rest,9,2.1972245773362196
sera,9,2.1972245773362196
trends,9,2.1972245773362196
avoid,9,2.1972245773362196
ICH,9,2.1972245773362196
ongoing,9,2.1972245773362196
mother,9,2.1972245773362196
remodelling,9,2.1972245773362196
remission,9,2.1972245773362196
consideration,9,2.1972245773362196
signaling,9,2.1972245773362196
volumes,9,2.1972245773362196
Hospital,9,2.1972245773362196
non-invasive,9,2.1972245773362196
modalities,9,2.1972245773362196
HRV,9,2.1972245773362196
timing,9,2.1972245773362196
regular,9,2.1972245773362196
hemorrhagic,9,2.1972245773362196
far,9,2.1972245773362196
phenomenon,9,2.1972245773362196
41,9,2.1972245773362196
cats,9,2.1972245773362196
ferrets,9,2.1972245773362196
advantages,9,2.1972245773362196
Recently,9,2.1972245773362196
continuous,9,2.1972245773362196
highlight,9,2.1972245773362196
titers,9,2.1972245773362196
2007,9,2.1972245773362196
definitions,9,2.1972245773362196
clearly,9,2.1972245773362196
conjunctivitis,9,2.1972245773362196
matter,9,2.1972245773362196
approval,9,2.1972245773362196
definition,9,2.1972245773362196
antihypertensive,9,2.1972245773362196
units,9,2.1972245773362196
demographic,9,2.1972245773362196
numerous,9,2.1972245773362196
aware,9,2.1972245773362196
DNA,9,2.1972245773362196
measurement,9,2.1972245773362196
cardiopulmonary,9,2.1972245773362196
reasons,9,2.1972245773362196
define,9,2.1972245773362196
decision,9,2.1972245773362196
Journal,9,2.1972245773362196
organ,9,2.1972245773362196
ward,9,2.1972245773362196
thoracic,9,2.1972245773362196
represent,9,2.1972245773362196
statistically,9,2.1972245773362196
attenuated,9,2.1972245773362196
remote,9,2.1972245773362196
electrocardiogram,9,2.1972245773362196
molecules,9,2.1972245773362196
85,9,2.1972245773362196
middle,9,2.1972245773362196
October,9,2.1972245773362196
swabs,9,2.1972245773362196
open,9,2.1972245773362196
along,9,2.1972245773362196
raised,9,2.1972245773362196
BMI,9,2.1972245773362196
nursing,9,2.1972245773362196
post,8,2.0794415416798357
ash,8,2.0794415416798357
pharmaceutical,8,2.0794415416798357
discovery,8,2.0794415416798357
utilization,8,2.0794415416798357
give,8,2.0794415416798357
detrimental,8,2.0794415416798357
uses,8,2.0794415416798357
Centers,8,2.0794415416798357
makes,8,2.0794415416798357
encountered,8,2.0794415416798357
associations,8,2.0794415416798357
TIMI,8,2.0794415416798357
vulnerable,8,2.0794415416798357
limit,8,2.0794415416798357
strong,8,2.0794415416798357
anti-inflammatory,8,2.0794415416798357
exhaled,8,2.0794415416798357
survived,8,2.0794415416798357
evidence-based,8,2.0794415416798357
challenging,8,2.0794415416798357
participated,8,2.0794415416798357
hyperresponsiveness,8,2.0794415416798357
antibiotics,8,2.0794415416798357
laboratory-confirmed,8,2.0794415416798357
us,8,2.0794415416798357
northern,8,2.0794415416798357
H1N1pdm,8,2.0794415416798357
approved,8,2.0794415416798357
commercial,8,2.0794415416798357
two-dimensional,8,2.0794415416798357
center,8,2.0794415416798357
69,8,2.0794415416798357
Four,8,2.0794415416798357
highlights,8,2.0794415416798357
methodology,8,2.0794415416798357
infants,8,2.0794415416798357
mediators,8,2.0794415416798357
mannitol,8,2.0794415416798357
ensure,8,2.0794415416798357
profiles,8,2.0794415416798357
cough,8,2.0794415416798357
dependent,8,2.0794415416798357
Africa,8,2.0794415416798357
mostly,8,2.0794415416798357
reflux,8,2.0794415416798357
allergens,8,2.0794415416798357
wood,8,2.0794415416798357
categories,8,2.0794415416798357
observational,8,2.0794415416798357
reflects,8,2.0794415416798357
initially,8,2.0794415416798357
angiographic,8,2.0794415416798357
youth,8,2.0794415416798357
Infarction,8,2.0794415416798357
eosinophil,8,2.0794415416798357
viability,8,2.0794415416798357
uptake,8,2.0794415416798357
instruction,8,2.0794415416798357
89,8,2.0794415416798357
cross-sectional,8,2.0794415416798357
scenarios,8,2.0794415416798357
became,8,2.0794415416798357
images,8,2.0794415416798357
July,8,2.0794415416798357
feasibility,8,2.0794415416798357
suffering,8,2.0794415416798357
Global,8,2.0794415416798357
steps,8,2.0794415416798357
imagery,8,2.0794415416798357
sometimes,8,2.0794415416798357
Turkey,8,2.0794415416798357
diagnostics,8,2.0794415416798357
real,8,2.0794415416798357
Based,8,2.0794415416798357
matrix,8,2.0794415416798357
T-wave,8,2.0794415416798357
reversible,8,2.0794415416798357
origin,8,2.0794415416798357
category,8,2.0794415416798357
AH5N1,8,2.0794415416798357
place,8,2.0794415416798357
simulation,8,2.0794415416798357
perceptions,8,2.0794415416798357
exposures,8,2.0794415416798357
venous,8,2.0794415416798357
lives,8,2.0794415416798357
inactivated,8,2.0794415416798357
segments,8,2.0794415416798357
actual,8,2.0794415416798357
contribution,8,2.0794415416798357
degrees,8,2.0794415416798357
brief,8,2.0794415416798357
products,8,2.0794415416798357
pretreatment,8,2.0794415416798357
marker,8,2.0794415416798357
warfarin,8,2.0794415416798357
fluid,8,2.0794415416798357
represents,8,2.0794415416798357
controlling,8,2.0794415416798357
CCC,8,2.0794415416798357
temporal,8,2.0794415416798357
responsive,8,2.0794415416798357
platforms,8,2.0794415416798357
residual,8,2.0794415416798357
Diagnosis,8,2.0794415416798357
becoming,8,2.0794415416798357
indicating,8,2.0794415416798357
issues,8,2.0794415416798357
61,8,2.0794415416798357
modification,8,2.0794415416798357
hence,8,2.0794415416798357
nAbs,8,2.0794415416798357
phenotypes,8,2.0794415416798357
post-stroke,8,2.0794415416798357
WUS,8,2.0794415416798357
issue,8,2.0794415416798357
all-cause,8,2.0794415416798357
dynamic,8,2.0794415416798357
families,8,2.0794415416798357
high-throughput,8,2.0794415416798357
SNP,8,2.0794415416798357
representing,8,2.0794415416798357
substantially,8,2.0794415416798357
her,8,2.0794415416798357
clinic,8,2.0794415416798357
focuses,8,2.0794415416798357
skills,8,2.0794415416798357
free,8,2.0794415416798357
uncomplicated,8,2.0794415416798357
here,8,2.0794415416798357
point-of-care,8,2.0794415416798357
defect,8,2.0794415416798357
Early,8,2.0794415416798357
possibilities,8,2.0794415416798357
decisions,8,2.0794415416798357
clinicians,8,2.0794415416798357
devastating,8,2.0794415416798357
paediatric,8,2.0794415416798357
87,8,2.0794415416798357
From,8,2.0794415416798357
indoor,8,2.0794415416798357
bleeding,8,2.0794415416798357
directed,8,2.0794415416798357
longitudinal,8,2.0794415416798357
supports,8,2.0794415416798357
Use,8,2.0794415416798357
neutralization,8,2.0794415416798357
induce,8,2.0794415416798357
tobacco,8,2.0794415416798357
spectrum,8,2.0794415416798357
adopted,8,2.0794415416798357
causal,8,2.0794415416798357
attitudes,8,2.0794415416798357
account,8,2.0794415416798357
weekly,8,2.0794415416798357
innovative,8,2.0794415416798357
temperature,8,2.0794415416798357
originated,8,2.0794415416798357
injuries,8,2.0794415416798357
helpful,8,2.0794415416798357
nitroglycerin,8,2.0794415416798357
immunological,8,2.0794415416798357
subgroups,8,2.0794415416798357
Over,8,2.0794415416798357
roles,8,2.0794415416798357
prolonged,8,2.0794415416798357
plaque,8,2.0794415416798357
Studies,8,2.0794415416798357
matched,8,2.0794415416798357
neurologic,8,2.0794415416798357
nocturnal,8,2.0794415416798357
43,8,2.0794415416798357
globe,8,2.0794415416798357
involvement,8,2.0794415416798357
spreading,8,2.0794415416798357
receptors,8,2.0794415416798357
distinct,8,2.0794415416798357
64,8,2.0794415416798357
enhance,8,2.0794415416798357
mite,8,2.0794415416798357
lost,8,2.0794415416798357
nurses,8,2.0794415416798357
Heart,8,2.0794415416798357
34,8,2.0794415416798357
deviation,8,2.0794415416798357
weighted,8,2.0794415416798357
month,8,2.0794415416798357
processing,7,1.9459101490553132
bias,7,1.9459101490553132
spatial,7,1.9459101490553132
forced,7,1.9459101490553132
robust,7,1.9459101490553132
light,7,1.9459101490553132
donors,7,1.9459101490553132
researchers,7,1.9459101490553132
diversity,7,1.9459101490553132
improvements,7,1.9459101490553132
EC50,7,1.9459101490553132
start,7,1.9459101490553132
EF,7,1.9459101490553132
know,7,1.9459101490553132
CCP,7,1.9459101490553132
characterize,7,1.9459101490553132
schoolchildren,7,1.9459101490553132
England,7,1.9459101490553132
105,7,1.9459101490553132
introduced,7,1.9459101490553132
referred,7,1.9459101490553132
classic,7,1.9459101490553132
exhibited,7,1.9459101490553132
201213,7,1.9459101490553132
elective,7,1.9459101490553132
cardioembolic,7,1.9459101490553132
representative,7,1.9459101490553132
humoral,7,1.9459101490553132
de,7,1.9459101490553132
Risk,7,1.9459101490553132
undertaken,7,1.9459101490553132
regulation,7,1.9459101490553132
biosolids,7,1.9459101490553132
intention,7,1.9459101490553132
appeared,7,1.9459101490553132
agonists,7,1.9459101490553132
Europeans,7,1.9459101490553132
Six,7,1.9459101490553132
ACT,7,1.9459101490553132
feature,7,1.9459101490553132
alone,7,1.9459101490553132
inside,7,1.9459101490553132
adapted,7,1.9459101490553132
oxidative,7,1.9459101490553132
markedly,7,1.9459101490553132
considerably,7,1.9459101490553132
Toronto,7,1.9459101490553132
quantification,7,1.9459101490553132
detail,7,1.9459101490553132
filling,7,1.9459101490553132
TRUNCATED,7,1.9459101490553132
AT,7,1.9459101490553132
sinus,7,1.9459101490553132
WORDS,7,1.9459101490553132
ACCP,7,1.9459101490553132
yielded,7,1.9459101490553132
elucidate,7,1.9459101490553132
sensitization,7,1.9459101490553132
91,7,1.9459101490553132
barriers,7,1.9459101490553132
psychosocial,7,1.9459101490553132
NAAT,7,1.9459101490553132
66,7,1.9459101490553132
decade,7,1.9459101490553132
elements,7,1.9459101490553132
gap,7,1.9459101490553132
superior,7,1.9459101490553132
valuable,7,1.9459101490553132
exclusion,7,1.9459101490553132
minority,7,1.9459101490553132
requirements,7,1.9459101490553132
differential,7,1.9459101490553132
indicates,7,1.9459101490553132
moderately,7,1.9459101490553132
mediated,7,1.9459101490553132
accompanied,7,1.9459101490553132
IgE,7,1.9459101490553132
ineffective,7,1.9459101490553132
Those,7,1.9459101490553132
specimen,7,1.9459101490553132
database,7,1.9459101490553132
largest,7,1.9459101490553132
AP,7,1.9459101490553132
influenzae,7,1.9459101490553132
CNS,7,1.9459101490553132
details,7,1.9459101490553132
bacterial,7,1.9459101490553132
reliability,7,1.9459101490553132
pathogens,7,1.9459101490553132
hygiene,7,1.9459101490553132
Little,7,1.9459101490553132
procedure,7,1.9459101490553132
similarities,7,1.9459101490553132
ambulance,7,1.9459101490553132
hyperreactivity,7,1.9459101490553132
methacholine,7,1.9459101490553132
grade,7,1.9459101490553132
spontaneously,7,1.9459101490553132
According,7,1.9459101490553132
inclusion,7,1.9459101490553132
Children,7,1.9459101490553132
online,7,1.9459101490553132
devices,7,1.9459101490553132
fold,7,1.9459101490553132
fungi,7,1.9459101490553132
delivered,7,1.9459101490553132
tolerance,7,1.9459101490553132
geographic,7,1.9459101490553132
smoke,7,1.9459101490553132
anxiety,7,1.9459101490553132
applications,7,1.9459101490553132
managing,7,1.9459101490553132
theory,7,1.9459101490553132
transfer,7,1.9459101490553132
COVID,7,1.9459101490553132
coding,7,1.9459101490553132
examining,7,1.9459101490553132
rhythm,7,1.9459101490553132
divided,7,1.9459101490553132
hemorrhage,7,1.9459101490553132
hundred,7,1.9459101490553132
towards,7,1.9459101490553132
biology,7,1.9459101490553132
overview,7,1.9459101490553132
angiogenesis,7,1.9459101490553132
picture,7,1.9459101490553132
clusters,7,1.9459101490553132
arrhythmia,7,1.9459101490553132
principal,7,1.9459101490553132
avoidance,7,1.9459101490553132
AKI,7,1.9459101490553132
chemical,7,1.9459101490553132
protocol,7,1.9459101490553132
pump,7,1.9459101490553132
exercise-induced,7,1.9459101490553132
92,7,1.9459101490553132
conjunction,7,1.9459101490553132
Association,7,1.9459101490553132
attempted,7,1.9459101490553132
mimic,7,1.9459101490553132
era,7,1.9459101490553132
multivariate,7,1.9459101490553132
slow,7,1.9459101490553132
electrocardiographic,7,1.9459101490553132
ambulatory,7,1.9459101490553132
surveys,7,1.9459101490553132
influenza-like,7,1.9459101490553132
amino,7,1.9459101490553132
November,7,1.9459101490553132
synthetic,7,1.9459101490553132
pH1N1,7,1.9459101490553132
principles,7,1.9459101490553132
mismatch,7,1.9459101490553132
conduct,7,1.9459101490553132
obese,7,1.9459101490553132
output,7,1.9459101490553132
topic,7,1.9459101490553132
amantadine,7,1.9459101490553132
former,7,1.9459101490553132
domains,7,1.9459101490553132
focusing,7,1.9459101490553132
careful,7,1.9459101490553132
Pacific,7,1.9459101490553132
thought,7,1.9459101490553132
feasible,7,1.9459101490553132
registry,7,1.9459101490553132
contained,7,1.9459101490553132
prone,7,1.9459101490553132
agencies,7,1.9459101490553132
troponin,7,1.9459101490553132
algorithm,7,1.9459101490553132
rarely,7,1.9459101490553132
Department,7,1.9459101490553132
gastrointestinal,7,1.9459101490553132
Individuals,7,1.9459101490553132
≥,7,1.9459101490553132
doses,7,1.9459101490553132
79,7,1.9459101490553132
congenital,7,1.9459101490553132
Rwanda,7,1.9459101490553132
steroids,7,1.9459101490553132
sexual,7,1.9459101490553132
echocardiographic,7,1.9459101490553132
prophylactic,7,1.9459101490553132
cannot,7,1.9459101490553132
Thrombolysis,7,1.9459101490553132
hemisphere,7,1.9459101490553132
sign,7,1.9459101490553132
enhancing,7,1.9459101490553132
54,7,1.9459101490553132
Time,7,1.9459101490553132
78,7,1.9459101490553132
antithrombotic,7,1.9459101490553132
phases,7,1.9459101490553132
showing,7,1.9459101490553132
anticoagulant,7,1.9459101490553132
CDT,7,1.9459101490553132
recognize,7,1.9459101490553132
radiological,7,1.9459101490553132
recovered,7,1.9459101490553132
proper,7,1.9459101490553132
containment,7,1.9459101490553132
scintigraphy,7,1.9459101490553132
mlm2,7,1.9459101490553132
promote,7,1.9459101490553132
Treatment,7,1.9459101490553132
excellent,7,1.9459101490553132
explanation,7,1.9459101490553132
Epidemiological,7,1.9459101490553132
IS,7,1.9459101490553132
epidemiologic,7,1.9459101490553132
stability,7,1.9459101490553132
Only,7,1.9459101490553132
corticosteroid,7,1.9459101490553132
persist,7,1.9459101490553132
material,7,1.9459101490553132
cortical,7,1.9459101490553132
IL-10,7,1.9459101490553132
find,7,1.9459101490553132
monitored,7,1.9459101490553132
analysed,7,1.9459101490553132
progressing,7,1.9459101490553132
scoring,7,1.9459101490553132
edema,7,1.9459101490553132
mucosal,7,1.9459101490553132
Some,7,1.9459101490553132
CABG,7,1.9459101490553132
immunogenicity,7,1.9459101490553132
health-care,7,1.9459101490553132
apply,7,1.9459101490553132
Currently,7,1.9459101490553132
self-reported,7,1.9459101490553132
perception,7,1.9459101490553132
anatomy,7,1.9459101490553132
Drug,7,1.9459101490553132
organizations,7,1.9459101490553132
Given,7,1.9459101490553132
assigned,7,1.9459101490553132
heterogeneous,7,1.9459101490553132
enzymes,7,1.9459101490553132
laboratories,7,1.9459101490553132
diffuse,7,1.9459101490553132
government,7,1.9459101490553132
97,7,1.9459101490553132
epithelial,7,1.9459101490553132
hypothesized,7,1.9459101490553132
septal,7,1.9459101490553132
supply,7,1.9459101490553132
confirmation,7,1.9459101490553132
debate,7,1.9459101490553132
throat,7,1.9459101490553132
usual,7,1.9459101490553132
causative,7,1.9459101490553132
enhanced,7,1.9459101490553132
microcirculation,7,1.9459101490553132
What,7,1.9459101490553132
linear,7,1.9459101490553132
N-acetyl,7,1.9459101490553132
CVA,7,1.9459101490553132
altered,7,1.9459101490553132
scarce,7,1.9459101490553132
M,7,1.9459101490553132
injection,7,1.9459101490553132
nationwide,7,1.9459101490553132
paraplegia,7,1.9459101490553132
ten,7,1.9459101490553132
comparisons,7,1.9459101490553132
BECH,6,1.791759469228055
thickening,6,1.791759469228055
segmental,6,1.791759469228055
cavity,6,1.791759469228055
PSO,6,1.791759469228055
cell-cell,6,1.791759469228055
panel,6,1.791759469228055
validation,6,1.791759469228055
why,6,1.791759469228055
2003,6,1.791759469228055
correlates,6,1.791759469228055
MVD,6,1.791759469228055
qualitative,6,1.791759469228055
platform,6,1.791759469228055
Germany,6,1.791759469228055
AHT,6,1.791759469228055
Chronic,6,1.791759469228055
instituted,6,1.791759469228055
mitigation,6,1.791759469228055
applying,6,1.791759469228055
hesitancy,6,1.791759469228055
performing,6,1.791759469228055
handling,6,1.791759469228055
Tfh,6,1.791759469228055
resource,6,1.791759469228055
water,6,1.791759469228055
88,6,1.791759469228055
evolving,6,1.791759469228055
Blacks,6,1.791759469228055
practical,6,1.791759469228055
Administration,6,1.791759469228055
create,6,1.791759469228055
accounting,6,1.791759469228055
explained,6,1.791759469228055
revascularization,6,1.791759469228055
Impella,6,1.791759469228055
summary,6,1.791759469228055
optimization,6,1.791759469228055
containing,6,1.791759469228055
preexisting,6,1.791759469228055
composition,6,1.791759469228055
PI,6,1.791759469228055
revised,6,1.791759469228055
poststroke,6,1.791759469228055
intake,6,1.791759469228055
identifies,6,1.791759469228055
eosinophils,6,1.791759469228055
personal,6,1.791759469228055
Australia,6,1.791759469228055
treadmill,6,1.791759469228055
receptor-binding,6,1.791759469228055
2014,6,1.791759469228055
cord,6,1.791759469228055
African,6,1.791759469228055
Between,6,1.791759469228055
worse,6,1.791759469228055
consistency,6,1.791759469228055
determinants,6,1.791759469228055
contemporary,6,1.791759469228055
sufficient,6,1.791759469228055
Veterans,6,1.791759469228055
correctly,6,1.791759469228055
intentions,6,1.791759469228055
observation,6,1.791759469228055
insight,6,1.791759469228055
random,6,1.791759469228055
interference,6,1.791759469228055
Left,6,1.791759469228055
twice,6,1.791759469228055
perceived,6,1.791759469228055
ones,6,1.791759469228055
SARS-CoV-2-specific,6,1.791759469228055
68,6,1.791759469228055
visited,6,1.791759469228055
compound,6,1.791759469228055
maintenance,6,1.791759469228055
selective,6,1.791759469228055
largely,6,1.791759469228055
CHD,6,1.791759469228055
collaboration,6,1.791759469228055
concomitant,6,1.791759469228055
bilateral,6,1.791759469228055
remained,6,1.791759469228055
recovering,6,1.791759469228055
P005,6,1.791759469228055
correlations,6,1.791759469228055
wheeze,6,1.791759469228055
adjusting,6,1.791759469228055
specialists,6,1.791759469228055
breath,6,1.791759469228055
beyond,6,1.791759469228055
consisted,6,1.791759469228055
Assessment,6,1.791759469228055
combinations,6,1.791759469228055
wastewater,6,1.791759469228055
Vaccination,6,1.791759469228055
dry,6,1.791759469228055
differ,6,1.791759469228055
prosocial,6,1.791759469228055
generation,6,1.791759469228055
ICU,6,1.791759469228055
neural,6,1.791759469228055
survive,6,1.791759469228055
soluble,6,1.791759469228055
themselves,6,1.791759469228055
mammalian,6,1.791759469228055
shift,6,1.791759469228055
Accurate,6,1.791759469228055
Many,6,1.791759469228055
nut,6,1.791759469228055
explicit,6,1.791759469228055
Pandemic,6,1.791759469228055
dedicated,6,1.791759469228055
positively,6,1.791759469228055
100000,6,1.791759469228055
International,6,1.791759469228055
SBP,6,1.791759469228055
ligation,6,1.791759469228055
reactivity,6,1.791759469228055
SNPs,6,1.791759469228055
developments,6,1.791759469228055
bronchodilators,6,1.791759469228055
IIV,6,1.791759469228055
suspicion,6,1.791759469228055
aspirin,6,1.791759469228055
respond,6,1.791759469228055
insufficiency,6,1.791759469228055
zone,6,1.791759469228055
making,6,1.791759469228055
usefulness,6,1.791759469228055
Aim,6,1.791759469228055
pathway,6,1.791759469228055
angiotensin-converting,6,1.791759469228055
counts,6,1.791759469228055
forward,6,1.791759469228055
seropositivity,6,1.791759469228055
Iran,6,1.791759469228055
1997,6,1.791759469228055
SF-36,6,1.791759469228055
oropharyngeal,6,1.791759469228055
thrombi,6,1.791759469228055
dyslipidemia,6,1.791759469228055
broad,6,1.791759469228055
incident,6,1.791759469228055
diverse,6,1.791759469228055
near,6,1.791759469228055
CoV-2,6,1.791759469228055
miRNAs,6,1.791759469228055
border,6,1.791759469228055
genotype,6,1.791759469228055
networks,6,1.791759469228055
49,6,1.791759469228055
proliferation,6,1.791759469228055
framework,6,1.791759469228055
gas,6,1.791759469228055
mixed,6,1.791759469228055
aid,6,1.791759469228055
CADASIL,6,1.791759469228055
endothelial,6,1.791759469228055
postinfarction,6,1.791759469228055
RRT,6,1.791759469228055
City,6,1.791759469228055
IgA,6,1.791759469228055
interpretation,6,1.791759469228055
77,6,1.791759469228055
perspective,6,1.791759469228055
WMSI,6,1.791759469228055
Evaluation,6,1.791759469228055
immunized,6,1.791759469228055
located,6,1.791759469228055
monoclonal,6,1.791759469228055
attributable,6,1.791759469228055
hydrogel,6,1.791759469228055
platelet,6,1.791759469228055
discusses,6,1.791759469228055
ECMO,6,1.791759469228055
Such,6,1.791759469228055
running,6,1.791759469228055
warranted,6,1.791759469228055
activated,6,1.791759469228055
background,6,1.791759469228055
Additionally,6,1.791759469228055
triggers,6,1.791759469228055
discussion,6,1.791759469228055
H275Y,6,1.791759469228055
emission,6,1.791759469228055
count,6,1.791759469228055
met,6,1.791759469228055
exist,6,1.791759469228055
formed,6,1.791759469228055
considerations,6,1.791759469228055
urgently,6,1.791759469228055
scanning,6,1.791759469228055
integrated,6,1.791759469228055
neuropsychological,6,1.791759469228055
glycoprotein,6,1.791759469228055
steroid,6,1.791759469228055
contacts,6,1.791759469228055
Mexico,6,1.791759469228055
connected,6,1.791759469228055
sampling,6,1.791759469228055
67,6,1.791759469228055
inverse,6,1.791759469228055
actions,6,1.791759469228055
95CI,6,1.791759469228055
typical,6,1.791759469228055
determinant,6,1.791759469228055
PubMed,6,1.791759469228055
indication,6,1.791759469228055
sequential,6,1.791759469228055
autoimmune,6,1.791759469228055
immunizations,6,1.791759469228055
false,6,1.791759469228055
briefly,6,1.791759469228055
trigger,6,1.791759469228055
arrest,6,1.791759469228055
yen,6,1.791759469228055
3D,6,1.791759469228055
contraction,6,1.791759469228055
Hypertension,6,1.791759469228055
in-person,6,1.791759469228055
fixed,6,1.791759469228055
dissection,6,1.791759469228055
weakness,6,1.791759469228055
FRPs,6,1.791759469228055
severely,6,1.791759469228055
certain,6,1.791759469228055
thousands,6,1.791759469228055
neck,6,1.791759469228055
France,6,1.791759469228055
females,6,1.791759469228055
depends,6,1.791759469228055
Understanding,6,1.791759469228055
randomly,6,1.791759469228055
SD,6,1.791759469228055
ideal,6,1.791759469228055
market,6,1.791759469228055
cleavage,6,1.791759469228055
ELISA,6,1.791759469228055
NA,6,1.791759469228055
face,6,1.791759469228055
accumulation,6,1.791759469228055
fungal,6,1.791759469228055
arrival,6,1.791759469228055
intracerebral,6,1.791759469228055
obtain,6,1.791759469228055
adjustment,6,1.791759469228055
intended,6,1.791759469228055
self-management,6,1.791759469228055
volunteers,6,1.791759469228055
Mac1,6,1.791759469228055
broad-spectrum,6,1.791759469228055
expensive,6,1.791759469228055
intra-arterial,6,1.791759469228055
reach,6,1.791759469228055
nonvalvular,6,1.791759469228055
lowering,6,1.791759469228055
compliance,6,1.791759469228055
postoperative,6,1.791759469228055
behaviour,6,1.791759469228055
take,6,1.791759469228055
enough,6,1.791759469228055
deterioration,6,1.791759469228055
B117,6,1.791759469228055
hypoxia,6,1.791759469228055
paucity,6,1.791759469228055
sustained,6,1.791759469228055
deficit,6,1.791759469228055
dental,6,1.791759469228055
territories,6,1.791759469228055
team,6,1.791759469228055
amplification,6,1.791759469228055
lateral,6,1.791759469228055
permanent,6,1.791759469228055
views,6,1.791759469228055
bind,6,1.791759469228055
accelerated,6,1.791759469228055
birth,6,1.791759469228055
Asia,6,1.791759469228055
patency,6,1.791759469228055
microvascular,6,1.791759469228055
accurately,6,1.791759469228055
methylene,6,1.791759469228055
easy,6,1.791759469228055
inhibitor,6,1.791759469228055
complexes,6,1.791759469228055
myoglobin,6,1.791759469228055
CXR,6,1.791759469228055
NS,6,1.791759469228055
μM,6,1.791759469228055
end-diastolic,6,1.791759469228055
05,6,1.791759469228055
PAI-1,6,1.791759469228055
extensively,6,1.791759469228055
Japanese,6,1.791759469228055
extraction,6,1.791759469228055
b,6,1.791759469228055
coagulation,6,1.791759469228055
probability,6,1.791759469228055
confirms,6,1.791759469228055
continue,6,1.791759469228055
flexible,6,1.791759469228055
2008,6,1.791759469228055
H3N2v,6,1.791759469228055
alterations,6,1.791759469228055
predictor,6,1.791759469228055
advanced,6,1.791759469228055
manage,6,1.791759469228055
H,6,1.791759469228055
counterpulsation,6,1.791759469228055
stroke-related,6,1.791759469228055
internal,6,1.791759469228055
BP,6,1.791759469228055
thyroid,6,1.791759469228055
maintain,6,1.791759469228055
wk,6,1.791759469228055
non-EVT,6,1.791759469228055
hospitalised,6,1.791759469228055
indicators,6,1.791759469228055
Survey,6,1.791759469228055
plus,6,1.791759469228055
creating,6,1.791759469228055
deadly,6,1.791759469228055
science,6,1.791759469228055
started,6,1.791759469228055
Bronchial,6,1.791759469228055
protocols,6,1.791759469228055
transluminal,6,1.791759469228055
localization,6,1.791759469228055
advice,6,1.791759469228055
effort,6,1.791759469228055
biochemical,6,1.791759469228055
pharmacies,6,1.791759469228055
Methods,6,1.791759469228055
placed,6,1.791759469228055
validate,6,1.791759469228055
partial,6,1.791759469228055
soon,5,1.6094379124341003
SHR-A3,5,1.6094379124341003
AUC,5,1.6094379124341003
removed,5,1.6094379124341003
alter,5,1.6094379124341003
generic,5,1.6094379124341003
NP,5,1.6094379124341003
extracellular,5,1.6094379124341003
SCT,5,1.6094379124341003
culture,5,1.6094379124341003
tPA,5,1.6094379124341003
106,5,1.6094379124341003
mixture,5,1.6094379124341003
CKmax,5,1.6094379124341003
Infarct,5,1.6094379124341003
demonstrates,5,1.6094379124341003
SNFs,5,1.6094379124341003
efficacious,5,1.6094379124341003
oseltamivir-resistant,5,1.6094379124341003
pharmacological,5,1.6094379124341003
stockpile,5,1.6094379124341003
well-known,5,1.6094379124341003
VT,5,1.6094379124341003
proximal,5,1.6094379124341003
A-S-C-O,5,1.6094379124341003
apparent,5,1.6094379124341003
reached,5,1.6094379124341003
stimulation,5,1.6094379124341003
kinase,5,1.6094379124341003
America,5,1.6094379124341003
regimens,5,1.6094379124341003
outline,5,1.6094379124341003
integral,5,1.6094379124341003
ablation,5,1.6094379124341003
broadly,5,1.6094379124341003
lipid,5,1.6094379124341003
scan,5,1.6094379124341003
MCE,5,1.6094379124341003
optimize,5,1.6094379124341003
manufacturing,5,1.6094379124341003
H7N9,5,1.6094379124341003
Brain,5,1.6094379124341003
end-systolic,5,1.6094379124341003
2012,5,1.6094379124341003
equipment,5,1.6094379124341003
epicardial,5,1.6094379124341003
yoga,5,1.6094379124341003
Israel,5,1.6094379124341003
Network,5,1.6094379124341003
Surveillance,5,1.6094379124341003
summarized,5,1.6094379124341003
Canadian,5,1.6094379124341003
neurovascular,5,1.6094379124341003
greatest,5,1.6094379124341003
kept,5,1.6094379124341003
perform,5,1.6094379124341003
mgml,5,1.6094379124341003
200,5,1.6094379124341003
neutrophil,5,1.6094379124341003
MVO2,5,1.6094379124341003
played,5,1.6094379124341003
precise,5,1.6094379124341003
PPCI,5,1.6094379124341003
private,5,1.6094379124341003
clinics,5,1.6094379124341003
conservative,5,1.6094379124341003
natriuretic,5,1.6094379124341003
PFV,5,1.6094379124341003
correct,5,1.6094379124341003
NAEPP,5,1.6094379124341003
How,5,1.6094379124341003
lasting,5,1.6094379124341003
NI,5,1.6094379124341003
Institute,5,1.6094379124341003
flipping,5,1.6094379124341003
mediate,5,1.6094379124341003
mood,5,1.6094379124341003
Strokes,5,1.6094379124341003
community-based,5,1.6094379124341003
dogs,5,1.6094379124341003
VC,5,1.6094379124341003
deficiency,5,1.6094379124341003
restricted,5,1.6094379124341003
inferoposterior,5,1.6094379124341003
intact,5,1.6094379124341003
cultures,5,1.6094379124341003
2D,5,1.6094379124341003
asthma-related,5,1.6094379124341003
studying,5,1.6094379124341003
214,5,1.6094379124341003
margin,5,1.6094379124341003
evaluations,5,1.6094379124341003
act,5,1.6094379124341003
PC20,5,1.6094379124341003
CMR,5,1.6094379124341003
cold,5,1.6094379124341003
Human,5,1.6094379124341003
comorbidities,5,1.6094379124341003
anticoagulation,5,1.6094379124341003
Brazil,5,1.6094379124341003
smaller,5,1.6094379124341003
Tl-ECT,5,1.6094379124341003
Whether,5,1.6094379124341003
83,5,1.6094379124341003
Islanders,5,1.6094379124341003
Spanish,5,1.6094379124341003
suffered,5,1.6094379124341003
E,5,1.6094379124341003
nor,5,1.6094379124341003
created,5,1.6094379124341003
supporting,5,1.6094379124341003
overweight,5,1.6094379124341003
Whites,5,1.6094379124341003
direction,5,1.6094379124341003
one-year,5,1.6094379124341003
institution,5,1.6094379124341003
bedside,5,1.6094379124341003
authorities,5,1.6094379124341003
energy,5,1.6094379124341003
reason,5,1.6094379124341003
conference,5,1.6094379124341003
allowed,5,1.6094379124341003
head,5,1.6094379124341003
Covasim,5,1.6094379124341003
Syndrome,5,1.6094379124341003
Doppler,5,1.6094379124341003
screen,5,1.6094379124341003
S2,5,1.6094379124341003
autophagy,5,1.6094379124341003
remdesivir,5,1.6094379124341003
warning,5,1.6094379124341003
coordination,5,1.6094379124341003
parallel,5,1.6094379124341003
lacking,5,1.6094379124341003
worsening,5,1.6094379124341003
epitopes,5,1.6094379124341003
pairs,5,1.6094379124341003
operated,5,1.6094379124341003
d,5,1.6094379124341003
LAA,5,1.6094379124341003
extended,5,1.6094379124341003
kidney,5,1.6094379124341003
Other,5,1.6094379124341003
peptides,5,1.6094379124341003
immunocompromised,5,1.6094379124341003
highlighting,5,1.6094379124341003
once,5,1.6094379124341003
endovascular,5,1.6094379124341003
81,5,1.6094379124341003
None,5,1.6094379124341003
estimation,5,1.6094379124341003
Approximately,5,1.6094379124341003
York,5,1.6094379124341003
ratios,5,1.6094379124341003
titres,5,1.6094379124341003
conjunctival,5,1.6094379124341003
NPS,5,1.6094379124341003
enormous,5,1.6094379124341003
intraaortic,5,1.6094379124341003
angiotensin,5,1.6094379124341003
attempt,5,1.6094379124341003
oxygenation,5,1.6094379124341003
ventricles,5,1.6094379124341003
postmortem,5,1.6094379124341003
reservoir,5,1.6094379124341003
extracurricular,5,1.6094379124341003
adolescents,5,1.6094379124341003
incomplete,5,1.6094379124341003
seem,5,1.6094379124341003
uncommon,5,1.6094379124341003
grafting,5,1.6094379124341003
began,5,1.6094379124341003
linked,5,1.6094379124341003
Prompt,5,1.6094379124341003
obesity,5,1.6094379124341003
resuscitation,5,1.6094379124341003
predominantly,5,1.6094379124341003
tear,5,1.6094379124341003
Seasonal,5,1.6094379124341003
×,5,1.6094379124341003
diagnose,5,1.6094379124341003
bronchitis,5,1.6094379124341003
compromise,5,1.6094379124341003
neonatal,5,1.6094379124341003
kinetics,5,1.6094379124341003
childs,5,1.6094379124341003
own,5,1.6094379124341003
hemorrhages,5,1.6094379124341003
consequence,5,1.6094379124341003
proved,5,1.6094379124341003
morphological,5,1.6094379124341003
SARS,5,1.6094379124341003
tissues,5,1.6094379124341003
alpha,5,1.6094379124341003
00001,5,1.6094379124341003
FFO,5,1.6094379124341003
fetal,5,1.6094379124341003
systematically,5,1.6094379124341003
Chest,5,1.6094379124341003
sinusitis,5,1.6094379124341003
airborne,5,1.6094379124341003
aerosols,5,1.6094379124341003
Clinicians,5,1.6094379124341003
parts,5,1.6094379124341003
changed,5,1.6094379124341003
incorporating,5,1.6094379124341003
illnesses,5,1.6094379124341003
i,5,1.6094379124341003
transmural,5,1.6094379124341003
registers,5,1.6094379124341003
professional,5,1.6094379124341003
dPCR,5,1.6094379124341003
atheromatous,5,1.6094379124341003
replacement,5,1.6094379124341003
concept,5,1.6094379124341003
upregulated,5,1.6094379124341003
fatigue,5,1.6094379124341003
dosage,5,1.6094379124341003
newer,5,1.6094379124341003
Mortality,5,1.6094379124341003
2013,5,1.6094379124341003
fetus,5,1.6094379124341003
Five,5,1.6094379124341003
QTcd,5,1.6094379124341003
radionuclide,5,1.6094379124341003
managed,5,1.6094379124341003
register,5,1.6094379124341003
exact,5,1.6094379124341003
complement,5,1.6094379124341003
Long-term,5,1.6094379124341003
allowing,5,1.6094379124341003
fibrinogen,5,1.6094379124341003
reciprocal,5,1.6094379124341003
spite,5,1.6094379124341003
CVD,5,1.6094379124341003
come,5,1.6094379124341003
observations,5,1.6094379124341003
2004,5,1.6094379124341003
addressed,5,1.6094379124341003
consciousness,5,1.6094379124341003
barrier,5,1.6094379124341003
Covid-19,5,1.6094379124341003
CMIRLV,5,1.6094379124341003
VA,5,1.6094379124341003
pericardial,5,1.6094379124341003
General,5,1.6094379124341003
occupying,5,1.6094379124341003
transmissibility,5,1.6094379124341003
reflect,5,1.6094379124341003
existence,5,1.6094379124341003
readily,5,1.6094379124341003
worked,5,1.6094379124341003
tracing,5,1.6094379124341003
luminal,5,1.6094379124341003
cohorts,5,1.6094379124341003
occasional,5,1.6094379124341003
immunoassays,5,1.6094379124341003
mimics,5,1.6094379124341003
routinely,5,1.6094379124341003
Primary,5,1.6094379124341003
recombinant,5,1.6094379124341003
dyspnea,5,1.6094379124341003
window,5,1.6094379124341003
Percutaneous,5,1.6094379124341003
haemorrhage,5,1.6094379124341003
Dox,5,1.6094379124341003
discomfort,5,1.6094379124341003
minimize,5,1.6094379124341003
AHAASA,5,1.6094379124341003
2000,5,1.6094379124341003
Type,5,1.6094379124341003
SNAb,5,1.6094379124341003
TAb,5,1.6094379124341003
2002,5,1.6094379124341003
gender,5,1.6094379124341003
adaptive,5,1.6094379124341003
driving,5,1.6094379124341003
EIAs,5,1.6094379124341003
statement,5,1.6094379124341003
medium,5,1.6094379124341003
partnership,5,1.6094379124341003
diagnoses,5,1.6094379124341003
utilizing,5,1.6094379124341003
categorized,5,1.6094379124341003
lifestyle,5,1.6094379124341003
interact,5,1.6094379124341003
departments,5,1.6094379124341003
Measure,5,1.6094379124341003
Vaccine,5,1.6094379124341003
programmes,5,1.6094379124341003
commentary,5,1.6094379124341003
atlas,5,1.6094379124341003
calls,5,1.6094379124341003
relationships,5,1.6094379124341003
multivessel,5,1.6094379124341003
Conversely,5,1.6094379124341003
FSM,5,1.6094379124341003
difficulty,5,1.6094379124341003
T-cell,5,1.6094379124341003
suppress,5,1.6094379124341003
57,5,1.6094379124341003
accepted,5,1.6094379124341003
working,5,1.6094379124341003
inversely,5,1.6094379124341003
predictability,5,1.6094379124341003
Cognitive,5,1.6094379124341003
hemiparesis,5,1.6094379124341003
failed,5,1.6094379124341003
20th,5,1.6094379124341003
Phylogenetic,5,1.6094379124341003
wider,5,1.6094379124341003
potent,5,1.6094379124341003
mode,5,1.6094379124341003
differs,5,1.6094379124341003
pertinent,5,1.6094379124341003
pathophysiologic,5,1.6094379124341003
updated,5,1.6094379124341003
He,5,1.6094379124341003
nail,5,1.6094379124341003
2005,5,1.6094379124341003
NPIs,5,1.6094379124341003
house,5,1.6094379124341003
users,5,1.6094379124341003
prescriptions,5,1.6094379124341003
mitigate,5,1.6094379124341003
nucleotide,5,1.6094379124341003
efficiently,5,1.6094379124341003
MHz,5,1.6094379124341003
monocytes,5,1.6094379124341003
substrate,5,1.6094379124341003
strength,5,1.6094379124341003
outpatients,5,1.6094379124341003
top,5,1.6094379124341003
generated,5,1.6094379124341003
stimulated,5,1.6094379124341003
Novel,5,1.6094379124341003
CST,5,1.6094379124341003
modality,5,1.6094379124341003
52,5,1.6094379124341003
scans,5,1.6094379124341003
assessments,5,1.6094379124341003
NMDs,5,1.6094379124341003
pathogenicity,5,1.6094379124341003
reveal,5,1.6094379124341003
BBB,5,1.6094379124341003
content,5,1.6094379124341003
subgroup,5,1.6094379124341003
contributing,5,1.6094379124341003
SE,5,1.6094379124341003
recipients,5,1.6094379124341003
white,5,1.6094379124341003
extension,5,1.6094379124341003
depend,5,1.6094379124341003
immunologic,5,1.6094379124341003
simultaneously,5,1.6094379124341003
infant,5,1.6094379124341003
examines,5,1.6094379124341003
overlap,5,1.6094379124341003
consultation,5,1.6094379124341003
inhibit,5,1.6094379124341003
SVD,5,1.6094379124341003
electronic,5,1.6094379124341003
Services,5,1.6094379124341003
regulate,5,1.6094379124341003
Institutes,5,1.6094379124341003
gold,5,1.6094379124341003
predicts,5,1.6094379124341003
G,5,1.6094379124341003
Its,5,1.6094379124341003
scenario,5,1.6094379124341003
nervous,5,1.6094379124341003
mRS,5,1.6094379124341003
bypassing,5,1.6094379124341003
velocity,5,1.6094379124341003
AUml,5,1.6094379124341003
cell-based,5,1.6094379124341003
antispike,5,1.6094379124341003
low-income,5,1.6094379124341003
turn,5,1.6094379124341003
nasal,5,1.6094379124341003
electrical,5,1.6094379124341003
gradually,5,1.6094379124341003
Ischemic,5,1.6094379124341003
fibrosis,5,1.6094379124341003
58,5,1.6094379124341003
enabling,5,1.6094379124341003
subcortical,5,1.6094379124341003
disparities,5,1.6094379124341003
subject,5,1.6094379124341003
virtual,5,1.6094379124341003
underdiagnosis,5,1.6094379124341003
contributes,5,1.6094379124341003
massive,5,1.6094379124341003
examinations,5,1.6094379124341003
JMI,5,1.6094379124341003
neutrophils,5,1.6094379124341003
impairments,5,1.6094379124341003
undertreatment,5,1.6094379124341003
BR,5,1.6094379124341003
BAL,5,1.6094379124341003
rural,5,1.6094379124341003
nonatopic,5,1.6094379124341003
continuously,5,1.6094379124341003
facilitating,5,1.6094379124341003
gastroesophageal,5,1.6094379124341003
intense,5,1.6094379124341003
operating,5,1.6094379124341003
embolic,5,1.6094379124341003
initiate,5,1.6094379124341003
males,5,1.6094379124341003
regarded,5,1.6094379124341003
Maoris,5,1.6094379124341003
companies,5,1.6094379124341003
LVT,5,1.6094379124341003
mHla-RBD,5,1.6094379124341003
presentations,5,1.6094379124341003
HR,5,1.6094379124341003
displayed,5,1.6094379124341003
LRE,5,1.6094379124341003
full,5,1.6094379124341003
language,5,1.6094379124341003
rRT-PCR,5,1.6094379124341003
visit,5,1.6094379124341003
dominance,5,1.6094379124341003
length,5,1.6094379124341003
learn,4,1.3862943611198906
winter,4,1.3862943611198906
virulence,4,1.3862943611198906
O,4,1.3862943611198906
HLH,4,1.3862943611198906
84,4,1.3862943611198906
obtaining,4,1.3862943611198906
Cerebrovascular,4,1.3862943611198906
simultaneous,4,1.3862943611198906
concepts,4,1.3862943611198906
screened,4,1.3862943611198906
125,4,1.3862943611198906
exerted,4,1.3862943611198906
glucose,4,1.3862943611198906
coupled,4,1.3862943611198906
sequelae,4,1.3862943611198906
reactive,4,1.3862943611198906
Rapid,4,1.3862943611198906
Europe,4,1.3862943611198906
teams,4,1.3862943611198906
ethical,4,1.3862943611198906
partially,4,1.3862943611198906
hr,4,1.3862943611198906
illustrate,4,1.3862943611198906
Sensitivity,4,1.3862943611198906
non-ST-segment,4,1.3862943611198906
favourable,4,1.3862943611198906
fitness,4,1.3862943611198906
Thirty-five,4,1.3862943611198906
atheroma,4,1.3862943611198906
pre-existing,4,1.3862943611198906
motivation,4,1.3862943611198906
macrophages,4,1.3862943611198906
Part,4,1.3862943611198906
zanamivir,4,1.3862943611198906
HCoV-OC43,4,1.3862943611198906
cerebrospinal,4,1.3862943611198906
intracoronary,4,1.3862943611198906
lobe,4,1.3862943611198906
missing,4,1.3862943611198906
R,4,1.3862943611198906
force,4,1.3862943611198906
healing,4,1.3862943611198906
pocket,4,1.3862943611198906
intubation,4,1.3862943611198906
religious,4,1.3862943611198906
Autophagy,4,1.3862943611198906
demonstrating,4,1.3862943611198906
residues,4,1.3862943611198906
febrile,4,1.3862943611198906
incubation,4,1.3862943611198906
141,4,1.3862943611198906
trauma,4,1.3862943611198906
ultrasonic,4,1.3862943611198906
rose,4,1.3862943611198906
hyperintensity,4,1.3862943611198906
huge,4,1.3862943611198906
introduce,4,1.3862943611198906
substitution,4,1.3862943611198906
conserved,4,1.3862943611198906
First,4,1.3862943611198906
aetiological,4,1.3862943611198906
quickly,4,1.3862943611198906
unlikely,4,1.3862943611198906
Community,4,1.3862943611198906
extracted,4,1.3862943611198906
TWN,4,1.3862943611198906
inception,4,1.3862943611198906
academic,4,1.3862943611198906
household,4,1.3862943611198906
SaO2,4,1.3862943611198906
relies,4,1.3862943611198906
took,4,1.3862943611198906
dead,4,1.3862943611198906
mRNA,4,1.3862943611198906
dataset,4,1.3862943611198906
emphasized,4,1.3862943611198906
recordings,4,1.3862943611198906
unvaccinated,4,1.3862943611198906
sampled,4,1.3862943611198906
uncertain,4,1.3862943611198906
digital,4,1.3862943611198906
creation,4,1.3862943611198906
foci,4,1.3862943611198906
combat,4,1.3862943611198906
persistence,4,1.3862943611198906
mutant,4,1.3862943611198906
prepared,4,1.3862943611198906
criterion,4,1.3862943611198906
excessive,4,1.3862943611198906
addressing,4,1.3862943611198906
Multiple,4,1.3862943611198906
modify,4,1.3862943611198906
paid,4,1.3862943611198906
shelter,4,1.3862943611198906
Netherlands,4,1.3862943611198906
dream,4,1.3862943611198906
materials,4,1.3862943611198906
aspect,4,1.3862943611198906
nanoparticles,4,1.3862943611198906
bedding,4,1.3862943611198906
descending,4,1.3862943611198906
1981,4,1.3862943611198906
47,4,1.3862943611198906
covariates,4,1.3862943611198906
Review,4,1.3862943611198906
experimentally,4,1.3862943611198906
122,4,1.3862943611198906
differed,4,1.3862943611198906
Latino,4,1.3862943611198906
paradigm,4,1.3862943611198906
manifestation,4,1.3862943611198906
pharmacotherapy,4,1.3862943611198906
utilized,4,1.3862943611198906
returned,4,1.3862943611198906
evident,4,1.3862943611198906
non-cardiac,4,1.3862943611198906
implantation,4,1.3862943611198906
valve,4,1.3862943611198906
imperative,4,1.3862943611198906
unsuccessful,4,1.3862943611198906
productivity,4,1.3862943611198906
connection,4,1.3862943611198906
NYC,4,1.3862943611198906
residence,4,1.3862943611198906
1992,4,1.3862943611198906
imbalance,4,1.3862943611198906
Research,4,1.3862943611198906
defining,4,1.3862943611198906
cure,4,1.3862943611198906
mites,4,1.3862943611198906
Kingdom,4,1.3862943611198906
normal-weight,4,1.3862943611198906
travel,4,1.3862943611198906
theories,4,1.3862943611198906
latter,4,1.3862943611198906
Black,4,1.3862943611198906
Ohio,4,1.3862943611198906
82,4,1.3862943611198906
registered,4,1.3862943611198906
fibrous,4,1.3862943611198906
Cochrane,4,1.3862943611198906
SCPS,4,1.3862943611198906
stimulating,4,1.3862943611198906
Toll-like,4,1.3862943611198906
reasonable,4,1.3862943611198906
integration,4,1.3862943611198906
case-control,4,1.3862943611198906
getting,4,1.3862943611198906
surrounding,4,1.3862943611198906
confounders,4,1.3862943611198906
correlate,4,1.3862943611198906
pulse,4,1.3862943611198906
400,4,1.3862943611198906
coinfection,4,1.3862943611198906
stakeholders,4,1.3862943611198906
246,4,1.3862943611198906
anatomic,4,1.3862943611198906
MBTE,4,1.3862943611198906
evolved,4,1.3862943611198906
Program,4,1.3862943611198906
dyspnoea,4,1.3862943611198906
post-pandemic,4,1.3862943611198906
Different,4,1.3862943611198906
translation,4,1.3862943611198906
dependency,4,1.3862943611198906
disturbances,4,1.3862943611198906
reinforce,4,1.3862943611198906
supported,4,1.3862943611198906
refractory,4,1.3862943611198906
real-world,4,1.3862943611198906
complexity,4,1.3862943611198906
avenues,4,1.3862943611198906
diurnal,4,1.3862943611198906
unable,4,1.3862943611198906
167,4,1.3862943611198906
Every,4,1.3862943611198906
die,4,1.3862943611198906
chemoprophylaxis,4,1.3862943611198906
bronchodilator,4,1.3862943611198906
shorter,4,1.3862943611198906
inhibitory,4,1.3862943611198906
serologic,4,1.3862943611198906
cigarette,4,1.3862943611198906
93,4,1.3862943611198906
four-fold,4,1.3862943611198906
Increased,4,1.3862943611198906
final,4,1.3862943611198906
P0001,4,1.3862943611198906
AdC68-19S,4,1.3862943611198906
demand,4,1.3862943611198906
difficulties,4,1.3862943611198906
describing,4,1.3862943611198906
outpatient,4,1.3862943611198906
fQRS,4,1.3862943611198906
hypotension,4,1.3862943611198906
Life,4,1.3862943611198906
ICS,4,1.3862943611198906
asked,4,1.3862943611198906
AGT,4,1.3862943611198906
doubt,4,1.3862943611198906
confounding,4,1.3862943611198906
dentist,4,1.3862943611198906
Affairs,4,1.3862943611198906
non-Q-wave,4,1.3862943611198906
too,4,1.3862943611198906
preceding,4,1.3862943611198906
People,4,1.3862943611198906
vaccine-induced,4,1.3862943611198906
02,4,1.3862943611198906
mgkg,4,1.3862943611198906
nucleocapsid,4,1.3862943611198906
autopsy,4,1.3862943611198906
ABCD2,4,1.3862943611198906
X-ray,4,1.3862943611198906
Factors,4,1.3862943611198906
2006,4,1.3862943611198906
isoproterenol,4,1.3862943611198906
capable,4,1.3862943611198906
⩾,4,1.3862943611198906
theoretical,4,1.3862943611198906
aOR,4,1.3862943611198906
employed,4,1.3862943611198906
TCM,4,1.3862943611198906
aneurysm,4,1.3862943611198906
adjust,4,1.3862943611198906
track,4,1.3862943611198906
psychiatric,4,1.3862943611198906
share,4,1.3862943611198906
QoL,4,1.3862943611198906
predisposing,4,1.3862943611198906
first-line,4,1.3862943611198906
exploration,4,1.3862943611198906
exists,4,1.3862943611198906
AHong,4,1.3862943611198906
translating,4,1.3862943611198906
isolate,4,1.3862943611198906
VS,4,1.3862943611198906
LTRAs,4,1.3862943611198906
unextracted,4,1.3862943611198906
Each,4,1.3862943611198906
city,4,1.3862943611198906
microscopic,4,1.3862943611198906
she,4,1.3862943611198906
rollout,4,1.3862943611198906
dramatic,4,1.3862943611198906
instances,4,1.3862943611198906
off,4,1.3862943611198906
comparatively,4,1.3862943611198906
mandatory,4,1.3862943611198906
lockdown,4,1.3862943611198906
adoption,4,1.3862943611198906
encouraging,4,1.3862943611198906
Cardiac,4,1.3862943611198906
collagen,4,1.3862943611198906
inner-city,4,1.3862943611198906
CMILRV,4,1.3862943611198906
Information,4,1.3862943611198906
300,4,1.3862943611198906
104,4,1.3862943611198906
hospitalisation,4,1.3862943611198906
coefficient,4,1.3862943611198906
084,4,1.3862943611198906
dreams,4,1.3862943611198906
impairs,4,1.3862943611198906
pathogenetic,4,1.3862943611198906
Mean,4,1.3862943611198906
begun,4,1.3862943611198906
clustering,4,1.3862943611198906
quantified,4,1.3862943611198906
advent,4,1.3862943611198906
Unit,4,1.3862943611198906
iv,4,1.3862943611198906
poultry,4,1.3862943611198906
Animal,4,1.3862943611198906
short-,4,1.3862943611198906
ii,4,1.3862943611198906
covid-19,4,1.3862943611198906
questionable,4,1.3862943611198906
valid,4,1.3862943611198906
follows,4,1.3862943611198906
eosinophilic,4,1.3862943611198906
tears,4,1.3862943611198906
RT-qPCR,4,1.3862943611198906
electron,4,1.3862943611198906
breast,4,1.3862943611198906
message,4,1.3862943611198906
narratives,4,1.3862943611198906
phenotype,4,1.3862943611198906
regimen,4,1.3862943611198906
preliminary,4,1.3862943611198906
143,4,1.3862943611198906
preparation,4,1.3862943611198906
MH,4,1.3862943611198906
revision,4,1.3862943611198906
Tamiflu,4,1.3862943611198906
antagonist,4,1.3862943611198906
incorporated,4,1.3862943611198906
prevented,4,1.3862943611198906
appreciably,4,1.3862943611198906
call,4,1.3862943611198906
Kong,4,1.3862943611198906
QOL,4,1.3862943611198906
interstitial,4,1.3862943611198906
86,4,1.3862943611198906
Existing,4,1.3862943611198906
accessible,4,1.3862943611198906
rely,4,1.3862943611198906
link,4,1.3862943611198906
Statistics,4,1.3862943611198906
stay,4,1.3862943611198906
triggering,4,1.3862943611198906
pathogen,4,1.3862943611198906
apoptosis,4,1.3862943611198906
North,4,1.3862943611198906
delivering,4,1.3862943611198906
multifactorial,4,1.3862943611198906
septum,4,1.3862943611198906
continuing,4,1.3862943611198906
controversial,4,1.3862943611198906
hematoma,4,1.3862943611198906
endarterectomy,4,1.3862943611198906
beta-2,4,1.3862943611198906
cost-effectiveness,4,1.3862943611198906
GMT,4,1.3862943611198906
killed,4,1.3862943611198906
constitute,4,1.3862943611198906
pharmacy,4,1.3862943611198906
vary,4,1.3862943611198906
influenza-related,4,1.3862943611198906
modelling,4,1.3862943611198906
centres,4,1.3862943611198906
ovarian,4,1.3862943611198906
Syrian,4,1.3862943611198906
smokers,4,1.3862943611198906
morphology,4,1.3862943611198906
cough-variant,4,1.3862943611198906
RBD-conjugated,4,1.3862943611198906
Evidence,4,1.3862943611198906
hundreds,4,1.3862943611198906
IVIG,4,1.3862943611198906
lethal,4,1.3862943611198906
shunt,4,1.3862943611198906
differentiated,4,1.3862943611198906
properties,4,1.3862943611198906
contain,4,1.3862943611198906
narrative,4,1.3862943611198906
eye,4,1.3862943611198906
sludge,4,1.3862943611198906
diameter,4,1.3862943611198906
She,4,1.3862943611198906
bird,4,1.3862943611198906
respondents,4,1.3862943611198906
promoting,4,1.3862943611198906
titre,4,1.3862943611198906
Asians,4,1.3862943611198906
multidisciplinary,4,1.3862943611198906
questionnaires,4,1.3862943611198906
designated,4,1.3862943611198906
inpatients,4,1.3862943611198906
108,4,1.3862943611198906
pronounced,4,1.3862943611198906
Higher,4,1.3862943611198906
external,4,1.3862943611198906
agreed,4,1.3862943611198906
ways,4,1.3862943611198906
College,4,1.3862943611198906
clinician,4,1.3862943611198906
worsen,4,1.3862943611198906
Cox,4,1.3862943611198906
deacetylase,4,1.3862943611198906
starting,4,1.3862943611198906
shaped,4,1.3862943611198906
answering,4,1.3862943611198906
recover,4,1.3862943611198906
Regional,4,1.3862943611198906
120,4,1.3862943611198906
summer,4,1.3862943611198906
TNG,4,1.3862943611198906
natural,4,1.3862943611198906
CNN,4,1.3862943611198906
provocation,4,1.3862943611198906
insufficient,4,1.3862943611198906
QTd,4,1.3862943611198906
attentional,4,1.3862943611198906
Oseltamivir,4,1.3862943611198906
preschool,4,1.3862943611198906
datasets,4,1.3862943611198906
inducing,4,1.3862943611198906
subjected,4,1.3862943611198906
justified,4,1.3862943611198906
HeO2,4,1.3862943611198906
situations,4,1.3862943611198906
subset,4,1.3862943611198906
BH,4,1.3862943611198906
neurosurgical,4,1.3862943611198906
hearts,4,1.3862943611198906
named,4,1.3862943611198906
Grade,4,1.3862943611198906
return,4,1.3862943611198906
appearance,4,1.3862943611198906
document,4,1.3862943611198906
qRT-PCR,4,1.3862943611198906
indices,4,1.3862943611198906
BA,4,1.3862943611198906
Questionnaire,4,1.3862943611198906
fluorescence,4,1.3862943611198906
familial,4,1.3862943611198906
extremely,4,1.3862943611198906
seriously,4,1.3862943611198906
CP,4,1.3862943611198906
false-negative,4,1.3862943611198906
Z,4,1.3862943611198906
anomalous,4,1.3862943611198906
hamsters,4,1.3862943611198906
termed,4,1.3862943611198906
CRRT,4,1.3862943611198906
Initiative,4,1.3862943611198906
innate,4,1.3862943611198906
HDM,4,1.3862943611198906
coronarosclerosis,4,1.3862943611198906
System,4,1.3862943611198906
FSMs,4,1.3862943611198906
policies,4,1.3862943611198906
39,4,1.3862943611198906
comorbid,4,1.3862943611198906
inappropriate,4,1.3862943611198906
Few,4,1.3862943611198906
inexpensive,4,1.3862943611198906
tocilizumab,4,1.3862943611198906
pure,4,1.3862943611198906
workplace,4,1.3862943611198906
indicator,4,1.3862943611198906
Notch3,4,1.3862943611198906
chosen,4,1.3862943611198906
success,4,1.3862943611198906
earthquakes,4,1.3862943611198906
Korean,4,1.3862943611198906
transformation,4,1.3862943611198906
sensitivities,4,1.3862943611198906
resolved,4,1.3862943611198906
technical,4,1.3862943611198906
leukosis,4,1.3862943611198906
antiarrhythmic,4,1.3862943611198906
quantify,4,1.3862943611198906
facilitated,4,1.3862943611198906
mouse,4,1.3862943611198906
101,4,1.3862943611198906
aerosol,4,1.3862943611198906
HPA,4,1.3862943611198906
muscle,4,1.3862943611198906
particles,4,1.3862943611198906
76,4,1.3862943611198906
Western,4,1.3862943611198906
73,4,1.3862943611198906
implement,4,1.3862943611198906
spasm,4,1.3862943611198906
Viral,4,1.3862943611198906
DC,4,1.3862943611198906
TAVR,4,1.3862943611198906
circumstances,4,1.3862943611198906
S-OIV,4,1.3862943611198906
Australian,4,1.3862943611198906
guided,4,1.3862943611198906
complaints,4,1.3862943611198906
closest,4,1.3862943611198906
appropriately,4,1.3862943611198906
herd,4,1.3862943611198906
medicines,4,1.3862943611198906
battery,4,1.3862943611198906
Importantly,4,1.3862943611198906
tremendous,4,1.3862943611198906
transmitted,4,1.3862943611198906
breastfeeding,4,1.3862943611198906
damages,4,1.3862943611198906
immense,4,1.3862943611198906
sVNT,4,1.3862943611198906
EVT-access,4,1.3862943611198906
visual,4,1.3862943611198906
milk,4,1.3862943611198906
Italian,4,1.3862943611198906
dispersion,4,1.3862943611198906
coming,4,1.3862943611198906
Cardiogenic,4,1.3862943611198906
antigens,4,1.3862943611198906
narrow,4,1.3862943611198906
cross-reactivity,4,1.3862943611198906
get,4,1.3862943611198906
greatly,4,1.3862943611198906
stronger,4,1.3862943611198906
varies,4,1.3862943611198906
potassium,4,1.3862943611198906
earthquake,4,1.3862943611198906
0005,4,1.3862943611198906
nearly,4,1.3862943611198906
surrogate,4,1.3862943611198906
readmission,4,1.3862943611198906
hematopoietic,4,1.3862943611198906
literacy,4,1.3862943611198906
resolve,4,1.3862943611198906
rs1800896,4,1.3862943611198906
enable,4,1.3862943611198906
sufficiently,4,1.3862943611198906
AHMPPI,4,1.3862943611198906
concurrent,4,1.3862943611198906
nonspecific,4,1.3862943611198906
instead,4,1.3862943611198906
haemodynamic,4,1.3862943611198906
antiplatelet,4,1.3862943611198906
stimulate,4,1.3862943611198906
CIs,4,1.3862943611198906
Identifying,4,1.3862943611198906
falls,4,1.3862943611198906
positions,4,1.3862943611198906
Src,4,1.3862943611198906
references,4,1.3862943611198906
occasions,4,1.3862943611198906
PICU,4,1.3862943611198906
dilation,4,1.3862943611198906
combating,4,1.3862943611198906
nAb,4,1.3862943611198906
adequately,4,1.3862943611198906
IVA,4,1.3862943611198906
quick,4,1.3862943611198906
facilitates,4,1.3862943611198906
school-based,4,1.3862943611198906
unrelated,4,1.3862943611198906
signal,4,1.3862943611198906
experiences,4,1.3862943611198906
opinion,4,1.3862943611198906
streptokinase,4,1.3862943611198906
unprecedented,4,1.3862943611198906
no-reflow,4,1.3862943611198906
RdRp,4,1.3862943611198906
seroconversion,4,1.3862943611198906
allele,4,1.3862943611198906
dinitrate,4,1.3862943611198906
popular,4,1.3862943611198906
ngml,4,1.3862943611198906
4G4G,4,1.3862943611198906
complicate,4,1.3862943611198906
nsp1,4,1.3862943611198906
explores,4,1.3862943611198906
ectopic,4,1.3862943611198906
SPSN,4,1.3862943611198906
behind,4,1.3862943611198906
definitive,4,1.3862943611198906
mind,4,1.3862943611198906
Additional,4,1.3862943611198906
adapt,4,1.3862943611198906
etiologic,4,1.3862943611198906
preinfarction,4,1.3862943611198906
cope,4,1.3862943611198906
net,4,1.3862943611198906
140,4,1.3862943611198906
catheterization,4,1.3862943611198906
guideline,4,1.3862943611198906
investigators,4,1.3862943611198906
Recognition,4,1.3862943611198906
poorer,4,1.3862943611198906
papers,4,1.3862943611198906
pericarditis,4,1.3862943611198906
Care,4,1.3862943611198906
seropositive,4,1.3862943611198906
cost-effective,4,1.3862943611198906
superiority,4,1.3862943611198906
oncology,4,1.3862943611198906
constraints,4,1.3862943611198906
TPA,4,1.3862943611198906
133,4,1.3862943611198906
abdominal,4,1.3862943611198906
Conclusions,4,1.3862943611198906
Intravenous,4,1.3862943611198906
basigin,4,1.3862943611198906
drawn,4,1.3862943611198906
vocal,4,1.3862943611198906
lineage,4,1.3862943611198906
socio-economic,4,1.3862943611198906
lines,4,1.3862943611198906
amplify,4,1.3862943611198906
SVC,4,1.3862943611198906
he,4,1.3862943611198906
High,4,1.3862943611198906
suppressing,4,1.3862943611198906
never,4,1.3862943611198906
test-negative,4,1.3862943611198906
syringe,4,1.3862943611198906
toll,4,1.3862943611198906
lymphadenopathy,4,1.3862943611198906
isosorbide,4,1.3862943611198906
exclude,4,1.3862943611198906
military,4,1.3862943611198906
suppression,4,1.3862943611198906
phynoptin,4,1.3862943611198906
bundle,4,1.3862943611198906
decreases,4,1.3862943611198906
interferon,4,1.3862943611198906
recanalization,4,1.3862943611198906
foreign,4,1.3862943611198906
Eleven,4,1.3862943611198906
neither,4,1.3862943611198906
peoples,4,1.3862943611198906
unloading,4,1.3862943611198906
ROIs,4,1.3862943611198906
complicating,4,1.3862943611198906
locations,4,1.3862943611198906
C-reactive,4,1.3862943611198906
multicenter,4,1.3862943611198906
PA,4,1.3862943611198906
IVE,4,1.3862943611198906
humor,3,1.0986122886681098
certification,3,1.0986122886681098
effusion,3,1.0986122886681098
vitreous,3,1.0986122886681098
74,3,1.0986122886681098
TX,3,1.0986122886681098
self,3,1.0986122886681098
regulated,3,1.0986122886681098
Twenty,3,1.0986122886681098
periprocedural,3,1.0986122886681098
aqueous,3,1.0986122886681098
industry,3,1.0986122886681098
170,3,1.0986122886681098
food,3,1.0986122886681098
protect,3,1.0986122886681098
Cardiovascular,3,1.0986122886681098
Strategies,3,1.0986122886681098
licorice,3,1.0986122886681098
K,3,1.0986122886681098
JNC,3,1.0986122886681098
reagents,3,1.0986122886681098
humidity,3,1.0986122886681098
offspring,3,1.0986122886681098
602,3,1.0986122886681098
experiencing,3,1.0986122886681098
bring,3,1.0986122886681098
triggered,3,1.0986122886681098
province,3,1.0986122886681098
minimum,3,1.0986122886681098
pseudovirus,3,1.0986122886681098
basal,3,1.0986122886681098
sublingual,3,1.0986122886681098
accompanying,3,1.0986122886681098
licensed,3,1.0986122886681098
pre-,3,1.0986122886681098
209,3,1.0986122886681098
04,3,1.0986122886681098
Thrombolytic,3,1.0986122886681098
intermittent,3,1.0986122886681098
strengthened,3,1.0986122886681098
857,3,1.0986122886681098
GER,3,1.0986122886681098
graded,3,1.0986122886681098
interplay,3,1.0986122886681098
tracer,3,1.0986122886681098
panels,3,1.0986122886681098
universal,3,1.0986122886681098
gained,3,1.0986122886681098
heavily,3,1.0986122886681098
microm,3,1.0986122886681098
Improvement,3,1.0986122886681098
protecting,3,1.0986122886681098
purchase,3,1.0986122886681098
thallium,3,1.0986122886681098
reviewing,3,1.0986122886681098
biopsy,3,1.0986122886681098
GPs,3,1.0986122886681098
origins,3,1.0986122886681098
living,3,1.0986122886681098
TOP,3,1.0986122886681098
incorrect,3,1.0986122886681098
Report,3,1.0986122886681098
partly,3,1.0986122886681098
hospital-based,3,1.0986122886681098
endpoint,3,1.0986122886681098
0002,3,1.0986122886681098
array,3,1.0986122886681098
unspecified,3,1.0986122886681098
cent,3,1.0986122886681098
Traditional,3,1.0986122886681098
acutely,3,1.0986122886681098
MCS,3,1.0986122886681098
aetiology,3,1.0986122886681098
Ang,3,1.0986122886681098
51,3,1.0986122886681098
Abbott,3,1.0986122886681098
pdm09,3,1.0986122886681098
motivated,3,1.0986122886681098
quantitatively,3,1.0986122886681098
Singapore,3,1.0986122886681098
faster,3,1.0986122886681098
HPAI,3,1.0986122886681098
Basigin,3,1.0986122886681098
back,3,1.0986122886681098
organized,3,1.0986122886681098
prominent,3,1.0986122886681098
copies,3,1.0986122886681098
typically,3,1.0986122886681098
addresses,3,1.0986122886681098
subtle,3,1.0986122886681098
BNT162b2,3,1.0986122886681098
114,3,1.0986122886681098
seeking,3,1.0986122886681098
messages,3,1.0986122886681098
inpatient,3,1.0986122886681098
unusual,3,1.0986122886681098
068,3,1.0986122886681098
Hospitals,3,1.0986122886681098
alert,3,1.0986122886681098
run,3,1.0986122886681098
doubled,3,1.0986122886681098
epi-aortic,3,1.0986122886681098
AMI-CS,3,1.0986122886681098
Doctors,3,1.0986122886681098
237,3,1.0986122886681098
removal,3,1.0986122886681098
subfertile,3,1.0986122886681098
Autopsy,3,1.0986122886681098
constantly,3,1.0986122886681098
difficult-to-treat,3,1.0986122886681098
compatible,3,1.0986122886681098
hygiene-related,3,1.0986122886681098
School-based,3,1.0986122886681098
display,3,1.0986122886681098
normalization,3,1.0986122886681098
univariate,3,1.0986122886681098
Unfortunately,3,1.0986122886681098
age-specific,3,1.0986122886681098
eucapnic,3,1.0986122886681098
black,3,1.0986122886681098
anticipate,3,1.0986122886681098
rule,3,1.0986122886681098
96,3,1.0986122886681098
equally,3,1.0986122886681098
persisting,3,1.0986122886681098
instability,3,1.0986122886681098
algorithms,3,1.0986122886681098
surveyed,3,1.0986122886681098
ROI,3,1.0986122886681098
muscular,3,1.0986122886681098
urgency,3,1.0986122886681098
pharmacologic,3,1.0986122886681098
Education,3,1.0986122886681098
combining,3,1.0986122886681098
well-established,3,1.0986122886681098
meant,3,1.0986122886681098
unsatisfactory,3,1.0986122886681098
hope,3,1.0986122886681098
uncertainty,3,1.0986122886681098
Nursing,3,1.0986122886681098
IVS,3,1.0986122886681098
provision,3,1.0986122886681098
behavioural,3,1.0986122886681098
turnaround,3,1.0986122886681098
option,3,1.0986122886681098
Following,3,1.0986122886681098
powerful,3,1.0986122886681098
pericardium,3,1.0986122886681098
generate,3,1.0986122886681098
immunocompetence,3,1.0986122886681098
patient-reported,3,1.0986122886681098
recruitment,3,1.0986122886681098
resolution,3,1.0986122886681098
Specific,3,1.0986122886681098
Poland,3,1.0986122886681098
converting,3,1.0986122886681098
Quantitative,3,1.0986122886681098
modest,3,1.0986122886681098
regularly,3,1.0986122886681098
calling,3,1.0986122886681098
catheter,3,1.0986122886681098
methodologies,3,1.0986122886681098
headache,3,1.0986122886681098
limits,3,1.0986122886681098
IF,3,1.0986122886681098
MHV,3,1.0986122886681098
triage,3,1.0986122886681098
Wales,3,1.0986122886681098
Texas,3,1.0986122886681098
expansion,3,1.0986122886681098
bronchospasm,3,1.0986122886681098
hazards,3,1.0986122886681098
pollution,3,1.0986122886681098
remembered,3,1.0986122886681098
coreceptor,3,1.0986122886681098
short-acting,3,1.0986122886681098
identical,3,1.0986122886681098
held,3,1.0986122886681098
vaccinate,3,1.0986122886681098
hyperglycemia,3,1.0986122886681098
completeness,3,1.0986122886681098
histology,3,1.0986122886681098
Food,3,1.0986122886681098
isothermal,3,1.0986122886681098
safer,3,1.0986122886681098
tendency,3,1.0986122886681098
alive,3,1.0986122886681098
griffithsin,3,1.0986122886681098
212,3,1.0986122886681098
escape,3,1.0986122886681098
decreasing,3,1.0986122886681098
encouraged,3,1.0986122886681098
post-operative,3,1.0986122886681098
Female,3,1.0986122886681098
21st,3,1.0986122886681098
agricultural,3,1.0986122886681098
pathophysiological,3,1.0986122886681098
manufacturers,3,1.0986122886681098
12-month,3,1.0986122886681098
closed,3,1.0986122886681098
bound,3,1.0986122886681098
phosphate,3,1.0986122886681098
seek,3,1.0986122886681098
PPH,3,1.0986122886681098
diagnosing,3,1.0986122886681098
antigenically,3,1.0986122886681098
meet,3,1.0986122886681098
combines,3,1.0986122886681098
fairs,3,1.0986122886681098
contraindicated,3,1.0986122886681098
methodological,3,1.0986122886681098
territory,3,1.0986122886681098
exhibitors,3,1.0986122886681098
averted,3,1.0986122886681098
I2,3,1.0986122886681098
dreaming,3,1.0986122886681098
ethnicity,3,1.0986122886681098
V,3,1.0986122886681098
132,3,1.0986122886681098
solutions,3,1.0986122886681098
D,3,1.0986122886681098
promotes,3,1.0986122886681098
sharing,3,1.0986122886681098
135,3,1.0986122886681098
redesign,3,1.0986122886681098
meter,3,1.0986122886681098
grafts,3,1.0986122886681098
pseudoviral,3,1.0986122886681098
multiplex,3,1.0986122886681098
namely,3,1.0986122886681098
feedback,3,1.0986122886681098
skilled,3,1.0986122886681098
carry,3,1.0986122886681098
prototypes,3,1.0986122886681098
neuroprotective,3,1.0986122886681098
vast,3,1.0986122886681098
BCI,3,1.0986122886681098
SARS-CoV-1,3,1.0986122886681098
diet,3,1.0986122886681098
Quality,3,1.0986122886681098
digestive,3,1.0986122886681098
reflected,3,1.0986122886681098
atlases,3,1.0986122886681098
Minnesota,3,1.0986122886681098
penetration,3,1.0986122886681098
hydrochloric,3,1.0986122886681098
adenovirus,3,1.0986122886681098
hypertensive,3,1.0986122886681098
1986,3,1.0986122886681098
womens,3,1.0986122886681098
analytical,3,1.0986122886681098
statistics,3,1.0986122886681098
genotypes,3,1.0986122886681098
SM,3,1.0986122886681098
codon,3,1.0986122886681098
plateau,3,1.0986122886681098
Changes,3,1.0986122886681098
judicious,3,1.0986122886681098
Screening,3,1.0986122886681098
ID,3,1.0986122886681098
classical,3,1.0986122886681098
illustrated,3,1.0986122886681098
reproductive,3,1.0986122886681098
Kaplan-Meier,3,1.0986122886681098
maximize,3,1.0986122886681098
belongs,3,1.0986122886681098
awakening,3,1.0986122886681098
9-1-1,3,1.0986122886681098
Taiwan,3,1.0986122886681098
TND-IVE,3,1.0986122886681098
geometric,3,1.0986122886681098
comorbidity,3,1.0986122886681098
fell,3,1.0986122886681098
morning,3,1.0986122886681098
Aortic,3,1.0986122886681098
excretion,3,1.0986122886681098
entirely,3,1.0986122886681098
DIT,3,1.0986122886681098
Motor,3,1.0986122886681098
challenged,3,1.0986122886681098
lateralization,3,1.0986122886681098
mobility,3,1.0986122886681098
hemispheric,3,1.0986122886681098
incidences,3,1.0986122886681098
middle-income,3,1.0986122886681098
impacts,3,1.0986122886681098
projects,3,1.0986122886681098
aeroallergen,3,1.0986122886681098
tight,3,1.0986122886681098
recombination,3,1.0986122886681098
extracranial,3,1.0986122886681098
vasodilator,3,1.0986122886681098
About,3,1.0986122886681098
fundamental,3,1.0986122886681098
non-pharmaceutical,3,1.0986122886681098
pets,3,1.0986122886681098
items,3,1.0986122886681098
cluster,3,1.0986122886681098
Malays,3,1.0986122886681098
usage,3,1.0986122886681098
adding,3,1.0986122886681098
automatic,3,1.0986122886681098
Indians,3,1.0986122886681098
914,3,1.0986122886681098
Injury,3,1.0986122886681098
eGLIA,3,1.0986122886681098
infusion,3,1.0986122886681098
ESO,3,1.0986122886681098
recommendation,3,1.0986122886681098
manuscript,3,1.0986122886681098
middle-aged,3,1.0986122886681098
giving,3,1.0986122886681098
resident,3,1.0986122886681098
apnea,3,1.0986122886681098
FDP,3,1.0986122886681098
facility,3,1.0986122886681098
neuroimaging,3,1.0986122886681098
endothelium,3,1.0986122886681098
acquired,3,1.0986122886681098
sustain,3,1.0986122886681098
unsuccessfully,3,1.0986122886681098
x,3,1.0986122886681098
half-maximal,3,1.0986122886681098
pair,3,1.0986122886681098
Dox-,3,1.0986122886681098
attractor,3,1.0986122886681098
perturbance,3,1.0986122886681098
Framingham,3,1.0986122886681098
constituents,3,1.0986122886681098
modulation,3,1.0986122886681098
diabetic,3,1.0986122886681098
manifest,3,1.0986122886681098
EC90,3,1.0986122886681098
concordance,3,1.0986122886681098
defense,3,1.0986122886681098
remarkable,3,1.0986122886681098
colleagues,3,1.0986122886681098
rs1800871,3,1.0986122886681098
high-sensitivity,3,1.0986122886681098
mitogen,3,1.0986122886681098
Center,3,1.0986122886681098
attenuation,3,1.0986122886681098
hypersensitivity,3,1.0986122886681098
IBAE,3,1.0986122886681098
synergistic,3,1.0986122886681098
breastmilk,3,1.0986122886681098
nutrition,3,1.0986122886681098
mutism,3,1.0986122886681098
computer-based,3,1.0986122886681098
lasted,3,1.0986122886681098
mothers,3,1.0986122886681098
histories,3,1.0986122886681098
modern,3,1.0986122886681098
drawing,3,1.0986122886681098
granulocytes,3,1.0986122886681098
someone,3,1.0986122886681098
Nine,3,1.0986122886681098
112,3,1.0986122886681098
hrs,3,1.0986122886681098
conflicting,3,1.0986122886681098
orientation,3,1.0986122886681098
functioning,3,1.0986122886681098
1968,3,1.0986122886681098
RR,3,1.0986122886681098
ascending,3,1.0986122886681098
preserve,3,1.0986122886681098
inferred,3,1.0986122886681098
select,3,1.0986122886681098
hosts,3,1.0986122886681098
aorta,3,1.0986122886681098
subunit,3,1.0986122886681098
184,3,1.0986122886681098
triple,3,1.0986122886681098
2017,3,1.0986122886681098
reassortment,3,1.0986122886681098
TLRs,3,1.0986122886681098
node,3,1.0986122886681098
1957,3,1.0986122886681098
419,3,1.0986122886681098
chemokines,3,1.0986122886681098
Monitoring,3,1.0986122886681098
lymphocytes,3,1.0986122886681098
mononuclear,3,1.0986122886681098
Killip,3,1.0986122886681098
heterosexual,3,1.0986122886681098
Project,3,1.0986122886681098
incorporate,3,1.0986122886681098
Americans,3,1.0986122886681098
India,3,1.0986122886681098
lesser,3,1.0986122886681098
saving,3,1.0986122886681098
judged,3,1.0986122886681098
echocardiograms,3,1.0986122886681098
pro-inflammatory,3,1.0986122886681098
ingredients,3,1.0986122886681098
066,3,1.0986122886681098
silent,3,1.0986122886681098
stabilization,3,1.0986122886681098
product,3,1.0986122886681098
saved,3,1.0986122886681098
replacing,3,1.0986122886681098
though,3,1.0986122886681098
rTMS,3,1.0986122886681098
behaviours,3,1.0986122886681098
Georges,3,1.0986122886681098
Valsalva,3,1.0986122886681098
progenitors,3,1.0986122886681098
well-designed,3,1.0986122886681098
false-positive,3,1.0986122886681098
CR,3,1.0986122886681098
Carotid,3,1.0986122886681098
atherosclerotic,3,1.0986122886681098
expectancy,3,1.0986122886681098
choices,3,1.0986122886681098
fashion,3,1.0986122886681098
mediastinitis,3,1.0986122886681098
at-risk,3,1.0986122886681098
s,3,1.0986122886681098
MMF,3,1.0986122886681098
Inadequate,3,1.0986122886681098
129,3,1.0986122886681098
accept,3,1.0986122886681098
Roche,3,1.0986122886681098
St,3,1.0986122886681098
vehicle-treated,3,1.0986122886681098
infancy,3,1.0986122886681098
MMF-treated,3,1.0986122886681098
built,3,1.0986122886681098
endocardial,3,1.0986122886681098
lying,3,1.0986122886681098
AOntario12522007,3,1.0986122886681098
L452R,3,1.0986122886681098
income,3,1.0986122886681098
SS,3,1.0986122886681098
state-of-the-art,3,1.0986122886681098
PET,3,1.0986122886681098
written,3,1.0986122886681098
rating,3,1.0986122886681098
interviewed,3,1.0986122886681098
MACEs,3,1.0986122886681098
computer,3,1.0986122886681098
Computed,3,1.0986122886681098
CA,3,1.0986122886681098
responded,3,1.0986122886681098
Patient,3,1.0986122886681098
BPT,3,1.0986122886681098
profound,3,1.0986122886681098
Prospective,3,1.0986122886681098
exhaustion,3,1.0986122886681098
fibrinolysis,3,1.0986122886681098
answer,3,1.0986122886681098
ultrasound,3,1.0986122886681098
unexposed,3,1.0986122886681098
environments,3,1.0986122886681098
E484K,3,1.0986122886681098
elicited,3,1.0986122886681098
N501Y,3,1.0986122886681098
rhetorics,3,1.0986122886681098
subtraction,3,1.0986122886681098
admitting,3,1.0986122886681098
whole-genome,3,1.0986122886681098
irreversible,3,1.0986122886681098
convulsion,3,1.0986122886681098
replaced,3,1.0986122886681098
003,3,1.0986122886681098
Notch,3,1.0986122886681098
assistance,3,1.0986122886681098
carrier,3,1.0986122886681098
broader,3,1.0986122886681098
Sequencing,3,1.0986122886681098
ETS,3,1.0986122886681098
EBV,3,1.0986122886681098
vein,3,1.0986122886681098
damaged,3,1.0986122886681098
patient-centered,3,1.0986122886681098
socioeconomic,3,1.0986122886681098
POMS,3,1.0986122886681098
causality,3,1.0986122886681098
patch,3,1.0986122886681098
produces,3,1.0986122886681098
Physicians,3,1.0986122886681098
suspect,3,1.0986122886681098
homeostasis,3,1.0986122886681098
Even,3,1.0986122886681098
bone,3,1.0986122886681098
dexamethasone,3,1.0986122886681098
Consequently,3,1.0986122886681098
tension,3,1.0986122886681098
exception,3,1.0986122886681098
QT,3,1.0986122886681098
emphasizing,3,1.0986122886681098
lymphatic,3,1.0986122886681098
stroke-like,3,1.0986122886681098
highlighted,3,1.0986122886681098
Limited,3,1.0986122886681098
Serological,3,1.0986122886681098
produce,3,1.0986122886681098
theophylline,3,1.0986122886681098
preparations,3,1.0986122886681098
herald,3,1.0986122886681098
187,3,1.0986122886681098
landscape,3,1.0986122886681098
epigenetic,3,1.0986122886681098
Allergy,3,1.0986122886681098
anti-viral,3,1.0986122886681098
dysplasia,3,1.0986122886681098
wedge,3,1.0986122886681098
ease,3,1.0986122886681098
compact,3,1.0986122886681098
iii,3,1.0986122886681098
injectable,3,1.0986122886681098
rt-PA,3,1.0986122886681098
transcatheter,3,1.0986122886681098
vomiting,3,1.0986122886681098
TAVI,3,1.0986122886681098
1974,3,1.0986122886681098
haemodynamics,3,1.0986122886681098
silico,3,1.0986122886681098
valvular,3,1.0986122886681098
Survivors,3,1.0986122886681098
exaggerated,3,1.0986122886681098
1978,3,1.0986122886681098
minute,3,1.0986122886681098
signals,3,1.0986122886681098
constructed,3,1.0986122886681098
out-of-hospital,3,1.0986122886681098
P001,3,1.0986122886681098
up-to-date,3,1.0986122886681098
pivotal,3,1.0986122886681098
Authorization,3,1.0986122886681098
Cases,3,1.0986122886681098
concerned,3,1.0986122886681098
definite,3,1.0986122886681098
microRNAs,3,1.0986122886681098
mast,3,1.0986122886681098
conductive,3,1.0986122886681098
Immunology,3,1.0986122886681098
leukotrienes,3,1.0986122886681098
calculate,3,1.0986122886681098
placenta,3,1.0986122886681098
091,3,1.0986122886681098
immunofluorescence,3,1.0986122886681098
favipiravir,3,1.0986122886681098
mucus,3,1.0986122886681098
specificities,3,1.0986122886681098
SARS-CoV‑2,3,1.0986122886681098
semaphorin3E,3,1.0986122886681098
progressed,3,1.0986122886681098
131,3,1.0986122886681098
regulator,3,1.0986122886681098
0003,3,1.0986122886681098
modulating,3,1.0986122886681098
AI,3,1.0986122886681098
households,3,1.0986122886681098
penetrating,3,1.0986122886681098
Therapy,3,1.0986122886681098
30-40,3,1.0986122886681098
liver,3,1.0986122886681098
true,3,1.0986122886681098
plausibility,3,1.0986122886681098
dehydrogenase,3,1.0986122886681098
contaminated,3,1.0986122886681098
angiograms,3,1.0986122886681098
serine,3,1.0986122886681098
POCT,3,1.0986122886681098
cholesterol,3,1.0986122886681098
Meanwhile,3,1.0986122886681098
alteration,3,1.0986122886681098
vaccinations,3,1.0986122886681098
conception,3,1.0986122886681098
sick,3,1.0986122886681098
learned,3,1.0986122886681098
probable,3,1.0986122886681098
followed-up,3,1.0986122886681098
induction,3,1.0986122886681098
spending,3,1.0986122886681098
Attack,3,1.0986122886681098
repeat,3,1.0986122886681098
Randomized,3,1.0986122886681098
disciplines,3,1.0986122886681098
Regarding,3,1.0986122886681098
descriptive,3,1.0986122886681098
surprising,3,1.0986122886681098
cerebellar,3,1.0986122886681098
relief,3,1.0986122886681098
Asthmatic,3,1.0986122886681098
Spain,3,1.0986122886681098
LVD,3,1.0986122886681098
effector,3,1.0986122886681098
differentiation,3,1.0986122886681098
decompressive,3,1.0986122886681098
mmHg,3,1.0986122886681098
calcium,3,1.0986122886681098
CHC,3,1.0986122886681098
user-friendly,3,1.0986122886681098
promise,3,1.0986122886681098
bicycle,3,1.0986122886681098
transcription-polymerase,3,1.0986122886681098
Airway,3,1.0986122886681098
immunosuppressive,3,1.0986122886681098
covering,3,1.0986122886681098
considering,3,1.0986122886681098
Portugal,3,1.0986122886681098
called,3,1.0986122886681098
regardless,3,1.0986122886681098
milder,3,1.0986122886681098
restrictions,3,1.0986122886681098
absenteeism,3,1.0986122886681098
restore,3,1.0986122886681098
thrombocytopaenia,3,1.0986122886681098
separate,3,1.0986122886681098
COVID-2019,3,1.0986122886681098
Egypt,3,1.0986122886681098
southern,3,1.0986122886681098
operations,3,1.0986122886681098
examples,3,1.0986122886681098
LAIV4,3,1.0986122886681098
university,3,1.0986122886681098
1990,3,1.0986122886681098
preoperative,3,1.0986122886681098
transfusion,3,1.0986122886681098
computerized,3,1.0986122886681098
Oxford,3,1.0986122886681098
maps,3,1.0986122886681098
predischarge,3,1.0986122886681098
zip,3,1.0986122886681098
Register,3,1.0986122886681098
Real-time,3,1.0986122886681098
Spontaneous,3,1.0986122886681098
Nineteen,3,1.0986122886681098
genetically,3,1.0986122886681098
Latinos,3,1.0986122886681098
NT-proBNP,3,1.0986122886681098
virology,3,1.0986122886681098
immunology,3,1.0986122886681098
co-circulation,3,1.0986122886681098
round,3,1.0986122886681098
classes,3,1.0986122886681098
CC,3,1.0986122886681098
unfavorable,3,1.0986122886681098
promises,3,1.0986122886681098
dual,3,1.0986122886681098
transplant,3,1.0986122886681098
CIND,3,1.0986122886681098
existed,3,1.0986122886681098
arrhythmic,3,1.0986122886681098
Turkish,3,1.0986122886681098
health-related,3,1.0986122886681098
recognizing,3,1.0986122886681098
Binfluenza,3,1.0986122886681098
pilot,3,1.0986122886681098
reproducible,3,1.0986122886681098
sub-Saharan,3,1.0986122886681098
remarkably,3,1.0986122886681098
April-June,3,1.0986122886681098
tended,3,1.0986122886681098
surgically,3,1.0986122886681098
importantly,3,1.0986122886681098
225,3,1.0986122886681098
Women,3,1.0986122886681098
involve,3,1.0986122886681098
viewed,3,1.0986122886681098
entities,3,1.0986122886681098
94,3,1.0986122886681098
Seven,3,1.0986122886681098
180,3,1.0986122886681098
Sciences,3,1.0986122886681098
slowly,3,1.0986122886681098
Nonetheless,3,1.0986122886681098
360,3,1.0986122886681098
example,3,1.0986122886681098
Symptom,3,1.0986122886681098
conceptual,3,1.0986122886681098
meteorological,3,1.0986122886681098
funding,3,1.0986122886681098
rising,3,1.0986122886681098
Utah,3,1.0986122886681098
peer-led,3,1.0986122886681098
stopped,3,1.0986122886681098
appendage,3,1.0986122886681098
233,3,1.0986122886681098
102,3,1.0986122886681098
030,3,1.0986122886681098
needing,3,1.0986122886681098
bronchoconstriction,3,1.0986122886681098
renin-angiotensin,3,1.0986122886681098
independence,3,1.0986122886681098
implementing,3,1.0986122886681098
011,3,1.0986122886681098
SCAD,3,1.0986122886681098
075,3,1.0986122886681098
advantage,3,1.0986122886681098
induces,3,1.0986122886681098
Various,3,1.0986122886681098
translational,3,1.0986122886681098
12-lead,3,1.0986122886681098
progenitor,3,1.0986122886681098
insertion,3,1.0986122886681098
brought,3,1.0986122886681098
014,3,1.0986122886681098
registration,3,1.0986122886681098
Lung,3,1.0986122886681098
high-income,3,1.0986122886681098
BHR,3,1.0986122886681098
hyper-responsiveness,3,1.0986122886681098
computerised,3,1.0986122886681098
prospectively,3,1.0986122886681098
worlds,3,1.0986122886681098
modules,3,1.0986122886681098
mAbs,3,1.0986122886681098
integrative,3,1.0986122886681098
FOV,3,1.0986122886681098
eyes,3,1.0986122886681098
tolerated,3,1.0986122886681098
consent,3,1.0986122886681098
leaders,3,1.0986122886681098
position,3,1.0986122886681098
contractility,3,1.0986122886681098
evidenced,3,1.0986122886681098
08,3,1.0986122886681098
primer,3,1.0986122886681098
convenience,3,1.0986122886681098
240,3,1.0986122886681098
epithelium,3,1.0986122886681098
summarise,3,1.0986122886681098
metabolic,3,1.0986122886681098
Index,3,1.0986122886681098
collateral,3,1.0986122886681098
meeting,3,1.0986122886681098
influencing,3,1.0986122886681098
Virus,3,1.0986122886681098
pose,3,1.0986122886681098
swimmers,3,1.0986122886681098
kinases,3,1.0986122886681098
electrographic,3,1.0986122886681098
arise,3,1.0986122886681098
RAAS,3,1.0986122886681098
Short-term,3,1.0986122886681098
2016,3,1.0986122886681098
raises,3,1.0986122886681098
complementary,3,1.0986122886681098
contractile,3,1.0986122886681098
contributors,3,1.0986122886681098
portal,3,1.0986122886681098
Stent,3,1.0986122886681098
decision-making,3,1.0986122886681098
preferred,3,1.0986122886681098
031,3,1.0986122886681098
day-to-day,3,1.0986122886681098
intracellular,3,1.0986122886681098
Interestingly,3,1.0986122886681098
hemagglutinin,3,1.0986122886681098
frontal,3,1.0986122886681098
confabulation,3,1.0986122886681098
hour,3,1.0986122886681098
premature,3,1.0986122886681098
minimal,3,1.0986122886681098
modeling,3,1.0986122886681098
western,3,1.0986122886681098
etiological,3,1.0986122886681098
first-ever,3,1.0986122886681098
rational,3,1.0986122886681098
human-to-human,3,1.0986122886681098
simply,3,1.0986122886681098
EDVI,3,1.0986122886681098
doing,3,1.0986122886681098
directions,3,1.0986122886681098
favour,3,1.0986122886681098
transducer,3,1.0986122886681098
Whilst,3,1.0986122886681098
haemagglutination,3,1.0986122886681098
untreated,3,1.0986122886681098
intermediate,3,1.0986122886681098
refute,3,1.0986122886681098
chance,3,1.0986122886681098
000,3,1.0986122886681098
poses,3,1.0986122886681098
intra-aortic,3,1.0986122886681098
outside,3,1.0986122886681098
ml,3,1.0986122886681098
glycosylation,3,1.0986122886681098
ammonia,3,1.0986122886681098
tuberculosis,3,1.0986122886681098
probes,3,1.0986122886681098
contracting,3,1.0986122886681098
gradual,3,1.0986122886681098
conscious,3,1.0986122886681098
anatomical,3,1.0986122886681098
Death,3,1.0986122886681098
subdivided,3,1.0986122886681098
Consensus,3,1.0986122886681098
nonfatal,3,1.0986122886681098
relieve,3,1.0986122886681098
TMGW,3,1.0986122886681098
cortex,3,1.0986122886681098
Follow-up,3,1.0986122886681098
N-13,3,1.0986122886681098
provinces,3,1.0986122886681098
supplied,3,1.0986122886681098
ostial,3,1.0986122886681098
mg100,3,1.0986122886681098
Maori,3,1.0986122886681098
213,3,1.0986122886681098
ESVI,3,1.0986122886681098
metformin,3,1.0986122886681098
capture,3,1.0986122886681098
estimating,3,1.0986122886681098
attempts,3,1.0986122886681098
097,3,1.0986122886681098
years-old,3,1.0986122886681098
201011,3,1.0986122886681098
thrombin,3,1.0986122886681098
charges,3,1.0986122886681098
10000,3,1.0986122886681098
visible,3,1.0986122886681098
shortness,3,1.0986122886681098
drawbacks,3,1.0986122886681098
overexpression,3,1.0986122886681098
herein,3,1.0986122886681098
aspergillosis,3,1.0986122886681098
owing,3,1.0986122886681098
non-responders,3,1.0986122886681098
virological,3,1.0986122886681098
LBBB,3,1.0986122886681098
ultimately,3,1.0986122886681098
stabilize,3,1.0986122886681098
hyperinflation,3,1.0986122886681098
repolarization,3,1.0986122886681098
biomarker,3,1.0986122886681098
Nevertheless,3,1.0986122886681098
pace,3,1.0986122886681098
vial,3,1.0986122886681098
strict,3,1.0986122886681098
full-length,3,1.0986122886681098
dosing,3,1.0986122886681098
wound,3,1.0986122886681098
Eight,3,1.0986122886681098
three-dimensional,3,1.0986122886681098
presumed,3,1.0986122886681098
iso,3,1.0986122886681098
Aspergillus,3,1.0986122886681098
encourage,3,1.0986122886681098
Ct,3,1.0986122886681098
1918-1919,3,1.0986122886681098
contacted,3,1.0986122886681098
campaigns,3,1.0986122886681098
IPC,3,1.0986122886681098
stunning,3,1.0986122886681098
infrequent,3,1.0986122886681098
trajectory,3,1.0986122886681098
time-dependent,3,1.0986122886681098
emphasize,3,1.0986122886681098
kUL,3,1.0986122886681098
posed,3,1.0986122886681098
prompted,3,1.0986122886681098
FDG,3,1.0986122886681098
occluded,3,1.0986122886681098
inversion,3,1.0986122886681098
malnutrition,3,1.0986122886681098
enables,3,1.0986122886681098
salvage,3,1.0986122886681098
missed,3,1.0986122886681098
drive,3,1.0986122886681098
preservation,3,1.0986122886681098
scar,3,1.0986122886681098
onwards,3,1.0986122886681098
medically,3,1.0986122886681098
amounted,3,1.0986122886681098
X,3,1.0986122886681098
prescription,3,1.0986122886681098
autoinflammatory,3,1.0986122886681098
repurposing,3,1.0986122886681098
crude,3,1.0986122886681098
pool,3,1.0986122886681098
moment,3,1.0986122886681098
angiogram,3,1.0986122886681098
neurogenesis,3,1.0986122886681098
mathematical,3,1.0986122886681098
sociodemographic,3,1.0986122886681098
contributed,3,1.0986122886681098
dissociation,3,1.0986122886681098
kinds,3,1.0986122886681098
storm,3,1.0986122886681098
multifaceted,3,1.0986122886681098
insurance,3,1.0986122886681098
dissemination,3,1.0986122886681098
virologically,3,1.0986122886681098
S1S2,3,1.0986122886681098
safely,3,1.0986122886681098
gated,3,1.0986122886681098
indium-111,3,1.0986122886681098
satisfactory,3,1.0986122886681098
MERS-CoV,3,1.0986122886681098
retrospectively,3,1.0986122886681098
organization,3,1.0986122886681098
personnel,3,1.0986122886681098
expressing,3,1.0986122886681098
proinflammatory,3,1.0986122886681098
unconcentrated,3,1.0986122886681098
route,3,1.0986122886681098
137,3,1.0986122886681098
surviving,3,1.0986122886681098
Rankin,3,1.0986122886681098
provocative,3,1.0986122886681098
interview,3,1.0986122886681098
graft,3,1.0986122886681098
signal-averaged,3,1.0986122886681098
categorical,3,1.0986122886681098
helps,3,1.0986122886681098
concentrated,3,1.0986122886681098
tomographic,3,1.0986122886681098
space,3,1.0986122886681098
receiver,3,1.0986122886681098
enhancement,3,1.0986122886681098
humanity,3,1.0986122886681098
AH1N1v,3,1.0986122886681098
preventable,3,1.0986122886681098
vertebral,3,1.0986122886681098
CT6,3,1.0986122886681098
perhaps,3,1.0986122886681098
Examination,3,1.0986122886681098
ruptured,3,1.0986122886681098
isoenzyme,3,1.0986122886681098
harsh,3,1.0986122886681098
fear,3,1.0986122886681098
federal,3,1.0986122886681098
canine,3,1.0986122886681098
qPCR,3,1.0986122886681098
intestinal,3,1.0986122886681098
compelling,3,1.0986122886681098
implicated,3,1.0986122886681098
VL,3,1.0986122886681098
snakebite,3,1.0986122886681098
Response,3,1.0986122886681098
Whereas,3,1.0986122886681098
co-morbidities,3,1.0986122886681098
distal,3,1.0986122886681098
accidents,3,1.0986122886681098
came,3,1.0986122886681098
doctors,3,1.0986122886681098
expCFR,3,1.0986122886681098
mesenchymal,3,1.0986122886681098
Montreal,3,1.0986122886681098
districts,3,1.0986122886681098
1232,3,1.0986122886681098
CT17,3,1.0986122886681098
lymphoid,3,1.0986122886681098
invasion,3,1.0986122886681098
PRNT90,3,1.0986122886681098
r-LVR,3,1.0986122886681098
Play,2,0.6931471805599453
thorough,2,0.6931471805599453
face-to-face,2,0.6931471805599453
assembly,2,0.6931471805599453
monomer,2,0.6931471805599453
waste,2,0.6931471805599453
monument,2,0.6931471805599453
cocaine-associated,2,0.6931471805599453
Changing,2,0.6931471805599453
antineoplastic,2,0.6931471805599453
mutants,2,0.6931471805599453
Arabia,2,0.6931471805599453
attractive,2,0.6931471805599453
REM,2,0.6931471805599453
Artery,2,0.6931471805599453
ivermectin,2,0.6931471805599453
shorten,2,0.6931471805599453
engraftment,2,0.6931471805599453
deteriorated,2,0.6931471805599453
Pharmacists,2,0.6931471805599453
regiments,2,0.6931471805599453
cohorting,2,0.6931471805599453
Saudi,2,0.6931471805599453
difficult-to-manage,2,0.6931471805599453
adjuvant,2,0.6931471805599453
ACS,2,0.6931471805599453
indeed,2,0.6931471805599453
rheumatic,2,0.6931471805599453
CSF,2,0.6931471805599453
VLP-based,2,0.6931471805599453
Northern,2,0.6931471805599453
acetylcholine,2,0.6931471805599453
interactive,2,0.6931471805599453
tube,2,0.6931471805599453
acceptability,2,0.6931471805599453
strictly,2,0.6931471805599453
immunostimulants,2,0.6931471805599453
Hyperthyroidism,2,0.6931471805599453
NPs,2,0.6931471805599453
pediatricians,2,0.6931471805599453
packaged,2,0.6931471805599453
690,2,0.6931471805599453
cardiologists,2,0.6931471805599453
alongside,2,0.6931471805599453
stenoses,2,0.6931471805599453
hold,2,0.6931471805599453
β2,2,0.6931471805599453
Hygiene,2,0.6931471805599453
18F-FDG,2,0.6931471805599453
mildly,2,0.6931471805599453
cytokine-mediated,2,0.6931471805599453
RBD-specific,2,0.6931471805599453
predominate,2,0.6931471805599453
error,2,0.6931471805599453
Without,2,0.6931471805599453
trust,2,0.6931471805599453
English,2,0.6931471805599453
in-depth,2,0.6931471805599453
projected,2,0.6931471805599453
Numerous,2,0.6931471805599453
resumption,2,0.6931471805599453
speculated,2,0.6931471805599453
preventer,2,0.6931471805599453
spectrometry,2,0.6931471805599453
Sigma,2,0.6931471805599453
Wake-Up,2,0.6931471805599453
immunosuppressants,2,0.6931471805599453
emphasizes,2,0.6931471805599453
postpartum,2,0.6931471805599453
1980,2,0.6931471805599453
capillary,2,0.6931471805599453
Sakai,2,0.6931471805599453
30-minute,2,0.6931471805599453
prepare,2,0.6931471805599453
Differences,2,0.6931471805599453
perinatal,2,0.6931471805599453
Middle,2,0.6931471805599453
fields,2,0.6931471805599453
mechanistic,2,0.6931471805599453
hyperthyroidism,2,0.6931471805599453
Valencia,2,0.6931471805599453
sizes,2,0.6931471805599453
pressures,2,0.6931471805599453
intraocular,2,0.6931471805599453
East,2,0.6931471805599453
multimodal,2,0.6931471805599453
informed,2,0.6931471805599453
biologic,2,0.6931471805599453
Physical,2,0.6931471805599453
elevations,2,0.6931471805599453
credible,2,0.6931471805599453
awakened,2,0.6931471805599453
dealing,2,0.6931471805599453
lacked,2,0.6931471805599453
Autonomous,2,0.6931471805599453
employing,2,0.6931471805599453
interrupt,2,0.6931471805599453
interested,2,0.6931471805599453
horizons,2,0.6931471805599453
TSH,2,0.6931471805599453
exhibiting,2,0.6931471805599453
Indeed,2,0.6931471805599453
Neurology,2,0.6931471805599453
Federation,2,0.6931471805599453
condensate,2,0.6931471805599453
Alzheimer,2,0.6931471805599453
Bayesian,2,0.6931471805599453
repetitive,2,0.6931471805599453
neurodegenerative,2,0.6931471805599453
neurodegeneration,2,0.6931471805599453
Dysregulation,2,0.6931471805599453
downstream,2,0.6931471805599453
7-10,2,0.6931471805599453
mapping,2,0.6931471805599453
economical,2,0.6931471805599453
impending,2,0.6931471805599453
variance,2,0.6931471805599453
Factor,2,0.6931471805599453
subjectively,2,0.6931471805599453
unnecessary,2,0.6931471805599453
VAL,2,0.6931471805599453
321,2,0.6931471805599453
Diagnostic,2,0.6931471805599453
Tumor,2,0.6931471805599453
RCTs,2,0.6931471805599453
266,2,0.6931471805599453
mediating,2,0.6931471805599453
worker,2,0.6931471805599453
FT4,2,0.6931471805599453
journals,2,0.6931471805599453
peer-reviewed,2,0.6931471805599453
2500,2,0.6931471805599453
searched,2,0.6931471805599453
prognostically,2,0.6931471805599453
Neurological,2,0.6931471805599453
DALYs,2,0.6931471805599453
normalized,2,0.6931471805599453
396,2,0.6931471805599453
thalamic,2,0.6931471805599453
escalating,2,0.6931471805599453
hydroxychloroquine,2,0.6931471805599453
Repeated,2,0.6931471805599453
modifying,2,0.6931471805599453
GAPDH,2,0.6931471805599453
demographics,2,0.6931471805599453
sole,2,0.6931471805599453
conducting,2,0.6931471805599453
obstacles,2,0.6931471805599453
539,2,0.6931471805599453
wished,2,0.6931471805599453
attitudinal,2,0.6931471805599453
esophagus,2,0.6931471805599453
pending,2,0.6931471805599453
complementaryalternative,2,0.6931471805599453
grams,2,0.6931471805599453
reluctant,2,0.6931471805599453
switching,2,0.6931471805599453
virion,2,0.6931471805599453
spinal,2,0.6931471805599453
alveolar,2,0.6931471805599453
Antigenic,2,0.6931471805599453
habits,2,0.6931471805599453
Pulmonary,2,0.6931471805599453
separation,2,0.6931471805599453
peramivir,2,0.6931471805599453
Forty,2,0.6931471805599453
Literature,2,0.6931471805599453
Haemophilus,2,0.6931471805599453
regeneration,2,0.6931471805599453
BVF,2,0.6931471805599453
Fibromuscular,2,0.6931471805599453
HDT,2,0.6931471805599453
Ongoing,2,0.6931471805599453
serotype,2,0.6931471805599453
night,2,0.6931471805599453
baricitinib,2,0.6931471805599453
Classification,2,0.6931471805599453
confused,2,0.6931471805599453
tachycardia,2,0.6931471805599453
Endovascular,2,0.6931471805599453
polyprotein,2,0.6931471805599453
selectin,2,0.6931471805599453
organic,2,0.6931471805599453
repositive,2,0.6931471805599453
classifications,2,0.6931471805599453
BID,2,0.6931471805599453
IMT,2,0.6931471805599453
perforation,2,0.6931471805599453
Methylene,2,0.6931471805599453
referral,2,0.6931471805599453
jointly,2,0.6931471805599453
Interleukin,2,0.6931471805599453
nanoparticle,2,0.6931471805599453
portion,2,0.6931471805599453
giant,2,0.6931471805599453
nsp7-10,2,0.6931471805599453
otitis,2,0.6931471805599453
verify,2,0.6931471805599453
Population,2,0.6931471805599453
excludes,2,0.6931471805599453
1964,2,0.6931471805599453
entire,2,0.6931471805599453
presumably,2,0.6931471805599453
gravity,2,0.6931471805599453
savings,2,0.6931471805599453
reminders,2,0.6931471805599453
222,2,0.6931471805599453
1985,2,0.6931471805599453
IL-1,2,0.6931471805599453
attending,2,0.6931471805599453
cm,2,0.6931471805599453
processed,2,0.6931471805599453
solid,2,0.6931471805599453
biventricular,2,0.6931471805599453
Rehabilitation,2,0.6931471805599453
altitude,2,0.6931471805599453
permanently,2,0.6931471805599453
ranges,2,0.6931471805599453
supposedly,2,0.6931471805599453
414,2,0.6931471805599453
moderate-severe,2,0.6931471805599453
smallest,2,0.6931471805599453
Ul,2,0.6931471805599453
socio-demographic,2,0.6931471805599453
PCRs,2,0.6931471805599453
evolves,2,0.6931471805599453
clefts,2,0.6931471805599453
nuclear,2,0.6931471805599453
PB2,2,0.6931471805599453
nutritional,2,0.6931471805599453
prolong,2,0.6931471805599453
substitutions,2,0.6931471805599453
p-interaction,2,0.6931471805599453
0006,2,0.6931471805599453
isolations,2,0.6931471805599453
compartments,2,0.6931471805599453
Tianjin,2,0.6931471805599453
≥1,2,0.6931471805599453
cholesterin,2,0.6931471805599453
avoided,2,0.6931471805599453
workup,2,0.6931471805599453
foam,2,0.6931471805599453
armhand,2,0.6931471805599453
judgment,2,0.6931471805599453
Correct,2,0.6931471805599453
inadequate,2,0.6931471805599453
lactate,2,0.6931471805599453
SIS,2,0.6931471805599453
Impact,2,0.6931471805599453
advance,2,0.6931471805599453
tachyarrhythmia,2,0.6931471805599453
atopy,2,0.6931471805599453
pollutants,2,0.6931471805599453
entering,2,0.6931471805599453
mapped,2,0.6931471805599453
RNA-dependent,2,0.6931471805599453
IL-1β,2,0.6931471805599453
VV-ECMO,2,0.6931471805599453
winters,2,0.6931471805599453
solved,2,0.6931471805599453
tropical,2,0.6931471805599453
Where,2,0.6931471805599453
Vietnam,2,0.6931471805599453
suffer,2,0.6931471805599453
ingredient,2,0.6931471805599453
initiating,2,0.6931471805599453
Avian,2,0.6931471805599453
transmembrane,2,0.6931471805599453
NSTEMI,2,0.6931471805599453
storms,2,0.6931471805599453
extracorporeal,2,0.6931471805599453
small-molecule,2,0.6931471805599453
recent-phase,2,0.6931471805599453
narrowing,2,0.6931471805599453
M2,2,0.6931471805599453
Circadian,2,0.6931471805599453
Digital,2,0.6931471805599453
295,2,0.6931471805599453
275,2,0.6931471805599453
precision,2,0.6931471805599453
proportional,2,0.6931471805599453
surgeons,2,0.6931471805599453
01,2,0.6931471805599453
conventionally,2,0.6931471805599453
FMA-UE,2,0.6931471805599453
3-5,2,0.6931471805599453
2001,2,0.6931471805599453
histopathological,2,0.6931471805599453
forefront,2,0.6931471805599453
Region,2,0.6931471805599453
Rh,2,0.6931471805599453
MN,2,0.6931471805599453
leukocytosis,2,0.6931471805599453
stimulant,2,0.6931471805599453
eighth,2,0.6931471805599453
non-ST-elevation,2,0.6931471805599453
manifested,2,0.6931471805599453
rescue,2,0.6931471805599453
fractured,2,0.6931471805599453
Loop,2,0.6931471805599453
leukocytes,2,0.6931471805599453
man-made,2,0.6931471805599453
Osaka,2,0.6931471805599453
Then,2,0.6931471805599453
charged,2,0.6931471805599453
anterolateral,2,0.6931471805599453
bullet,2,0.6931471805599453
unaffected,2,0.6931471805599453
postural,2,0.6931471805599453
5-34,2,0.6931471805599453
revascularized,2,0.6931471805599453
usefully,2,0.6931471805599453
negatively,2,0.6931471805599453
readmitted,2,0.6931471805599453
antagonists,2,0.6931471805599453
cities,2,0.6931471805599453
VCG,2,0.6931471805599453
vectorcardiography,2,0.6931471805599453
hit,2,0.6931471805599453
Brewers,2,0.6931471805599453
resolves,2,0.6931471805599453
distinction,2,0.6931471805599453
suggestive,2,0.6931471805599453
leukotriene,2,0.6931471805599453
Richard,2,0.6931471805599453
radiologic,2,0.6931471805599453
fiber,2,0.6931471805599453
deciding,2,0.6931471805599453
Act,2,0.6931471805599453
subsequently,2,0.6931471805599453
subunits,2,0.6931471805599453
W,2,0.6931471805599453
convenient,2,0.6931471805599453
0018,2,0.6931471805599453
spatio-temporal,2,0.6931471805599453
school-age,2,0.6931471805599453
504,2,0.6931471805599453
compulsory,2,0.6931471805599453
Army,2,0.6931471805599453
intimal,2,0.6931471805599453
kind,2,0.6931471805599453
extrasystoles,2,0.6931471805599453
facial,2,0.6931471805599453
reproduce,2,0.6931471805599453
adrenal,2,0.6931471805599453
affinity,2,0.6931471805599453
extremity,2,0.6931471805599453
Critical,2,0.6931471805599453
incremental,2,0.6931471805599453
093,2,0.6931471805599453
fragmentation,2,0.6931471805599453
Therapeutic,2,0.6931471805599453
weather,2,0.6931471805599453
fragmented,2,0.6931471805599453
CLOCK,2,0.6931471805599453
BMAL1,2,0.6931471805599453
Ireland,2,0.6931471805599453
catecholamine,2,0.6931471805599453
inconsistent,2,0.6931471805599453
modulated,2,0.6931471805599453
VNS,2,0.6931471805599453
aviators,2,0.6931471805599453
flying,2,0.6931471805599453
long-lasting,2,0.6931471805599453
plasticity,2,0.6931471805599453
fat,2,0.6931471805599453
aviation,2,0.6931471805599453
ABO,2,0.6931471805599453
FFMI,2,0.6931471805599453
24-hour,2,0.6931471805599453
TnI,2,0.6931471805599453
N-terminal,2,0.6931471805599453
realistic,2,0.6931471805599453
Simultaneously,2,0.6931471805599453
organised,2,0.6931471805599453
bench,2,0.6931471805599453
epidrugs,2,0.6931471805599453
modes,2,0.6931471805599453
methylation,2,0.6931471805599453
vectorial,2,0.6931471805599453
Switzerland,2,0.6931471805599453
recording,2,0.6931471805599453
layers,2,0.6931471805599453
acts,2,0.6931471805599453
RAS,2,0.6931471805599453
root,2,0.6931471805599453
317,2,0.6931471805599453
Angiotensin-converting,2,0.6931471805599453
fibrinolytic,2,0.6931471805599453
BFMI,2,0.6931471805599453
band,2,0.6931471805599453
whites,2,0.6931471805599453
suddenly,2,0.6931471805599453
GISSI,2,0.6931471805599453
Arrhythmias,2,0.6931471805599453
Witwatersrand,2,0.6931471805599453
recruits,2,0.6931471805599453
PCR-confirmed,2,0.6931471805599453
paramount,2,0.6931471805599453
maintained,2,0.6931471805599453
5-years,2,0.6931471805599453
worsened,2,0.6931471805599453
AST,2,0.6931471805599453
HIV,2,0.6931471805599453
Takotsubo,2,0.6931471805599453
impacting,2,0.6931471805599453
evenly,2,0.6931471805599453
pheochromocytoma,2,0.6931471805599453
pilgrims,2,0.6931471805599453
nonpharmaceutical,2,0.6931471805599453
answered,2,0.6931471805599453
Surveys,2,0.6931471805599453
clots,2,0.6931471805599453
Trial,2,0.6931471805599453
Improved,2,0.6931471805599453
2016-2017,2,0.6931471805599453
prevents,2,0.6931471805599453
precisely,2,0.6931471805599453
Easy,2,0.6931471805599453
obvious,2,0.6931471805599453
beta-blockade,2,0.6931471805599453
convincingly,2,0.6931471805599453
Sam,2,0.6931471805599453
MACE,2,0.6931471805599453
hemispheres,2,0.6931471805599453
remove,2,0.6931471805599453
extra,2,0.6931471805599453
train,2,0.6931471805599453
lineages,2,0.6931471805599453
mitigating,2,0.6931471805599453
gait-training,2,0.6931471805599453
implication,2,0.6931471805599453
carcinogenicity,2,0.6931471805599453
So,2,0.6931471805599453
convolutional,2,0.6931471805599453
Special,2,0.6931471805599453
anticipated,2,0.6931471805599453
hepatotoxicity,2,0.6931471805599453
316,2,0.6931471805599453
Serious,2,0.6931471805599453
1071,2,0.6931471805599453
establishment,2,0.6931471805599453
elucidated,2,0.6931471805599453
dioxide,2,0.6931471805599453
carbon,2,0.6931471805599453
NFA,2,0.6931471805599453
Nanyang,2,0.6931471805599453
intakes,2,0.6931471805599453
non-mutagenic,2,0.6931471805599453
syncytial,2,0.6931471805599453
zero,2,0.6931471805599453
Province,2,0.6931471805599453
databases,2,0.6931471805599453
anti-influenza,2,0.6931471805599453
amounts,2,0.6931471805599453
Philippines,2,0.6931471805599453
identifiable,2,0.6931471805599453
cryptogenic,2,0.6931471805599453
Hong,2,0.6931471805599453
3611,2,0.6931471805599453
1342,2,0.6931471805599453
designs,2,0.6931471805599453
AR,2,0.6931471805599453
imposed,2,0.6931471805599453
MCAO,2,0.6931471805599453
Efforts,2,0.6931471805599453
quarantine,2,0.6931471805599453
postprocedural,2,0.6931471805599453
shifts,2,0.6931471805599453
thromboembolic,2,0.6931471805599453
NOEs,2,0.6931471805599453
illuminate,2,0.6931471805599453
sciences,2,0.6931471805599453
Once,2,0.6931471805599453
helices,2,0.6931471805599453
contrasts,2,0.6931471805599453
286,2,0.6931471805599453
rhinitis,2,0.6931471805599453
ethically,2,0.6931471805599453
fractional,2,0.6931471805599453
label,2,0.6931471805599453
Beta,2,0.6931471805599453
Gamma,2,0.6931471805599453
1356,2,0.6931471805599453
benchmark,2,0.6931471805599453
3991,2,0.6931471805599453
physiology,2,0.6931471805599453
blocks,2,0.6931471805599453
building,2,0.6931471805599453
FEV1FVC,2,0.6931471805599453
1349,2,0.6931471805599453
4122,2,0.6931471805599453
3481,2,0.6931471805599453
montelukast,2,0.6931471805599453
ligands,2,0.6931471805599453
1919,2,0.6931471805599453
doxycycline,2,0.6931471805599453
dampness,2,0.6931471805599453
HRCurrent,2,0.6931471805599453
heating,2,0.6931471805599453
eNO,2,0.6931471805599453
allergenic,2,0.6931471805599453
insensitive,2,0.6931471805599453
nights,2,0.6931471805599453
classifying,2,0.6931471805599453
modifiable,2,0.6931471805599453
antiinflammatory,2,0.6931471805599453
bodies,2,0.6931471805599453
residential,2,0.6931471805599453
vectors,2,0.6931471805599453
build,2,0.6931471805599453
Exposure,2,0.6931471805599453
serum-free,2,0.6931471805599453
observable,2,0.6931471805599453
favorably,2,0.6931471805599453
maximizing,2,0.6931471805599453
accelerates,2,0.6931471805599453
cationic,2,0.6931471805599453
ideas,2,0.6931471805599453
coughing,2,0.6931471805599453
aeroallergens,2,0.6931471805599453
correlating,2,0.6931471805599453
Young,2,0.6931471805599453
belief,2,0.6931471805599453
peer,2,0.6931471805599453
molecule,2,0.6931471805599453
trivalent,2,0.6931471805599453
late-onset,2,0.6931471805599453
Flk-1,2,0.6931471805599453
contamination,2,0.6931471805599453
histologically,2,0.6931471805599453
045,2,0.6931471805599453
carcinoma,2,0.6931471805599453
completing,2,0.6931471805599453
Africans,2,0.6931471805599453
343,2,0.6931471805599453
demonstration,2,0.6931471805599453
weak,2,0.6931471805599453
heterozygote,2,0.6931471805599453
occupant,2,0.6931471805599453
blockers,2,0.6931471805599453
840,2,0.6931471805599453
prick,2,0.6931471805599453
Electrical,2,0.6931471805599453
comprising,2,0.6931471805599453
extract,2,0.6931471805599453
busy,2,0.6931471805599453
murine,2,0.6931471805599453
express,2,0.6931471805599453
believed,2,0.6931471805599453
add,2,0.6931471805599453
bacteria,2,0.6931471805599453
plaques,2,0.6931471805599453
historical,2,0.6931471805599453
pteronyssinus,2,0.6931471805599453
Dermatophagoides,2,0.6931471805599453
homes,2,0.6931471805599453
sensitized,2,0.6931471805599453
CLRD,2,0.6931471805599453
adult-onset,2,0.6931471805599453
housing,2,0.6931471805599453
childhood-onset,2,0.6931471805599453
cardiomyocyte,2,0.6931471805599453
put,2,0.6931471805599453
nonetheless,2,0.6931471805599453
vivid,2,0.6931471805599453
Nation,2,0.6931471805599453
midlife,2,0.6931471805599453
SM-IVE,2,0.6931471805599453
excluding,2,0.6931471805599453
microglia,2,0.6931471805599453
Well-Integrated,2,0.6931471805599453
Across,2,0.6931471805599453
inactivity,2,0.6931471805599453
structured,2,0.6931471805599453
Be,2,0.6931471805599453
Wise,2,0.6931471805599453
healthier,2,0.6931471805599453
permeation,2,0.6931471805599453
Hispanic,2,0.6931471805599453
NAMRU-3,2,0.6931471805599453
Shortening,2,0.6931471805599453
distinguishing,2,0.6931471805599453
architecture,2,0.6931471805599453
annually,2,0.6931471805599453
mentioned,2,0.6931471805599453
rtPA,2,0.6931471805599453
transported,2,0.6931471805599453
neurons,2,0.6931471805599453
or2,2,0.6931471805599453
receipt,2,0.6931471805599453
PWV,2,0.6931471805599453
fecal-viral,2,0.6931471805599453
stiffness,2,0.6931471805599453
Registry,2,0.6931471805599453
Coverdell,2,0.6931471805599453
Paul,2,0.6931471805599453
precipitating,2,0.6931471805599453
underestimated,2,0.6931471805599453
dangerous,2,0.6931471805599453
pig,2,0.6931471805599453
headaches,2,0.6931471805599453
relating,2,0.6931471805599453
evidenced-based,2,0.6931471805599453
resected,2,0.6931471805599453
AB,2,0.6931471805599453
figure,2,0.6931471805599453
myeloperoxidase,2,0.6931471805599453
recur,2,0.6931471805599453
831,2,0.6931471805599453
counter-pulsation,2,0.6931471805599453
INSIGHT,2,0.6931471805599453
autologous,2,0.6931471805599453
NASBA,2,0.6931471805599453
sequencing-based,2,0.6931471805599453
Antiplatelet,2,0.6931471805599453
entity,2,0.6931471805599453
795,2,0.6931471805599453
Cerebral,2,0.6931471805599453
Sweden,2,0.6931471805599453
NEMSIS,2,0.6931471805599453
next-generation,2,0.6931471805599453
aiming,2,0.6931471805599453
Mental,2,0.6931471805599453
readout,2,0.6931471805599453
presymptomatic,2,0.6931471805599453
gives,2,0.6931471805599453
cytopathology,2,0.6931471805599453
ferret,2,0.6931471805599453
officially,2,0.6931471805599453
diffusion,2,0.6931471805599453
nations,2,0.6931471805599453
producing,2,0.6931471805599453
fluctuation,2,0.6931471805599453
computational,2,0.6931471805599453
endpoints,2,0.6931471805599453
participate,2,0.6931471805599453
Sample,2,0.6931471805599453
refined,2,0.6931471805599453
VBDE,2,0.6931471805599453
excluded,2,0.6931471805599453
nonteaching,2,0.6931471805599453
corrected,2,0.6931471805599453
oil,2,0.6931471805599453
overlooked,2,0.6931471805599453
2009-2010,2,0.6931471805599453
bronchoalveolar,2,0.6931471805599453
CD147,2,0.6931471805599453
109,2,0.6931471805599453
steady,2,0.6931471805599453
hospital-level,2,0.6931471805599453
deployment,2,0.6931471805599453
PHC,2,0.6931471805599453
supratentorial,2,0.6931471805599453
infratentorial,2,0.6931471805599453
distinguished,2,0.6931471805599453
works,2,0.6931471805599453
AGTs,2,0.6931471805599453
346,2,0.6931471805599453
permits,2,0.6931471805599453
endemic,2,0.6931471805599453
undertreated,2,0.6931471805599453
encounter,2,0.6931471805599453
differentiate,2,0.6931471805599453
pressing,2,0.6931471805599453
LAIV,2,0.6931471805599453
marginal,2,0.6931471805599453
010,2,0.6931471805599453
219,2,0.6931471805599453
Thirty,2,0.6931471805599453
Reducing,2,0.6931471805599453
anti-platelet,2,0.6931471805599453
dog,2,0.6931471805599453
vaccine-related,2,0.6931471805599453
CCU,2,0.6931471805599453
Tokyo,2,0.6931471805599453
Being,2,0.6931471805599453
1995,2,0.6931471805599453
Large,2,0.6931471805599453
EUA,2,0.6931471805599453
monthly,2,0.6931471805599453
district,2,0.6931471805599453
temporally,2,0.6931471805599453
surely,2,0.6931471805599453
declining,2,0.6931471805599453
definitely,2,0.6931471805599453
disturbance,2,0.6931471805599453
769,2,0.6931471805599453
warrants,2,0.6931471805599453
nodes,2,0.6931471805599453
lymph,2,0.6931471805599453
Ischaemic,2,0.6931471805599453
comprised,2,0.6931471805599453
translated,2,0.6931471805599453
Initial,2,0.6931471805599453
proceeding,2,0.6931471805599453
1000,2,0.6931471805599453
stop,2,0.6931471805599453
ORs,2,0.6931471805599453
fossa,2,0.6931471805599453
0011,2,0.6931471805599453
olive,2,0.6931471805599453
Thirty-six,2,0.6931471805599453
subscale,2,0.6931471805599453
expand,2,0.6931471805599453
right-sided,2,0.6931471805599453
evolutionary,2,0.6931471805599453
fibers,2,0.6931471805599453
Expert,2,0.6931471805599453
hypotensive,2,0.6931471805599453
covered,2,0.6931471805599453
BM1918,2,0.6931471805599453
instructions,2,0.6931471805599453
ICIs,2,0.6931471805599453
grades,2,0.6931471805599453
Better,2,0.6931471805599453
antibiotic,2,0.6931471805599453
failures,2,0.6931471805599453
deficiencies,2,0.6931471805599453
Environmental,2,0.6931471805599453
treatable,2,0.6931471805599453
TTs,2,0.6931471805599453
H2N2,2,0.6931471805599453
Method,2,0.6931471805599453
GR,2,0.6931471805599453
weakly,2,0.6931471805599453
00005,2,0.6931471805599453
Significant,2,0.6931471805599453
sent,2,0.6931471805599453
necrotic,2,0.6931471805599453
Implementation,2,0.6931471805599453
EMs,2,0.6931471805599453
Experimental,2,0.6931471805599453
rs1800872,2,0.6931471805599453
stratify,2,0.6931471805599453
single-nucleotide,2,0.6931471805599453
unpredictable,2,0.6931471805599453
angiographically,2,0.6931471805599453
USEPA,2,0.6931471805599453
Cellular,2,0.6931471805599453
AU,2,0.6931471805599453
NIs,2,0.6931471805599453
UL,2,0.6931471805599453
isocapnic,2,0.6931471805599453
losses,2,0.6931471805599453
low-intensity,2,0.6931471805599453
postmyocardial,2,0.6931471805599453
etc,2,0.6931471805599453
2-dimensional,2,0.6931471805599453
interventricular,2,0.6931471805599453
depended,2,0.6931471805599453
Individual,2,0.6931471805599453
hepatitis,2,0.6931471805599453
autonomic,2,0.6931471805599453
skeletal,2,0.6931471805599453
revolutionized,2,0.6931471805599453
front-line,2,0.6931471805599453
Performance,2,0.6931471805599453
LCBI,2,0.6931471805599453
feces,2,0.6931471805599453
LCBIs,2,0.6931471805599453
establishes,2,0.6931471805599453
336,2,0.6931471805599453
bloodstream,2,0.6931471805599453
threatening,2,0.6931471805599453
optimized,2,0.6931471805599453
09,2,0.6931471805599453
Victoria,2,0.6931471805599453
residuals,2,0.6931471805599453
Safety,2,0.6931471805599453
negatives,2,0.6931471805599453
cytoplasmic,2,0.6931471805599453
WHAT,2,0.6931471805599453
tHcy,2,0.6931471805599453
prescribing,2,0.6931471805599453
indeterminate,2,0.6931471805599453
117,2,0.6931471805599453
QTc,2,0.6931471805599453
peaked,2,0.6931471805599453
albumin,2,0.6931471805599453
elicit,2,0.6931471805599453
engineered,2,0.6931471805599453
predominated,2,0.6931471805599453
January-February,2,0.6931471805599453
intrafamilial,2,0.6931471805599453
Dutch,2,0.6931471805599453
shelters,2,0.6931471805599453
repurposed,2,0.6931471805599453
mRNA-based,2,0.6931471805599453
Potential,2,0.6931471805599453
VNT,2,0.6931471805599453
engineering,2,0.6931471805599453
rectal,2,0.6931471805599453
evolve,2,0.6931471805599453
Thailand,2,0.6931471805599453
retrieved,2,0.6931471805599453
109L,2,0.6931471805599453
files,2,0.6931471805599453
sternotomy,2,0.6931471805599453
strip,2,0.6931471805599453
pollen,2,0.6931471805599453
urinary,2,0.6931471805599453
Schirmers,2,0.6931471805599453
hsCRP,2,0.6931471805599453
BSL-2,2,0.6931471805599453
enters,2,0.6931471805599453
Complications,2,0.6931471805599453
111,2,0.6931471805599453
025,2,0.6931471805599453
3rd,2,0.6931471805599453
Statement,2,0.6931471805599453
341,2,0.6931471805599453
353,2,0.6931471805599453
46-fold,2,0.6931471805599453
No1-9,2,0.6931471805599453
hypobiotic,2,0.6931471805599453
Positive,2,0.6931471805599453
music-supported,2,0.6931471805599453
stroke-induced,2,0.6931471805599453
searches,2,0.6931471805599453
Embase,2,0.6931471805599453
116,2,0.6931471805599453
scientists,2,0.6931471805599453
124,2,0.6931471805599453
trophic,2,0.6931471805599453
094,2,0.6931471805599453
sections,2,0.6931471805599453
epidermal,2,0.6931471805599453
autoregulation,2,0.6931471805599453
guiding,2,0.6931471805599453
life-saving,2,0.6931471805599453
generating,2,0.6931471805599453
T-cells,2,0.6931471805599453
predictions,2,0.6931471805599453
FluCAN,2,0.6931471805599453
Eighty-one,2,0.6931471805599453
individually,2,0.6931471805599453
amplicons,2,0.6931471805599453
Less,2,0.6931471805599453
shortly,2,0.6931471805599453
personalized,2,0.6931471805599453
Function,2,0.6931471805599453
Wolf,2,0.6931471805599453
Arm,2,0.6931471805599453
EM,2,0.6931471805599453
358,2,0.6931471805599453
057,2,0.6931471805599453
064,2,0.6931471805599453
ascertain,2,0.6931471805599453
047,2,0.6931471805599453
008,2,0.6931471805599453
087,2,0.6931471805599453
142,2,0.6931471805599453
074,2,0.6931471805599453
provoke,2,0.6931471805599453
Action,2,0.6931471805599453
trajectories,2,0.6931471805599453
myofibroblasts,2,0.6931471805599453
subepithelial,2,0.6931471805599453
054,2,0.6931471805599453
Fugl-Meyer,2,0.6931471805599453
-015,2,0.6931471805599453
perennial,2,0.6931471805599453
reproducibility,2,0.6931471805599453
relations,2,0.6931471805599453
teenage,2,0.6931471805599453
loop,2,0.6931471805599453
adenosine,2,0.6931471805599453
gaining,2,0.6931471805599453
reversing,2,0.6931471805599453
unreliable,2,0.6931471805599453
Practice,2,0.6931471805599453
≥15,2,0.6931471805599453
Work-related,2,0.6931471805599453
inherent,2,0.6931471805599453
irritant-induced,2,0.6931471805599453
new-onset,2,0.6931471805599453
boy,2,0.6931471805599453
immunoassay,2,0.6931471805599453
situ,2,0.6931471805599453
Brugada,2,0.6931471805599453
precordial,2,0.6931471805599453
documentation,2,0.6931471805599453
inconclusive,2,0.6931471805599453
V2,2,0.6931471805599453
Hence,2,0.6931471805599453
exchange,2,0.6931471805599453
Communicable,2,0.6931471805599453
CoVs,2,0.6931471805599453
vitamin,2,0.6931471805599453
inorganic-,2,0.6931471805599453
atherothrombotic,2,0.6931471805599453
migration,2,0.6931471805599453
971,2,0.6931471805599453
CVRF,2,0.6931471805599453
branches,2,0.6931471805599453
specialized,2,0.6931471805599453
unit-level,2,0.6931471805599453
5-10,2,0.6931471805599453
chapter,2,0.6931471805599453
transitional,2,0.6931471805599453
HRV-induced,2,0.6931471805599453
Scotland,2,0.6931471805599453
Morbidity,2,0.6931471805599453
basilar,2,0.6931471805599453
hyperresponsive,2,0.6931471805599453
stimuli,2,0.6931471805599453
cessation,2,0.6931471805599453
commercially,2,0.6931471805599453
coping,2,0.6931471805599453
develops,2,0.6931471805599453
Central,2,0.6931471805599453
carrying,2,0.6931471805599453
publishes,2,0.6931471805599453
CLIA-iFlash,2,0.6931471805599453
helped,2,0.6931471805599453
delineate,2,0.6931471805599453
consisting,2,0.6931471805599453
Biotech,2,0.6931471805599453
Univariate,2,0.6931471805599453
10hour,2,0.6931471805599453
causation,2,0.6931471805599453
precipitation,2,0.6931471805599453
Ventricular,2,0.6931471805599453
additionally,2,0.6931471805599453
wind,2,0.6931471805599453
dewfrost,2,0.6931471805599453
p0001,2,0.6931471805599453
Fast,2,0.6931471805599453
Cumulative,2,0.6931471805599453
hinder,2,0.6931471805599453
anesthesia,2,0.6931471805599453
chemiluminescence,2,0.6931471805599453
exceeded,2,0.6931471805599453
high-energy,2,0.6931471805599453
effluents,2,0.6931471805599453
template,2,0.6931471805599453
DTD,2,0.6931471805599453
below,2,0.6931471805599453
contributions,2,0.6931471805599453
CK-MB,2,0.6931471805599453
337,2,0.6931471805599453
FA,2,0.6931471805599453
forming,2,0.6931471805599453
130,2,0.6931471805599453
launch,2,0.6931471805599453
Associated,2,0.6931471805599453
depressive,2,0.6931471805599453
3-terminal,2,0.6931471805599453
-3,2,0.6931471805599453
LFIA,2,0.6931471805599453
three-year,2,0.6931471805599453
deletions,2,0.6931471805599453
113,2,0.6931471805599453
tracked,2,0.6931471805599453
Reported,2,0.6931471805599453
HRQOL,2,0.6931471805599453
eosinophilia,2,0.6931471805599453
population-based,2,0.6931471805599453
AdC68-19RBDs,2,0.6931471805599453
I-MOVE,2,0.6931471805599453
vasospasm,2,0.6931471805599453
distance,2,0.6931471805599453
typesubtype-specific,2,0.6931471805599453
modelled,2,0.6931471805599453
bundle-branch,2,0.6931471805599453
charge,2,0.6931471805599453
553,2,0.6931471805599453
Litomosoides,2,0.6931471805599453
enter,2,0.6931471805599453
Another,2,0.6931471805599453
revising,2,0.6931471805599453
recurrences,2,0.6931471805599453
extrapolated,2,0.6931471805599453
Available,2,0.6931471805599453
Antihypertensive,2,0.6931471805599453
vasculature,2,0.6931471805599453
gL,2,0.6931471805599453
fibrin,2,0.6931471805599453
dual-marker,2,0.6931471805599453
copeptin,2,0.6931471805599453
HI,2,0.6931471805599453
Evidence-based,2,0.6931471805599453
Colombia,2,0.6931471805599453
shared,2,0.6931471805599453
peripartum,2,0.6931471805599453
irritant,2,0.6931471805599453
rises,2,0.6931471805599453
possesses,2,0.6931471805599453
1-year,2,0.6931471805599453
endogenous,2,0.6931471805599453
Collectively,2,0.6931471805599453
TNFi,2,0.6931471805599453
aspiration,2,0.6931471805599453
AdC68-19RBD,2,0.6931471805599453
argue,2,0.6931471805599453
immunosuppressed,2,0.6931471805599453
masses,2,0.6931471805599453
subtyping,2,0.6931471805599453
Kong168,2,0.6931471805599453
interactive-critical,2,0.6931471805599453
nosocomial,2,0.6931471805599453
Alberta,2,0.6931471805599453
Echocardiography,2,0.6931471805599453
ASPIRE,2,0.6931471805599453
contraindications,2,0.6931471805599453
normally,2,0.6931471805599453
Diseases,2,0.6931471805599453
University,2,0.6931471805599453
MMP-9,2,0.6931471805599453
Second,2,0.6931471805599453
Sixty-nine,2,0.6931471805599453
metalloproteinase,2,0.6931471805599453
listed,2,0.6931471805599453
Pfizer-BioNTech,2,0.6931471805599453
nonatherosclerotic,2,0.6931471805599453
webs,2,0.6931471805599453
coronarography,2,0.6931471805599453
overcome,2,0.6931471805599453
recruited,2,0.6931471805599453
NPEs,2,0.6931471805599453
USSR,2,0.6931471805599453
periinfarct,2,0.6931471805599453
Until,2,0.6931471805599453
IV-rtPA,2,0.6931471805599453
prototype,2,0.6931471805599453
phenomena,2,0.6931471805599453
Observed,2,0.6931471805599453
merit,2,0.6931471805599453
redistribution,2,0.6931471805599453
Not,2,0.6931471805599453
neurosurgery,2,0.6931471805599453
importation,2,0.6931471805599453
telephone,2,0.6931471805599453
diminish,2,0.6931471805599453
preclinical,2,0.6931471805599453
aneurysms,2,0.6931471805599453
overcoming,2,0.6931471805599453
extreme,2,0.6931471805599453
OHCA,2,0.6931471805599453
revealing,2,0.6931471805599453
PRB,2,0.6931471805599453
309,2,0.6931471805599453
hospital-acquired,2,0.6931471805599453
daughter,2,0.6931471805599453
35326,2,0.6931471805599453
explanations,2,0.6931471805599453
infective,2,0.6931471805599453
walking,2,0.6931471805599453
pneumothorax,2,0.6931471805599453
update,2,0.6931471805599453
congestion,2,0.6931471805599453
sodium,2,0.6931471805599453
radiography,2,0.6931471805599453
scales,2,0.6931471805599453
quality-of-life,2,0.6931471805599453
252,2,0.6931471805599453
French,2,0.6931471805599453
echocardiographically,2,0.6931471805599453
blunt,2,0.6931471805599453
Dentists,2,0.6931471805599453
hyaluronic,2,0.6931471805599453
fits,2,0.6931471805599453
verification,2,0.6931471805599453
MDCT,2,0.6931471805599453
multidetector,2,0.6931471805599453
supplement,2,0.6931471805599453
ergometry,2,0.6931471805599453
match,2,0.6931471805599453
RNAi,2,0.6931471805599453
086,2,0.6931471805599453
243,2,0.6931471805599453
fabricated,2,0.6931471805599453
088,2,0.6931471805599453
reproduction,2,0.6931471805599453
siRNAs,2,0.6931471805599453
marrow,2,0.6931471805599453
siRNA,2,0.6931471805599453
Ag-RDTs,2,0.6931471805599453
large-focal,2,0.6931471805599453
terminal,2,0.6931471805599453
deleterious,2,0.6931471805599453
Vaccines,2,0.6931471805599453
Medicine,2,0.6931471805599453
HPV,2,0.6931471805599453
noneosinophilic,2,0.6931471805599453
check,2,0.6931471805599453
paired,2,0.6931471805599453
laser,2,0.6931471805599453
PE,2,0.6931471805599453
encounters,2,0.6931471805599453
separated,2,0.6931471805599453
thallium-201,2,0.6931471805599453
g,2,0.6931471805599453
κ,2,0.6931471805599453
submitted,2,0.6931471805599453
neurologists,2,0.6931471805599453
cervical,2,0.6931471805599453
15-20,2,0.6931471805599453
Clinically,2,0.6931471805599453
post-myocardial,2,0.6931471805599453
hereditary,2,0.6931471805599453
educate,2,0.6931471805599453
intramural,2,0.6931471805599453
chloride,2,0.6931471805599453
Tl-201,2,0.6931471805599453
Q-MI,2,0.6931471805599453
curb,2,0.6931471805599453
non,2,0.6931471805599453
procedural,2,0.6931471805599453
characterised,2,0.6931471805599453
MeV-based,2,0.6931471805599453
quantitated,2,0.6931471805599453
somatic,2,0.6931471805599453
snuff,2,0.6931471805599453
warrant,2,0.6931471805599453
Neurologic,2,0.6931471805599453
nCoV-19,2,0.6931471805599453
bizarre,2,0.6931471805599453
neuropsychiatric,2,0.6931471805599453
ChAdOx1,2,0.6931471805599453
centuries,2,0.6931471805599453
allele-specific,2,0.6931471805599453
Gloucestershire,2,0.6931471805599453
antimyosin,2,0.6931471805599453
parishes,2,0.6931471805599453
unrestricted,2,0.6931471805599453
non-adherence,2,0.6931471805599453
influenzal,2,0.6931471805599453
Britain,2,0.6931471805599453
reliably,2,0.6931471805599453
single-photon,2,0.6931471805599453
SPECT,2,0.6931471805599453
176,2,0.6931471805599453
homocysteine,2,0.6931471805599453
originally,2,0.6931471805599453
record,2,0.6931471805599453
Besides,2,0.6931471805599453
anosmia,2,0.6931471805599453
expert-reviewed,2,0.6931471805599453
Nor,2,0.6931471805599453
IL,2,0.6931471805599453
storage,2,0.6931471805599453
technetium,2,0.6931471805599453
hypokinesis,2,0.6931471805599453
Myoglobin,2,0.6931471805599453
primers,2,0.6931471805599453
parameter,2,0.6931471805599453
visualization,2,0.6931471805599453
salbutamol,2,0.6931471805599453
Movement,2,0.6931471805599453
asymmetry,2,0.6931471805599453
unilateral,2,0.6931471805599453
DNAm,2,0.6931471805599453
impossible,2,0.6931471805599453
execution,2,0.6931471805599453
collecting,2,0.6931471805599453
NY,2,0.6931471805599453
injured,2,0.6931471805599453
establishing,2,0.6931471805599453
indexes,2,0.6931471805599453
murmur,2,0.6931471805599453
heard,2,0.6931471805599453
enabled,2,0.6931471805599453
pancreas,2,0.6931471805599453
probabilities,2,0.6931471805599453
pointed,2,0.6931471805599453
money,2,0.6931471805599453
reaches,2,0.6931471805599453
see,2,0.6931471805599453
text,2,0.6931471805599453
imply,2,0.6931471805599453
discount,2,0.6931471805599453
127,2,0.6931471805599453
Practices,2,0.6931471805599453
181,2,0.6931471805599453
society,2,0.6931471805599453
blood-pressure,2,0.6931471805599453
196,2,0.6931471805599453
0048,2,0.6931471805599453
geo-centroid,2,0.6931471805599453
tasks,2,0.6931471805599453
4G,2,0.6931471805599453
reverse-transcriptase,2,0.6931471805599453
500,2,0.6931471805599453
supplementary,2,0.6931471805599453
Similar,2,0.6931471805599453
231,2,0.6931471805599453
224,2,0.6931471805599453
interleukin-6,2,0.6931471805599453
SARS-Cov-2,2,0.6931471805599453
analyzing,2,0.6931471805599453
MMP,2,0.6931471805599453
spared,2,0.6931471805599453
saturation,2,0.6931471805599453
Out,2,0.6931471805599453
table,2,0.6931471805599453
CPT,2,0.6931471805599453
relieved,2,0.6931471805599453
demanding,2,0.6931471805599453
151,2,0.6931471805599453
Their,2,0.6931471805599453
197,2,0.6931471805599453
figures,2,0.6931471805599453
self-expanding,2,0.6931471805599453
830,2,0.6931471805599453
plane,2,0.6931471805599453
forecast,2,0.6931471805599453
AIMI,2,0.6931471805599453
adjunct,2,0.6931471805599453
otherwise,2,0.6931471805599453
090,2,0.6931471805599453
Effect,2,0.6931471805599453
POC,2,0.6931471805599453
stressed,2,0.6931471805599453
stents,2,0.6931471805599453
defines,2,0.6931471805599453
titer,2,0.6931471805599453
996,2,0.6931471805599453
read,2,0.6931471805599453
self-limited,2,0.6931471805599453
939,2,0.6931471805599453
198,2,0.6931471805599453
atlas-assisted,2,0.6931471805599453
Direct,2,0.6931471805599453
facing,2,0.6931471805599453
Unacceptable,2,0.6931471805599453
IL-1A,2,0.6931471805599453
regulating,2,0.6931471805599453
Peak,2,0.6931471805599453
acting,2,0.6931471805599453
modulate,2,0.6931471805599453
regulators,2,0.6931471805599453
Coalition,2,0.6931471805599453
TO,2,0.6931471805599453
Previous,2,0.6931471805599453
depicted,2,0.6931471805599453
Demographic,2,0.6931471805599453
diffusion-weighted,2,0.6931471805599453
mucosa,2,0.6931471805599453
smooth,2,0.6931471805599453
T2,2,0.6931471805599453
breathing,2,0.6931471805599453
NIH,2,0.6931471805599453
height,2,0.6931471805599453
accident,2,0.6931471805599453
Host,2,0.6931471805599453
portable,2,0.6931471805599453
data-driven,2,0.6931471805599453
reversibility,2,0.6931471805599453
Islands,2,0.6931471805599453
undergo,2,0.6931471805599453
Last,2,0.6931471805599453
arteriography,2,0.6931471805599453
WE,2,0.6931471805599453
theme,2,0.6931471805599453
NEED,2,0.6931471805599453
person,2,0.6931471805599453
Hemodynamic,2,0.6931471805599453
pumping,2,0.6931471805599453
universities,2,0.6931471805599453
06,2,0.6931471805599453
Anticoagulation,2,0.6931471805599453
07,2,0.6931471805599453
power,2,0.6931471805599453
thromboembolism,2,0.6931471805599453
Atrial,2,0.6931471805599453
engage,2,0.6931471805599453
makers,2,0.6931471805599453
H1v,2,0.6931471805599453
ROC,2,0.6931471805599453
long-axis,2,0.6931471805599453
IL-1B,2,0.6931471805599453
Flow,2,0.6931471805599453
intramuscular,2,0.6931471805599453
saline,2,0.6931471805599453
Like,2,0.6931471805599453
cubic,2,0.6931471805599453
emerge,2,0.6931471805599453
1084,2,0.6931471805599453
166,2,0.6931471805599453
Discharge,2,0.6931471805599453
bridge,2,0.6931471805599453
200910,2,0.6931471805599453
transventricular,2,0.6931471805599453
angiopathy,2,0.6931471805599453
mitral,2,0.6931471805599453
atherogenic,2,0.6931471805599453
home-based,2,0.6931471805599453
believe,2,0.6931471805599453
underscore,2,0.6931471805599453
parasternal,2,0.6931471805599453
surge,2,0.6931471805599453
chloroquine,2,0.6931471805599453
azithromycin,2,0.6931471805599453
hypokinesia,2,0.6931471805599453
hyperlipidemia,2,0.6931471805599453
Viruses,2,0.6931471805599453
histone,2,0.6931471805599453
dyskinesia,2,0.6931471805599453
akinesia,2,0.6931471805599453
discoveries,2,0.6931471805599453
polypeptide,2,0.6931471805599453
IAV-infected,2,0.6931471805599453
fluorescent,2,0.6931471805599453
210,2,0.6931471805599453
Likewise,2,0.6931471805599453
multifocal,2,0.6931471805599453
keep,2,0.6931471805599453
property,2,0.6931471805599453
posing,2,0.6931471805599453
hourly,2,0.6931471805599453
viperin,2,0.6931471805599453
limiting,2,0.6931471805599453
edition,2,0.6931471805599453
relapsed,2,0.6931471805599453
distinguish,2,0.6931471805599453
PTKs,2,0.6931471805599453
high-dose,2,0.6931471805599453
misdiagnosis,2,0.6931471805599453
shortened,2,0.6931471805599453
apart,2,0.6931471805599453
Practitioner,2,0.6931471805599453
interim,2,0.6931471805599453
201516,2,0.6931471805599453
Adjusted,2,0.6931471805599453
governments,2,0.6931471805599453
ARI,2,0.6931471805599453
attended,2,0.6931471805599453
Comparisons,2,0.6931471805599453
sequenced,2,0.6931471805599453
Sequential,2,0.6931471805599453
260,2,0.6931471805599453
haemagglutinin,2,0.6931471805599453
223,2,0.6931471805599453
Allplex,2,0.6931471805599453
Argentina,2,0.6931471805599453
inaccuracies,2,0.6931471805599453
obstetric,2,0.6931471805599453
interface,2,0.6931471805599453
curative,2,0.6931471805599453
≥75,2,0.6931471805599453
benign,2,0.6931471805599453
workload,2,0.6931471805599453
Centre,2,0.6931471805599453
sex-standardized,2,0.6931471805599453
age-,2,0.6931471805599453
4-fold,2,0.6931471805599453
presumptive,2,0.6931471805599453
gave,2,0.6931471805599453
sales,2,0.6931471805599453
consultations,2,0.6931471805599453
sore,2,0.6931471805599453
FCR,2,0.6931471805599453
postponed,2,0.6931471805599453
°C,2,0.6931471805599453
radialis,2,0.6931471805599453
carpi,2,0.6931471805599453
Science,2,0.6931471805599453
acquaintances,2,0.6931471805599453
rabbits,2,0.6931471805599453
Rationale,2,0.6931471805599453
30-min,2,0.6931471805599453
POS,2,0.6931471805599453
laminar,2,0.6931471805599453
fitting,2,0.6931471805599453
ascertainment,2,0.6931471805599453
biosafety,2,0.6931471805599453
droplets,2,0.6931471805599453
amplitude,2,0.6931471805599453
protected,2,0.6931471805599453
prodromal,2,0.6931471805599453
Delta,2,0.6931471805599453
R0,2,0.6931471805599453
154,2,0.6931471805599453
ancestral,2,0.6931471805599453
subventricular,2,0.6931471805599453
left-ventricular-assist,2,0.6931471805599453
preterm,2,0.6931471805599453
neonates,2,0.6931471805599453
secretions,2,0.6931471805599453
749,2,0.6931471805599453
msec,2,0.6931471805599453
hamster,2,0.6931471805599453
Taken,2,0.6931471805599453
dysregulation,2,0.6931471805599453
PTK,2,0.6931471805599453
coexisting,2,0.6931471805599453
bradykinin,2,0.6931471805599453
neuroadrenergic,2,0.6931471805599453
LD-A,2,0.6931471805599453
helium,2,0.6931471805599453
non-human,2,0.6931471805599453
primates,2,0.6931471805599453
infer,2,0.6931471805599453
ascertained,2,0.6931471805599453
reinfarction,2,0.6931471805599453
et,2,0.6931471805599453
C-ACT,2,0.6931471805599453
fit,2,0.6931471805599453
BABM,2,0.6931471805599453
tightness,2,0.6931471805599453
delta,2,0.6931471805599453
restriction,2,0.6931471805599453
anomaly,2,0.6931471805599453
achievements,2,0.6931471805599453
School,2,0.6931471805599453
flutter,2,0.6931471805599453
Conference,2,0.6931471805599453
lies,2,0.6931471805599453
defenses,2,0.6931471805599453
acceleration,2,0.6931471805599453
render,2,0.6931471805599453
organisms,2,0.6931471805599453
appreciated,2,0.6931471805599453
transferred,2,0.6931471805599453
800,2,0.6931471805599453
conferred,2,0.6931471805599453
alarming,2,0.6931471805599453
experiments,2,0.6931471805599453
wild,2,0.6931471805599453
debates,2,0.6931471805599453
unrecognized,2,0.6931471805599453
Important,2,0.6931471805599453
sparser,2,0.6931471805599453
histopathologic,2,0.6931471805599453
Extracorporeal,2,0.6931471805599453
preventative,2,0.6931471805599453
latest,2,0.6931471805599453
Specifically,2,0.6931471805599453
communications,2,0.6931471805599453
Saitama,2,0.6931471805599453
Euroimmun,2,0.6931471805599453
heparin,2,0.6931471805599453
450,2,0.6931471805599453
Infection,2,0.6931471805599453
CD4,2,0.6931471805599453
CD8,2,0.6931471805599453
memory,2,0.6931471805599453
donation,2,0.6931471805599453
parent,2,0.6931471805599453
Angioplasty,2,0.6931471805599453
Diagnostics,2,0.6931471805599453
planned,2,0.6931471805599453
mediation,2,0.6931471805599453
LVEF,2,0.6931471805599453
weaned,2,0.6931471805599453
LVED,2,0.6931471805599453
LVES,2,0.6931471805599453
nationally,2,0.6931471805599453
subclinical,2,0.6931471805599453
hypokinetic,2,0.6931471805599453
XFD,2,0.6931471805599453
spring,2,0.6931471805599453
corresponded,2,0.6931471805599453
clustered,2,0.6931471805599453
proportions,2,0.6931471805599453
Appropriate,2,0.6931471805599453
associate,2,0.6931471805599453
Fifty-three,2,0.6931471805599453
gathered,2,0.6931471805599453
calendar,2,0.6931471805599453
Thirty-eight,2,0.6931471805599453
served,2,0.6931471805599453
tertiary,2,0.6931471805599453
Two-dimensional,2,0.6931471805599453
labelled,2,0.6931471805599453
outlined,2,0.6931471805599453
depressed,2,0.6931471805599453
antiplatelets,2,0.6931471805599453
antipsychotic,2,0.6931471805599453
hyperkinetic,2,0.6931471805599453
distinctly,2,0.6931471805599453
represented,2,0.6931471805599453
institute,2,0.6931471805599453
seasonality,2,0.6931471805599453
calculations,2,0.6931471805599453
infecting,2,0.6931471805599453
intranasally,2,0.6931471805599453
subsets,2,0.6931471805599453
yields,2,0.6931471805599453
tropism,2,0.6931471805599453
intricate,2,0.6931471805599453
zoonotic,2,0.6931471805599453
DAOS,2,0.6931471805599453
2-3,2,0.6931471805599453
thoroughly,2,0.6931471805599453
employ,2,0.6931471805599453
Beijing,2,0.6931471805599453
probe,2,0.6931471805599453
unexplained,2,0.6931471805599453
conjugate,2,0.6931471805599453
inducible,2,0.6931471805599453
low-risk,2,0.6931471805599453
cut,2,0.6931471805599453
knowledgeable,2,0.6931471805599453
biosensing,2,0.6931471805599453
BHong,2,0.6931471805599453
cytotoxicity,2,0.6931471805599453
solely,2,0.6931471805599453
Johansen,2,0.6931471805599453
caregivers,2,0.6931471805599453
striking,2,0.6931471805599453
fight,2,0.6931471805599453
preconditioning,2,0.6931471805599453
Gøtzsche,2,0.6931471805599453
CSI,2,0.6931471805599453
Gastroesophageal,2,0.6931471805599453
fourth,2,0.6931471805599453
reprogramming,2,0.6931471805599453
36-48,2,0.6931471805599453
Poor,2,0.6931471805599453
962,2,0.6931471805599453
ranked,2,0.6931471805599453
Annual,2,0.6931471805599453
bronchiectasis,2,0.6931471805599453
unseen,2,0.6931471805599453
adultchild,2,0.6931471805599453
positioning,2,0.6931471805599453
HAM,2,0.6931471805599453
Measurements,2,0.6931471805599453
cross-validation,2,0.6931471805599453
10-fold,2,0.6931471805599453
cytotoxic,2,0.6931471805599453
classifiers,2,0.6931471805599453
forest,2,0.6931471805599453
Responses,2,0.6931471805599453
chair,2,0.6931471805599453
attributed,2,0.6931471805599453
Very,2,0.6931471805599453
fifth,2,0.6931471805599453
faces,2,0.6931471805599453
continents,2,0.6931471805599453
fair,2,0.6931471805599453
biosensors,2,0.6931471805599453
VTM,2,0.6931471805599453
spin,2,0.6931471805599453
captured,2,0.6931471805599453
Healthcare,2,0.6931471805599453
Database,2,0.6931471805599453
676,2,0.6931471805599453
derivatives,2,0.6931471805599453
200405,2,0.6931471805599453
biosciences,2,0.6931471805599453
claims,2,0.6931471805599453
pH,2,0.6931471805599453
exam,2,0.6931471805599453
N2,2,0.6931471805599453
seizure,2,0.6931471805599453
chi-square,2,0.6931471805599453
esophageal,2,0.6931471805599453
N1,2,0.6931471805599453
Laboratory,2,0.6931471805599453
RSV,2,0.6931471805599453
reflexes,2,0.6931471805599453
VTM-3840,2,0.6931471805599453
today,2,0.6931471805599453
basically,2,0.6931471805599453
ResNet,2,0.6931471805599453
PACSI,2,0.6931471805599453
MobileNet,2,0.6931471805599453
phenotypic,2,0.6931471805599453
explaining,2,0.6931471805599453
simulations,2,0.6931471805599453
disease-19,2,0.6931471805599453
adolescence,2,0.6931471805599453
sure,2,0.6931471805599453
stressful,2,0.6931471805599453
properly,2,0.6931471805599453
L,2,0.6931471805599453
Antibody,2,0.6931471805599453
referents,2,0.6931471805599453
HAI,2,0.6931471805599453
till,2,0.6931471805599453
positron,2,0.6931471805599453
forces,2,0.6931471805599453
USA,2,0.6931471805599453
exceeding,2,0.6931471805599453
post-MI,2,0.6931471805599453
attendance,2,0.6931471805599453
biopsies,2,0.6931471805599453
concrete,2,0.6931471805599453
B1351,2,0.6931471805599453
dropped,2,0.6931471805599453
caring,2,0.6931471805599453
acceptance,2,0.6931471805599453
opportunities,2,0.6931471805599453
waning,2,0.6931471805599453
encephalitis,2,0.6931471805599453
developers,2,0.6931471805599453
pretreated,2,0.6931471805599453
additive,2,0.6931471805599453
inhibiting,2,0.6931471805599453
injected,2,0.6931471805599453
Isoproterenol,2,0.6931471805599453
career,2,0.6931471805599453
precede,2,0.6931471805599453
tail,2,0.6931471805599453
referent,2,0.6931471805599453
population-level,2,0.6931471805599453
Society,2,0.6931471805599453
downregulated,2,0.6931471805599453
bioscience,2,0.6931471805599453
single-stranded,2,0.6931471805599453
transcriptase,2,0.6931471805599453
classify,2,0.6931471805599453
Establishing,2,0.6931471805599453
cured,2,0.6931471805599453
reading,2,0.6931471805599453
loads,2,0.6931471805599453
attribution,2,0.6931471805599453
machine,2,0.6931471805599453
Translating,2,0.6931471805599453
DSP,2,0.6931471805599453
log10,2,0.6931471805599453
software,2,0.6931471805599453
San,2,0.6931471805599453
reflex,2,0.6931471805599453
subjective,2,0.6931471805599453
antibacterial,2,0.6931471805599453
metabolites,2,0.6931471805599453
Area,2,0.6931471805599453
copiesmL,2,0.6931471805599453
proteolytic,2,0.6931471805599453
dominated,2,0.6931471805599453
NOS,2,0.6931471805599453
God,2,0.6931471805599453
genotyping,2,0.6931471805599453
county,2,0.6931471805599453
provider,2,0.6931471805599453
153,2,0.6931471805599453
characterizes,2,0.6931471805599453
antigen-specific,2,0.6931471805599453
Psychological,2,0.6931471805599453
performances,2,0.6931471805599453
DNT,2,0.6931471805599453
discrepancies,2,0.6931471805599453
right-hemisphere,2,0.6931471805599453
multistage,2,0.6931471805599453
ecological,2,0.6931471805599453
anti-vaccine,2,0.6931471805599453
diagram,2,0.6931471805599453
dysfunctioning,2,0.6931471805599453
063,2,0.6931471805599453
interpret,2,0.6931471805599453
doctor,2,0.6931471805599453
diagramming,2,0.6931471805599453
indirectly,2,0.6931471805599453
immunotherapeutics,2,0.6931471805599453
nonischemic,2,0.6931471805599453
Seventeen,2,0.6931471805599453
one-year-beforeone-year-after,2,0.6931471805599453
visiting,2,0.6931471805599453
metoprolol,2,0.6931471805599453
House,2,0.6931471805599453
Standardized,2,0.6931471805599453
integrating,2,0.6931471805599453
purchased,2,0.6931471805599453
constrictiva,2,0.6931471805599453
responsively,2,0.6931471805599453
Persons,2,0.6931471805599453
shed,2,0.6931471805599453
4-5,2,0.6931471805599453
covers,2,0.6931471805599453
Twelve,2,0.6931471805599453
Protein,2,0.6931471805599453
SNF-associated,2,0.6931471805599453
reductase,2,0.6931471805599453
reflection,2,0.6931471805599453
low-dose,2,0.6931471805599453
ACE,2,0.6931471805599453
balance,2,0.6931471805599453
Continued,2,0.6931471805599453
239,2,0.6931471805599453
emotion,2,0.6931471805599453
4-year-old,2,0.6931471805599453
Blood,2,0.6931471805599453
aggregation,2,0.6931471805599453
combine,2,0.6931471805599453
down,2,0.6931471805599453
144,2,0.6931471805599453
vulnerability,2,0.6931471805599453
dietary,2,0.6931471805599453
appealing,2,0.6931471805599453
microbleeds,2,0.6931471805599453
CD68,2,0.6931471805599453
002,2,0.6931471805599453
whereby,2,0.6931471805599453
imagined,2,0.6931471805599453
loading,2,0.6931471805599453
borderline,2,0.6931471805599453
0035,2,0.6931471805599453
deposited,2,0.6931471805599453
diagrams,2,0.6931471805599453
affective,2,0.6931471805599453
Trials,2,0.6931471805599453
stockpiled,2,0.6931471805599453
bronchiolitis,2,0.6931471805599453
Trialists,2,0.6931471805599453
ready,2,0.6931471805599453
extends,2,0.6931471805599453
PHIs,2,0.6931471805599453
Service,2,0.6931471805599453
RD,2,0.6931471805599453
rigorous,2,0.6931471805599453
Eighty-five,2,0.6931471805599453
donor,2,0.6931471805599453
sexes,2,0.6931471805599453
4th,2,0.6931471805599453
Groups,2,0.6931471805599453
docking,2,0.6931471805599453
possess,2,0.6931471805599453
63,2,0.6931471805599453
couples,2,0.6931471805599453
hyperstimulation-IVFICSI,2,0.6931471805599453
aerobic,2,0.6931471805599453
lowered,2,0.6931471805599453
extraordinary,2,0.6931471805599453
enzymatic,2,0.6931471805599453
real-life,2,0.6931471805599453
nonstructural,2,0.6931471805599453
Controls,2,0.6931471805599453
invaluable,2,0.6931471805599453
sets,2,0.6931471805599453
N1N2N3,2,0.6931471805599453
IVUS-VH,2,0.6931471805599453
born,2,0.6931471805599453
prognoses,2,0.6931471805599453
endo-systolic,2,0.6931471805599453
antihypertensives,2,0.6931471805599453
alleviating,2,0.6931471805599453
mNIHSS,2,0.6931471805599453
plasmablasts,2,0.6931471805599453
operators,2,0.6931471805599453
posttransplant,2,0.6931471805599453
updates,2,0.6931471805599453
5000,2,0.6931471805599453
4428,2,0.6931471805599453
Infections,2,0.6931471805599453
immunise,2,0.6931471805599453
offering,2,0.6931471805599453
alcohol,2,0.6931471805599453
sensory,2,0.6931471805599453
continually,2,0.6931471805599453
resultant,2,0.6931471805599453
Yet,2,0.6931471805599453
burdens,2,0.6931471805599453
announced,2,0.6931471805599453
appetite,2,0.6931471805599453
helping,2,0.6931471805599453
CoviVac,2,0.6931471805599453
hypotheses,2,0.6931471805599453
rodents,2,0.6931471805599453
luciferase,2,0.6931471805599453
gustatory,2,0.6931471805599453
olfactory,2,0.6931471805599453
Ninety-six,2,0.6931471805599453
41-50,2,0.6931471805599453
totaling,2,0.6931471805599453
ambivalence,2,0.6931471805599453
RWM,2,0.6931471805599453
pre-determined,2,0.6931471805599453
ABPA,2,0.6931471805599453
dysregulated,2,0.6931471805599453
conditional,2,0.6931471805599453
etiopathogenetic,2,0.6931471805599453
cognate,2,0.6931471805599453
30-year-old,2,0.6931471805599453
necessity,2,0.6931471805599453
isocyanate-induced,2,0.6931471805599453
secretion,2,0.6931471805599453
Application,2,0.6931471805599453
enzyme-linked,2,0.6931471805599453
code,2,0.6931471805599453
hypertensives,2,0.6931471805599453
Thirty-one,2,0.6931471805599453
virus-specific,2,0.6931471805599453
eliciting,2,0.6931471805599453
carrageenan,2,0.6931471805599453
bowel,2,0.6931471805599453
maintaining,2,0.6931471805599453
hemodialyzed,2,0.6931471805599453
Bland-Altman,2,0.6931471805599453
codes,2,0.6931471805599453
nurse,2,0.6931471805599453
immunosorbent,2,0.6931471805599453
pools,2,0.6931471805599453
teach,2,0.6931471805599453
work-place,2,0.6931471805599453
RTR,2,0.6931471805599453
premenstrually,2,0.6931471805599453
arising,2,0.6931471805599453
tree,2,0.6931471805599453
163,2,0.6931471805599453
counter,2,0.6931471805599453
generalizable,2,0.6931471805599453
COVID-19-related,2,0.6931471805599453
realized,2,0.6931471805599453
atrioventricular,2,0.6931471805599453
Rwandas,2,0.6931471805599453
White,2,0.6931471805599453
age-related,2,0.6931471805599453
anemia,2,0.6931471805599453
10-year,2,0.6931471805599453
workshop,2,0.6931471805599453
149,2,0.6931471805599453
transplanted,2,0.6931471805599453
proximate,2,0.6931471805599453
cg05575921,2,0.6931471805599453
hypomethylation,2,0.6931471805599453
911,2,0.6931471805599453
128,2,0.6931471805599453
counterparts,2,0.6931471805599453
propagation,2,0.6931471805599453
2018,2,0.6931471805599453
electroencephalogram,2,0.6931471805599453
computer-aided,2,0.6931471805599453
PD20,2,0.6931471805599453
seemingly,2,0.6931471805599453
disproportionately,2,0.6931471805599453
Mexican-Americans,2,0.6931471805599453
thickness,2,0.6931471805599453
Smoking,2,0.6931471805599453
AHRR,2,0.6931471805599453
lifesaving,2,0.6931471805599453
EC,2,0.6931471805599453
1971,2,0.6931471805599453
spanning,2,0.6931471805599453
GP,2,0.6931471805599453
571,2,0.6931471805599453
radiograph,2,0.6931471805599453
Hopefully,2,0.6931471805599453
synthesis,2,0.6931471805599453
interventional,2,0.6931471805599453
non-structural,2,0.6931471805599453
tailored,2,0.6931471805599453
DBP,2,0.6931471805599453
aVF,2,0.6931471805599453
antiasthmatic,2,0.6931471805599453
PCR-based,2,0.6931471805599453
pursued,2,0.6931471805599453
SAR-CoV-2,2,0.6931471805599453
Ia,2,0.6931471805599453
stent,2,0.6931471805599453
participating,2,0.6931471805599453
µgmL,2,0.6931471805599453
Successful,2,0.6931471805599453
twenty,2,0.6931471805599453
consequent,2,0.6931471805599453
lipids,2,0.6931471805599453
817,2,0.6931471805599453
comprise,2,0.6931471805599453
interfering,2,0.6931471805599453
provoking,2,0.6931471805599453
endoluminal,2,0.6931471805599453
confusion,2,0.6931471805599453
shifted,2,0.6931471805599453
epileptic,2,0.6931471805599453
foundation,2,0.6931471805599453
experts,2,0.6931471805599453
stimulus,2,0.6931471805599453
uneventful,2,0.6931471805599453
achieving,2,0.6931471805599453
pneumococcus,2,0.6931471805599453
capsules,2,0.6931471805599453
just,2,0.6931471805599453
antioxidant,2,0.6931471805599453
post-infarction,2,0.6931471805599453
restoration,2,0.6931471805599453
pragmatic,2,0.6931471805599453
pokeweed,2,0.6931471805599453
rp,2,0.6931471805599453
kinase-MB,2,0.6931471805599453
625,2,0.6931471805599453
shaping,2,0.6931471805599453
Neuro-occupation,2,0.6931471805599453
03,2,0.6931471805599453
overmortality,2,0.6931471805599453
exemplify,2,0.6931471805599453
synergistically,2,0.6931471805599453
fatty,2,0.6931471805599453
subgenomic,2,0.6931471805599453
EIB,2,0.6931471805599453
applicable,2,0.6931471805599453
Ipratropium,2,0.6931471805599453
186,2,0.6931471805599453
HNE,2,0.6931471805599453
acids,2,0.6931471805599453
lipoprotein,2,0.6931471805599453
encompassing,2,0.6931471805599453
task,2,0.6931471805599453
883,2,0.6931471805599453
away,2,0.6931471805599453
DMP,2,0.6931471805599453
counselling,2,0.6931471805599453
pregnancies,2,0.6931471805599453
emphysema,2,0.6931471805599453
inhabitants,2,0.6931471805599453
pneumococcal,2,0.6931471805599453
31172,2,0.6931471805599453
malignant,2,0.6931471805599453
pleural,2,0.6931471805599453
novo,2,0.6931471805599453
Development,2,0.6931471805599453
dramatically,2,0.6931471805599453
aging,2,0.6931471805599453
Frequent,2,0.6931471805599453
community-acquired,2,0.6931471805599453
freely,2,0.6931471805599453
centralized,2,0.6931471805599453
confer,2,0.6931471805599453
irritation,2,0.6931471805599453
aggravated,2,0.6931471805599453
gonadotrophin-releasing,2,0.6931471805599453
Adamantane-resistant,1,0.0
sizable,1,0.0
sophistication,1,0.0
interpreting,1,0.0
a-specific,1,0.0
tachycardic,1,0.0
thyrotropin,1,0.0
signalling,1,0.0
Permanent,1,0.0
152,1,0.0
underlie,1,0.0
endotoxin,1,0.0
pollutant,1,0.0
adamantane,1,0.0
cross-neutralization,1,0.0
defy,1,0.0
hypothetical,1,0.0
evolutionarily,1,0.0
finally,1,0.0
self-damaging,1,0.0
ordered,1,0.0
RESULTS,1,0.0
4834-6210,1,0.0
African-American,1,0.0
51-74,1,0.0
24-31,1,0.0
LBCH,1,0.0
3793,1,0.0
large-artery,1,0.0
centerpiece,1,0.0
3375-4211,1,0.0
282,1,0.0
mold,1,0.0
161,1,0.0
bimodal,1,0.0
Sarbecoviruses,1,0.0
interatrial,1,0.0
8661-12687,1,0.0
unless,1,0.0
niche,1,0.0
listeriosis,1,0.0
Anesthesia,1,0.0
prognosing,1,0.0
oseltamivir-based,1,0.0
epidural,1,0.0
ocular,1,0.0
elusive,1,0.0
judging,1,0.0
implied,1,0.0
pointing,1,0.0
influenza-induced,1,0.0
five-year,1,0.0
masking,1,0.0
Influenza-attributed,1,0.0
VAs,1,0.0
hypothesize,1,0.0
trimester,1,0.0
budget,1,0.0
Markov,1,0.0
6-11,1,0.0
Common,1,0.0
serologically,1,0.0
3-6,1,0.0
23000,1,0.0
peripherally,1,0.0
Stay†,1,0.0
adaptable,1,0.0
vetting,1,0.0
primo-infection,1,0.0
species-specific,1,0.0
t,1,0.0
mandated,1,0.0
Brazilian,1,0.0
200000,1,0.0
partners,1,0.0
03Conclusion,1,0.0
withdrawn,1,0.0
Urban,1,0.0
pyelonephritis,1,0.0
twenty-eight,1,0.0
2288,1,0.0
Spinal,1,0.0
chorioamniotitis,1,0.0
electively,1,0.0
submission,1,0.0
Managerial,1,0.0
Cost,1,0.0
transesophageal,1,0.0
Polynesians,1,0.0
receptor-lipopolysaccharide,1,0.0
dysphasia,1,0.0
cocktail,1,0.0
Endoluminal,1,0.0
thyroxin,1,0.0
Le,1,0.0
cytology,1,0.0
ELISAs,1,0.0
Bonheur,1,0.0
2538,1,0.0
TLR-LPS,1,0.0
flux,1,0.0
2112-2964,1,0.0
throughput,1,0.0
capabilities,1,0.0
simplicity,1,0.0
5522,1,0.0
end-users,1,0.0
emboligenic,1,0.0
Childrens,1,0.0
Comprehensive,1,0.0
toll-like,1,0.0
cross-neutralize,1,0.0
Characterization,1,0.0
polypharmacy,1,0.0
accessibility,1,0.0
Accounting,1,0.0
3-19,1,0.0
calculating,1,0.0
clinic-based,1,0.0
laboratory-based,1,0.0
Open,1,0.0
Bureau,1,0.0
Labor,1,0.0
drainage,1,0.0
Polymorphism,1,0.0
second-generation,1,0.0
expressive,1,0.0
kindergarten,1,0.0
valuations,1,0.0
10674,1,0.0
METHODS,1,0.0
heritable,1,0.0
Cessation,1,0.0
Island,1,0.0
460,1,0.0
tension-anxiety,1,0.0
30-43,1,0.0
geometry,1,0.0
Equally,1,0.0
Specially,1,0.0
applies,1,0.0
degrees-60,1,0.0
degrees-120,1,0.0
Arterial,1,0.0
compounded,1,0.0
subcategory,1,0.0
791,1,0.0
industrial,1,0.0
periodic,1,0.0
broke,1,0.0
Beck,1,0.0
Zhejiang,1,0.0
necessitate,1,0.0
recalled,1,0.0
word,1,0.0
immigrants,1,0.0
pigs,1,0.0
optimally,1,0.0
misinterpretation,1,0.0
exhibit,1,0.0
exclusively,1,0.0
engaged,1,0.0
occupationally,1,0.0
2053,1,0.0
reinforced,1,0.0
mobile,1,0.0
conceivably,1,0.0
possible--before,1,0.0
playing,1,0.0
resettlement,1,0.0
Jet,1,0.0
stays,1,0.0
test--cardiopulmonary,1,0.0
shortcomings,1,0.0
H3N2v-associated,1,0.0
parietal,1,0.0
topography,1,0.0
bilaterally,1,0.0
Abciximab,1,0.0
ic,1,0.0
wish,1,0.0
substudy,1,0.0
native-born,1,0.0
broncho-pulmonary,1,0.0
barns,1,0.0
followup,1,0.0
intima-media,1,0.0
big,1,0.0
Incidence,1,0.0
sequence-independent,1,0.0
1973,1,0.0
365,1,0.0
vigor-activity,1,0.0
930,1,0.0
ruptures,1,0.0
fecal-viral-excreting,1,0.0
averaging,1,0.0
covariance,1,0.0
1b,1,0.0
Thirty-three,1,0.0
microembolic,1,0.0
1a,1,0.0
Fecal,1,0.0
frame,1,0.0
envelope,1,0.0
depression-dejection,1,0.0
down-trend,1,0.0
automatically,1,0.0
3235,1,0.0
fecal,1,0.0
single-primer,1,0.0
nanopore,1,0.0
Validation,1,0.0
observationally,1,0.0
Deficiencies,1,0.0
primersprobes,1,0.0
multitarget,1,0.0
929-100,1,0.0
862-972,1,0.0
nonsevere,1,0.0
objectively,1,0.0
931,1,0.0
Dunedin,1,0.0
314,1,0.0
secure,1,0.0
CCA,1,0.0
External,1,0.0
dimensions,1,0.0
plot,1,0.0
mumol,1,0.0
interviewer,1,0.0
Perth,1,0.0
1298,1,0.0
confined,1,0.0
shortage,1,0.0
thanks,1,0.0
DRGs,1,0.0
c,1,0.0
Hemo-vascular,1,0.0
satisfactorily,1,0.0
B16172,1,0.0
complement-mediated,1,0.0
immune-histochemical,1,0.0
driver,1,0.0
Ninth,1,0.0
co-localized,1,0.0
abusive,1,0.0
Progress,1,0.0
C5b-9,1,0.0
Infectious,1,0.0
deposits,1,0.0
1980s,1,0.0
releasing,1,0.0
lytic,1,0.0
explode,1,0.0
precedes,1,0.0
hemo-vascular,1,0.0
interfere,1,0.0
10-13,1,0.0
Revision,1,0.0
La,1,0.0
3879,1,0.0
Immunological,1,0.0
Just,1,0.0
intermediately,1,0.0
Islander,1,0.0
drain,1,0.0
44-68,1,0.0
monetary,1,0.0
plague,1,0.0
unifying,1,0.0
smoothly,1,0.0
Poste,1,0.0
Visp,1,0.0
1-6,1,0.0
quality-adjusted,1,0.0
breadth,1,0.0
nausea,1,0.0
ICD-9,1,0.0
Profile,1,0.0
QALYs,1,0.0
10-12,1,0.0
Symposium,1,0.0
Hashimotos,1,0.0
305,1,0.0
overlying,1,0.0
furnished,1,0.0
high-efficiency,1,0.0
OBJECTIVE,1,0.0
incurred,1,0.0
Published,1,0.0
recency,1,0.0
IRA,1,0.0
509,1,0.0
syndrome-coronavirus,1,0.0
postinjury,1,0.0
digitally,1,0.0
CONCLUSIONS,1,0.0
Tunisian,1,0.0
Spielberger,1,0.0
exams,1,0.0
Nonrandomized,1,0.0
hematochemical,1,0.0
dose-efficacy,1,0.0
hand-lung,1,0.0
Beclojet,1,0.0
manages,1,0.0
AFI,1,0.0
immigration,1,0.0
double-blind,1,0.0
174700,1,0.0
subdural,1,0.0
Resistant,1,0.0
diagnosis-related,1,0.0
watershedhypoperfusion,1,0.0
thyroiditis,1,0.0
Backgroundaims,1,0.0
P1,1,0.0
immuno-allergological,1,0.0
138,1,0.0
Swiss,1,0.0
writing,1,0.0
GLPSS,1,0.0
32500,1,0.0
nonstroke,1,0.0
indispensable,1,0.0
180-day,1,0.0
well-developed,1,0.0
erroneously,1,0.0
Alpha,1,0.0
Mood,1,0.0
Premature,1,0.0
X24073,1,0.0
Ct-value,1,0.0
electrocution,1,0.0
dial,1,0.0
90000,1,0.0
single-mode,1,0.0
610,1,0.0
successive,1,0.0
1900,1,0.0
cutaneous,1,0.0
HHA,1,0.0
1973--4,1,0.0
0--4,1,0.0
hydrazided,1,0.0
HA-CHO,1,0.0
17-90,1,0.0
heat,1,0.0
9The,1,0.0
bore,1,0.0
brunt,1,0.0
disabilities,1,0.0
Cells,1,0.0
voltage,1,0.0
entrusted,1,0.0
oxidized,1,0.0
brisk,1,0.0
Having,1,0.0
Schiff,1,0.0
cleavable,1,0.0
homogeneous,1,0.0
DA-PPy,1,0.0
injecting,1,0.0
in-vitro,1,0.0
HA-CHOHHA,1,0.0
intramyocardially,1,0.0
displacement,1,0.0
Th1-biased,1,0.0
certainly,1,0.0
MeV,1,0.0
Insertion,1,0.0
constitutional,1,0.0
Adverse,1,0.0
bradycardia,1,0.0
circuit,1,0.0
non-IgE,1,0.0
inflammometry,1,0.0
low-amplitude,1,0.0
measles,1,0.0
visceral,1,0.0
mandates,1,0.0
inotropic,1,0.0
perforating,1,0.0
angiogenic,1,0.0
ST-segment-elevation,1,0.0
histological,1,0.0
arteriolopathies,1,0.0
echocardiographical,1,0.0
burns,1,0.0
GelDADA-PPy,1,0.0
insensitivity,1,0.0
leucocytes,1,0.0
painting,1,0.0
brewing,1,0.0
advocating,1,0.0
profession,1,0.0
prove,1,0.0
belong,1,0.0
anti-hypertensive,1,0.0
contracted,1,0.0
anti-fibrotic,1,0.0
destructive,1,0.0
flare-ups,1,0.0
anti-hypertrophic,1,0.0
acquiring,1,0.0
said,1,0.0
singularly,1,0.0
skewed,1,0.0
Ro,1,0.0
Overweight,1,0.0
reassurance,1,0.0
constant,1,0.0
double,1,0.0
189,1,0.0
allergist,1,0.0
figuring,1,0.0
2415,1,0.0
turmoil,1,0.0
2126,1,0.0
ishemic,1,0.0
Re-analysis,1,0.0
stenosing,1,0.0
cardiorrhexis,1,0.0
unmatched,1,0.0
Knowing,1,0.0
one-third,1,0.0
polypyrrole,1,0.0
stated,1,0.0
journeys,1,0.0
Peter,1,0.0
dopamine-functionalized,1,0.0
conjugates,1,0.0
GelDA,1,0.0
dopamine-gelatin,1,0.0
Recommendations,1,0.0
ionic,1,0.0
Aldhous,1,0.0
discovers,1,0.0
Fe3-induced,1,0.0
BAC,1,0.0
dont,1,0.0
FVC,1,0.0
self-adhesive,1,0.0
thousand,1,0.0
25-75,1,0.0
three-fold,1,0.0
coadministration,1,0.0
patches,1,0.0
school-wide,1,0.0
biomaterial,1,0.0
hydrogels,1,0.0
Objecive,1,0.0
tissue-engineering,1,0.0
ourselves,1,0.0
spirometry,1,0.0
cast,1,0.0
multifunctional,1,0.0
protein-specific,1,0.0
outward,1,0.0
bulging,1,0.0
dyspneic,1,0.0
irreplaceable,1,0.0
swift,1,0.0
systole,1,0.0
72-year-old,1,0.0
wet,1,0.0
recovers,1,0.0
holosystolic,1,0.0
peri-interventional,1,0.0
color,1,0.0
obviously,1,0.0
sternal,1,0.0
pretibial,1,0.0
Assuming,1,0.0
Evaluate,1,0.0
outweigh,1,0.0
187000,1,0.0
eletrocardiogram,1,0.0
489,1,0.0
economics,1,0.0
ABo,1,0.0
pays,1,0.0
oedema,1,0.0
Fifty-eight,1,0.0
pay,1,0.0
decided,1,0.0
kinesis,1,0.0
Bedside,1,0.0
Examinations,1,0.0
cardio-embolic,1,0.0
1528,1,0.0
histopathology,1,0.0
1725,1,0.0
728,1,0.0
p005,1,0.0
autolysis,1,0.0
stressors,1,0.0
opposed,1,0.0
CVE,1,0.0
stretching,1,0.0
waviness,1,0.0
1125,1,0.0
716,1,0.0
end-stage,1,0.0
8-15,1,0.0
⩽,1,0.0
dialysis,1,0.0
etiopathogenia,1,0.0
embolus,1,0.0
holds,1,0.0
760,1,0.0
Retrospective,1,0.0
twofold,1,0.0
rythmical,1,0.0
pull,1,0.0
seemed,1,0.0
paralyzed,1,0.0
ago,1,0.0
subcostal,1,0.0
PR,1,0.0
S203T,1,0.0
Regions,1,0.0
modeled,1,0.0
Behavioral,1,0.0
V3R,1,0.0
April-December,1,0.0
SEIR,1,0.0
685,1,0.0
Virological,1,0.0
V6R,1,0.0
well-characterized,1,0.0
domestic,1,0.0
rule-out,1,0.0
early-passage,1,0.0
Atopy,1,0.0
Adult,1,0.0
art,1,0.0
setup,1,0.0
mature,1,0.0
loose,1,0.0
caveats,1,0.0
preclude,1,0.0
mouse-adapted,1,0.0
burn,1,0.0
Upon,1,0.0
killing,1,0.0
Pneumothorax,1,0.0
V4,1,0.0
signature,1,0.0
reactors,1,0.0
2760,1,0.0
begins,1,0.0
USVI,1,0.0
Copeptin,1,0.0
left-to-right,1,0.0
shunting,1,0.0
distances,1,0.0
Virgin,1,0.0
centre,1,0.0
hydrogen,1,0.0
seventh,1,0.0
disulphine,1,0.0
disposition,1,0.0
adsorb,1,0.0
Proximal,1,0.0
Ph,1,0.0
electrocardiographically,1,0.0
BRFSS,1,0.0
borders,1,0.0
14000,1,0.0
Spatial,1,0.0
203T,1,0.0
divergence,1,0.0
refers,1,0.0
AH1N109,1,0.0
cardiomyoplasty,1,0.0
notifications,1,0.0
sporadically,1,0.0
right-heart,1,0.0
prairie,1,0.0
photon,1,0.0
Saskatchewan,1,0.0
49-83,1,0.0
publications,1,0.0
neurorestorative,1,0.0
relax,1,0.0
Swedish,1,0.0
Mammography,1,0.0
restorative,1,0.0
Now,1,0.0
or5,1,0.0
practice-based,1,0.0
participatory,1,0.0
migrating,1,0.0
neuroblasts,1,0.0
De-identified,1,0.0
chemotactic,1,0.0
543,1,0.0
Cohort,1,0.0
metalloproteinases,1,0.0
Discussion,1,0.0
1998-2008,1,0.0
thinking,1,0.0
1680,1,0.0
1310,1,0.0
potentiation,1,0.0
subarachnoid,1,0.0
inspired,1,0.0
Rt-PCR,1,0.0
quintile,1,0.0
650,1,0.0
accomplishments,1,0.0
analyzes,1,0.0
correlative,1,0.0
bronchialbronchiolar,1,0.0
policymakers,1,0.0
dozen,1,0.0
Intranasal,1,0.0
Excitingly,1,0.0
Promotion,1,0.0
8085,1,0.0
Asia-Pacific,1,0.0
Hosmer-Lemeshow,1,0.0
Combinations,1,0.0
mandating,1,0.0
CAD,1,0.0
Phase,1,0.0
conduction,1,0.0
Perhaps,1,0.0
12-hour,1,0.0
equations,1,0.0
correspond,1,0.0
ischaemia,1,0.0
Treatments,1,0.0
Obstetricians,1,0.0
34670,1,0.0
self-regulation,1,0.0
No30-35,1,0.0
Implications,1,0.0
unfortunately,1,0.0
empiric,1,0.0
ICUs,1,0.0
intensive-care,1,0.0
nuclei,1,0.0
hardly,1,0.0
p00001,1,0.0
predictable,1,0.0
covert,1,0.0
intractable,1,0.0
290,1,0.0
theory-based,1,0.0
replicable,1,0.0
6-month,1,0.0
tried,1,0.0
conveyed,1,0.0
deployed,1,0.0
p004,1,0.0
overstated,1,0.0
enrich,1,0.0
-0009,1,0.0
1192,1,0.0
conclusions,1,0.0
caregiver,1,0.0
Key,1,0.0
precludes,1,0.0
multilevel,1,0.0
concurrently,1,0.0
parentscaregivers,1,0.0
co-create,1,0.0
derail,1,0.0
submit,1,0.0
marketed,1,0.0
everything,1,0.0
Computational,1,0.0
modulators,1,0.0
Kappa,1,0.0
constructs,1,0.0
nanomolar,1,0.0
311,1,0.0
Ebola,1,0.0
Zika,1,0.0
no132131,1,0.0
signatures,1,0.0
activity-based,1,0.0
spaces,1,0.0
092,1,0.0
DOHMH,1,0.0
explanatory,1,0.0
056,1,0.0
038,1,0.0
rRTPCR,1,0.0
structure-activity,1,0.0
042,1,0.0
no21,1,0.0
Calcium,1,0.0
tertile,1,0.0
204,1,0.0
Pregnant,1,0.0
335,1,0.0
HCWs,1,0.0
AMI-RV,1,0.0
scope,1,0.0
Close,1,0.0
No1-29,1,0.0
7572,1,0.0
Manitoba,1,0.0
546,1,0.0
476,1,0.0
Throat,1,0.0
708,1,0.0
tape,1,0.0
Context,1,0.0
Mitigating,1,0.0
ST-depression,1,0.0
vulnerabilities,1,0.0
note,1,0.0
Non-smokers,1,0.0
Euroimmune,1,0.0
Twin,1,0.0
Cities,1,0.0
watch,1,0.0
ECLIA-Elecsys®,1,0.0
metro,1,0.0
electrochemiluminescence,1,0.0
worst,1,0.0
sparse,1,0.0
Oak,1,0.0
fragmentary,1,0.0
Ridge,1,0.0
urbanization,1,0.0
large-vessel,1,0.0
coordinate,1,0.0
interviews,1,0.0
opposition,1,0.0
4-week,1,0.0
985,1,0.0
XL,1,0.0
excitement,1,0.0
upperlower,1,0.0
exudate,1,0.0
Ab,1,0.0
cell-specific,1,0.0
inclusive,1,0.0
IGM,1,0.0
EDN,1,0.0
neurotoxin,1,0.0
0285,1,0.0
worth,1,0.0
0224,1,0.0
eosinophil-derived,1,0.0
0331,1,0.0
0163,1,0.0
ECP,1,0.0
geographical,1,0.0
random-digit,1,0.0
dialing,1,0.0
kin,1,0.0
societies,1,0.0
921,1,0.0
CPRintubation,1,0.0
22-80,1,0.0
swabsMethods,1,0.0
843,1,0.0
afforded,1,0.0
Medication,1,0.0
DiaSorin,1,0.0
Goggle,1,0.0
Advances,1,0.0
207,1,0.0
intrahost,1,0.0
viral-load-based,1,0.0
Distribution,1,0.0
transcriptase-PCR,1,0.0
loss-to-follow-up,1,0.0
performedResults,1,0.0
oblique,1,0.0
micro-targeting,1,0.0
Implemented,1,0.0
ventriculograms,1,0.0
572,1,0.0
footballers,1,0.0
LVG,1,0.0
endo,1,0.0
29713,1,0.0
Python,1,0.0
apoptotic,1,0.0
flexibility,1,0.0
customized,1,0.0
laptop,1,0.0
end-labelling,1,0.0
Endo-diastolic,1,0.0
Nick,1,0.0
RMW,1,0.0
condensation,1,0.0
reperfusionABSTRACT,1,0.0
chromatin,1,0.0
workplaces,1,0.0
350,1,0.0
CLIA-LIAISON®,1,0.0
adversely,1,0.0
hypodensity,1,0.0
No10-35,1,0.0
audiences,1,0.0
YHLO,1,0.0
Perioperative,1,0.0
Access,1,0.0
Shenzhen,1,0.0
tryptase,1,0.0
newly-developed,1,0.0
well-recognized,1,0.0
best-practice,1,0.0
immunoregulatory,1,0.0
prostaglandins,1,0.0
rationalize,1,0.0
Technogenetics,1,0.0
No10-29,1,0.0
30-35,1,0.0
expired,1,0.0
Modulation,1,0.0
Reverse-transcriptase-polymerase-chain-reaction,1,0.0
Agent-based,1,0.0
MBCK,1,0.0
Simulator,1,0.0
open-source,1,0.0
country-specific,1,0.0
immunochromatographic,1,0.0
pyrophosphate,1,0.0
intervene,1,0.0
medullary,1,0.0
transitioning,1,0.0
biggest,1,0.0
purified,1,0.0
cDNA,1,0.0
RSLAs,1,0.0
Amplicons,1,0.0
Long,1,0.0
MinIONGridION,1,0.0
Nanopore,1,0.0
length-based,1,0.0
ampliconread,1,0.0
underpin,1,0.0
insertions,1,0.0
drivers,1,0.0
impair,1,0.0
Ethnopharmacological,1,0.0
progresses,1,0.0
deserves,1,0.0
remember,1,0.0
suppresses,1,0.0
validating,1,0.0
selecting,1,0.0
pre-analytical,1,0.0
Taskforce,1,0.0
IFCC,1,0.0
Chemistry,1,0.0
instrumentation-based,1,0.0
carries,1,0.0
acid-based,1,0.0
Standard,1,0.0
quantifying,1,0.0
bidirectional,1,0.0
myofibroblast,1,0.0
TH2,1,0.0
cooperates,1,0.0
receptor-mediated,1,0.0
basement,1,0.0
collagens,1,0.0
deposit,1,0.0
Beneath,1,0.0
mediator-generating,1,0.0
attachments,1,0.0
columnar,1,0.0
epithelial-mesenchymal,1,0.0
factor-beta,1,0.0
discover,1,0.0
transforming,1,0.0
non-elderly,1,0.0
Australians,1,0.0
Indigenous,1,0.0
631,1,0.0
minus,1,0.0
hospitalisations,1,0.0
summarises,1,0.0
operates,1,0.0
Alert,1,0.0
Prehospital,1,0.0
formulas,1,0.0
chromatographic,1,0.0
theoretically,1,0.0
propagate,1,0.0
disease-cardiac,1,0.0
midregional,1,0.0
0860,1,0.0
0870,1,0.0
0798,1,0.0
0786,1,0.0
453,1,0.0
190,1,0.0
statistic,1,0.0
Inter-rater,1,0.0
inter-rater,1,0.0
categorizes,1,0.0
source-other,1,0.0
Atherosclerosis-small,1,0.0
MR-proANP,1,0.0
supplementation,1,0.0
supportive,1,0.0
whichever,1,0.0
e,1,0.0
coexistence,1,0.0
Mixed,1,0.0
indicated--pulmonary,1,0.0
or--if,1,0.0
anticholinergics,1,0.0
re-evaluated,1,0.0
discriminatory,1,0.0
smoker,1,0.0
proatrial,1,0.0
Twenty-six,1,0.0
unremittent,1,0.0
radiation,1,0.0
prerequisite,1,0.0
Good,1,0.0
550,1,0.0
Total,1,0.0
Selective,1,0.0
PyP,1,0.0
99Tcm,1,0.0
scintigraphically,1,0.0
674,1,0.0
Combined,1,0.0
informal,1,0.0
Informal,1,0.0
puzzle,1,0.0
self-efficacy,1,0.0
362-371,1,0.0
yield,1,0.0
standing,1,0.0
197-202,1,0.0
demographers,1,0.0
prefecture-level,1,0.0
166-277,1,0.0
047-088,1,0.0
481000,1,0.0
257000,1,0.0
1918-19,1,0.0
Predictors,1,0.0
deposition,1,0.0
practitioner,1,0.0
8000,1,0.0
collects,1,0.0
inactivating,1,0.0
nm,1,0.0
60-140,1,0.0
particle-like,1,0.0
enveloped,1,0.0
Coronaviruses,1,0.0
appreciation,1,0.0
rhinovirus,1,0.0
situated,1,0.0
Laboratories,1,0.0
Public,1,0.0
CDR,1,0.0
CDSC,1,0.0
nanomaterials,1,0.0
PHLS,1,0.0
OPCS,1,0.0
Censuses,1,0.0
Office,1,0.0
Bed,1,0.0
MOSA,1,0.0
Schools,1,0.0
Officers,1,0.0
RCGP,1,0.0
Schemes,1,0.0
Spotter,1,0.0
neglected,1,0.0
sensing,1,0.0
metal,1,0.0
adduction,1,0.0
intercurrent,1,0.0
hyperuricaemia,1,0.0
hypertriglyceridaemia,1,0.0
Hypercholesterolaemia,1,0.0
daily--3,1,0.0
cigarettes,1,0.0
Excessive,1,0.0
years--2,1,0.0
next-of-kin,1,0.0
unequivocal,1,0.0
clinico-epidemiological,1,0.0
preserved,1,0.0
chemotherapeutic,1,0.0
sensors,1,0.0
metal-conjugates,1,0.0
3Clike,1,0.0
Metal-conjugates,1,0.0
radioassay,1,0.0
Q-RT-PCR,1,0.0
helicase,1,0.0
duplex-unwinding,1,0.0
bismuth,1,0.0
complexes-,1,0.0
Metal,1,0.0
electrochemical,1,0.0
colorimetric,1,0.0
Synthetic,1,0.0
bronchoscopy,1,0.0
ailments,1,0.0
collect,1,0.0
logical,1,0.0
deconditioning,1,0.0
COVID”,1,0.0
“long,1,0.0
work-related,1,0.0
clues,1,0.0
Work-Related,1,0.0
enpaneled,1,0.0
work-exacerbated,1,0.0
infantile,1,0.0
peculiar,1,0.0
Certain,1,0.0
scheme,1,0.0
contingent,1,0.0
surpassed,1,0.0
underdiagnosed,1,0.0
Much,1,0.0
prevailed,1,0.0
on-site,1,0.0
3750,1,0.0
441,1,0.0
MITI,1,0.0
Intervention,1,0.0
Triage,1,0.0
pieces,1,0.0
practitioner-based,1,0.0
Selecting,1,0.0
httpsbitly3y8n0Bt,1,0.0
400000,1,0.0
astograph,1,0.0
tetrapolar,1,0.0
2009-July,1,0.0
stockpiles,1,0.0
updating,1,0.0
provisions,1,0.0
swine-origin,1,0.0
imminent,1,0.0
declaration,1,0.0
Organizations,1,0.0
ensures,1,0.0
after-load,1,0.0
eukinetic,1,0.0
rheography,1,0.0
radiocardiography,1,0.0
disaggregate,1,0.0
Hunan,1,0.0
Xiangtan,1,0.0
brother,1,0.0
girl,1,0.0
12-year-old,1,0.0
undefined,1,0.0
Modelling,1,0.0
altering,1,0.0
classroom,1,0.0
Residential,1,0.0
117276,1,0.0
infectivity,1,0.0
ill-defined,1,0.0
tamponade,1,0.0
57-year-old,1,0.0
Gene-expression,1,0.0
BVictoria,1,0.0
6-17,1,0.0
773,1,0.0
licensure,1,0.0
specify,1,0.0
hemagglutination,1,0.0
Attribution,1,0.0
intercorrelated,1,0.0
karma,1,0.0
twice--4,1,0.0
Hindu,1,0.0
Seventy,1,0.0
overrepresented,1,0.0
32-70,1,0.0
ontology,1,0.0
Gene,1,0.0
vipirin,1,0.0
IFIT2,1,0.0
repeats,1,0.0
tetratricopeptide,1,0.0
interferon-induced,1,0.0
Interferon-regulated,1,0.0
microarray,1,0.0
oligonucleotide,1,0.0
gene-expression,1,0.0
sitting,1,0.0
30-62,1,0.0
stepped,1,0.0
twenty-nine,1,0.0
hypochlorite,1,0.0
County,1,0.0
Nueces,1,0.0
packaging,1,0.0
impinge,1,0.0
sessions,1,0.0
manuals,1,0.0
accomplish,1,0.0
alike,1,0.0
usable,1,0.0
nonimmunologic,1,0.0
microscopy,1,0.0
histologic,1,0.0
debated,1,0.0
translate,1,0.0
Existence,1,0.0
mucous,1,0.0
temporary,1,0.0
Chlorine,1,0.0
educators,1,0.0
accountability,1,0.0
rigor,1,0.0
Think,1,0.0
Discover,1,0.0
Watch,1,0.0
cohesive,1,0.0
choose,1,0.0
sit,1,0.0
non-invasively,1,0.0
countrywide,1,0.0
Mycoplasma,1,0.0
hereof,1,0.0
alertness,1,0.0
decelerating,1,0.0
handle,1,0.0
opinionated,1,0.0
XXI,1,0.0
ever,1,0.0
scene,1,0.0
astounding,1,0.0
hyper-homocysteinemia,1,0.0
vitamins,1,0.0
pharmacotherapies,1,0.0
Chlamydia,1,0.0
biosensing-related,1,0.0
go,1,0.0
episode,1,0.0
Relative,1,0.0
haemoglobin,1,0.0
G6PD,1,0.0
Xga,1,0.0
Lea,1,0.0
199,1,0.0
eighty-six,1,0.0
putting,1,0.0
sandstorm,1,0.0
violent,1,0.0
spot,1,0.0
investigates,1,0.0
neurobehavioral,1,0.0
in-situ,1,0.0
ataxic,1,0.0
temporo-occipital,1,0.0
embolisms,1,0.0
midbrain,1,0.0
Posterior,1,0.0
pontine,1,0.0
viscosity,1,0.0
In-situ,1,0.0
neglect,1,0.0
perforator,1,0.0
classically,1,0.0
Accordingly,1,0.0
occasionally,1,0.0
composed,1,0.0
Humoral,1,0.0
gut,1,0.0
myocarial,1,0.0
Counterpulsation,1,0.0
plausible,1,0.0
desaturation,1,0.0
syndromeinfarct,1,0.0
0045,1,0.0
cardiac-embolic,1,0.0
0046,1,0.0
0009,1,0.0
spells,1,0.0
non-Hispanic,1,0.0
uninsured,1,0.0
0007,1,0.0
countered,1,0.0
Oligoryzomys,1,0.0
unstudied,1,0.0
Anderson,1,0.0
Tatum,1,0.0
frustratingly,1,0.0
roll-outs,1,0.0
record-breaking,1,0.0
web,1,0.0
Perceptions,1,0.0
327,1,0.0
292,1,0.0
paper-and-pencil,1,0.0
infodemic,1,0.0
Rodentia,1,0.0
allergistspulmonologists,1,0.0
syncope,1,0.0
Asthma-related,1,0.0
expectations,1,0.0
internists,1,0.0
pulmonologists,1,0.0
allergists,1,0.0
≥12,1,0.0
telephone-based,1,0.0
Insight,1,0.0
Panel,1,0.0
Third,1,0.0
nigripes,1,0.0
Muridae,1,0.0
Premenstrual,1,0.0
glandular,1,0.0
Kigali,1,0.0
genus,1,0.0
diversification,1,0.0
host-switching,1,0.0
marsupials,1,0.0
parasite,1,0.0
petteri,1,0.0
sheathed,1,0.0
microfilaria,1,0.0
protruded,1,0.0
aperture,1,0.0
cloacal,1,0.0
asymmetrical,1,0.0
semideciduous,1,0.0
annular,1,0.0
transparent,1,0.0
capsule,1,0.0
buccal,1,0.0
dorsally,1,0.0
displaced,1,0.0
amphids,1,0.0
carinii,1,0.0
sp,1,0.0
odilae,1,0.0
Misiones,1,0.0
rainforest,1,0.0
suboptimal,1,0.0
Past,1,0.0
C6T,1,0.0
premenstrual,1,0.0
roughly,1,0.0
714,1,0.0
myalgia,1,0.0
Organiza,1,0.0
demic,1,0.0
Diarrhoea,1,0.0
2-12,1,0.0
3-12,1,0.0
2019-2019-nCoV,1,0.0
everyday,1,0.0
in-,1,0.0
chances,1,0.0
worthy,1,0.0
R279Q,1,0.0
hormone-analogue,1,0.0
prednisolone,1,0.0
dips,1,0.0
menopause,1,0.0
analogue,1,0.0
hormone,1,0.0
long-acting,1,0.0
gonadotrophin,1,0.0
necessitating,1,0.0
32-yr,1,0.0
perimenstrually,1,0.0
40-100,1,0.0
leucopoenia,1,0.0
P014,1,0.0
P004,1,0.0
Antiviral,1,0.0
-C1562T,1,0.0
-T1702A,1,0.0
Matrix,1,0.0
West,1,0.0
COVID19,1,0.0
Moderna,1,0.0
suicidesuicide,1,0.0
Reports,1,0.0
foreseen,1,0.0
microbiologic,1,0.0
office-based,1,0.0
hyperpnea,1,0.0
244,1,0.0
Pearsons,1,0.0
PD15,1,0.0
320,1,0.0
155,1,0.0
635,1,0.0
Dinkihaler,1,0.0
encapsulated,1,0.0
powder,1,0.0
Fifteen,1,0.0
yr,1,0.0
drying,1,0.0
hyperosmolar,1,0.0
elapsed,1,0.0
contacting,1,0.0
crossed,1,0.0
system-wide,1,0.0
439,1,0.0
SVCs,1,0.0
contrifugation,1,0.0
shell,1,0.0
non-MI,1,0.0
drug-target-disease,1,0.0
MI-related,1,0.0
bipartite,1,0.0
interactome,1,0.0
interactors,1,0.0
system-level,1,0.0
Gene-disease,1,0.0
Candidate,1,0.0
pelleted,1,0.0
Severely,1,0.0
Elderly,1,0.0
Vasculitis,1,0.0
680000,1,0.0
qualitatively,1,0.0
Prolonging,1,0.0
downstroke,1,0.0
Alterations,1,0.0
heretofore,1,0.0
abrogated,1,0.0
Late,1,0.0
lavendustin,1,0.0
smear,1,0.0
complements,1,0.0
nontreated,1,0.0
discriminate,1,0.0
demographicpre-stroke,1,0.0
stepwise,1,0.0
Separate,1,0.0
340,1,0.0
Drawing,1,0.0
Clock,1,0.0
reader,1,0.0
Cultural,1,0.0
allergistsimmunologists,1,0.0
familiarize,1,0.0
neutrophilic,1,0.0
Eosinophilic,1,0.0
Induced,1,0.0
tubes,1,0.0
delaying,1,0.0
morbid,1,0.0
readings,1,0.0
449,1,0.0
potentialities,1,0.0
attends,1,0.0
potency,1,0.0
shrews,1,0.0
monkeys,1,0.0
infect,1,0.0
onto,1,0.0
lentiviral-based,1,0.0
tyrosine,1,0.0
tPA-treated,1,0.0
Orientation,1,0.0
Results-,1,0.0
EVT-capable,1,0.0
Nationwide,1,0.0
373,1,0.0
255,1,0.0
347,1,0.0
455,1,0.0
308,1,0.0
Flipping,1,0.0
15-minute,1,0.0
713,1,0.0
stroke-centers,1,0.0
1941,1,0.0
drive-time,1,0.0
Conclusions-,1,0.0
nearest,1,0.0
Model-B,1,0.0
EVT-centers,1,0.0
greedy,1,0.0
Model-A,1,0.0
state-level,1,0.0
15-,1,0.0
trauma-models,1,0.0
EVT-center,1,0.0
Medicaid,1,0.0
Medicare,1,0.0
stratified,1,0.0
Bypassing,1,0.0
one-fifth,1,0.0
tissue-type,1,0.0
physically,1,0.0
categorize,1,0.0
categorizing,1,0.0
authorization,1,0.0
seriousness,1,0.0
naive,1,0.0
schemes,1,0.0
ATRIA,1,0.0
Fibrillation,1,0.0
CHA2DS2-VASc,1,0.0
CHADS2,1,0.0
truly,1,0.0
nonvitamin,1,0.0
provoked,1,0.0
Optimization,1,0.0
Isocapnic,1,0.0
equivalent,1,0.0
Bronchoconstriction,1,0.0
USD,1,0.0
expenditure,1,0.0
countrys,1,0.0
expense,1,0.0
afford,1,0.0
Generally,1,0.0
cockroaches,1,0.0
tailoring,1,0.0
gaps,1,0.0
premorbid,1,0.0
Barthel,1,0.0
Prevalence,1,0.0
referring,1,0.0
NPV,1,0.0
immunoglobin,1,0.0
antibody-dependent,1,0.0
Effective,1,0.0
appointment,1,0.0
Is,1,0.0
Simplification,1,0.0
Appointment,1,0.0
preventers,1,0.0
Self-management,1,0.0
discharging,1,0.0
unify,1,0.0
unified,1,0.0
neurotropic,1,0.0
prioritize,1,0.0
chose,1,0.0
subfertility,1,0.0
proxy,1,0.0
100-384,1,0.0
IVFICSI,1,0.0
ICSI,1,0.0
sperm,1,0.0
IVFintracytoplasmic,1,0.0
hyperstimulation,1,0.0
singletons,1,0.0
Oxford-AstraZeneca,1,0.0
RIDT,1,0.0
crosstalk,1,0.0
synergism,1,0.0
south,1,0.0
introspective,1,0.0
Investigating,1,0.0
Enzymatic,1,0.0
alphahydroxybutytrate,1,0.0
103,1,0.0
04p0006,1,0.0
517,1,0.0
alphahydroxybutyrate,1,0.0
speedily,1,0.0
AVictoria75,1,0.0
island,1,0.0
apparently,1,0.0
AScotland74,1,0.0
ataxia,1,0.0
Highland,1,0.0
applicability,1,0.0
conveniently,1,0.0
haemolysis,1,0.0
radial,1,0.0
linearly,1,0.0
AH1N1B,1,0.0
8-102,1,0.0
1970-1995,1,0.0
multiplication,1,0.0
clue,1,0.0
dysgeusia,1,0.0
influenza-infected,1,0.0
neutralize,1,0.0
Reintegration,1,0.0
macaques,1,0.0
18-28,1,0.0
Melbourne,1,0.0
high-,1,0.0
supplemented,1,0.0
film,1,0.0
resting,1,0.0
anti-virals,1,0.0
constraint,1,0.0
schedule,1,0.0
surroundings,1,0.0
yearly,1,0.0
meriting,1,0.0
rhesus,1,0.0
1-75,1,0.0
Vaccinated,1,0.0
golden,1,0.0
BALBc,1,0.0
Single-dose,1,0.0
AdC68,1,0.0
derivative,1,0.0
occupations,1,0.0
reintegration,1,0.0
Conclusion,1,0.0
Deterioration,1,0.0
Living,1,0.0
Normal,1,0.0
2-63,1,0.0
puts,1,0.0
enriched,1,0.0
transcranial,1,0.0
enrichment,1,0.0
antibody-secreting,1,0.0
arduous,1,0.0
antibody-discovery,1,0.0
discovering,1,0.0
cloning,1,0.0
paresis,1,0.0
sham,1,0.0
ipsilesional,1,0.0
contralesional,1,0.0
down-regulating,1,0.0
brain-computer,1,0.0
Combining,1,0.0
Capsule,1,0.0
admirable,1,0.0
Regulators,1,0.0
Sexual,1,0.0
Intrinsic,1,0.0
advertisement,1,0.0
Facebook,1,0.0
876,1,0.0
171,1,0.0
Kanagawa,1,0.0
cross-correlation,1,0.0
Syrup,1,0.0
Dry,1,0.0
geo-mapping,1,0.0
stroke-treating,1,0.0
Methods-,1,0.0
countries2,1,0.0
histocompatibility,1,0.0
interleukin-10,1,0.0
paralleled,1,0.0
Preliminary,1,0.0
Nepal,1,0.0
pandemic-fighting,1,0.0
terrible,1,0.0
possession,1,0.0
incurring,1,0.0
requisite,1,0.0
20113,1,0.0
witnessing,1,0.0
deaths1,1,0.0
inflammation-prone,1,0.0
615,1,0.0
Worldwide,1,0.0
symptom-monitoring,1,0.0
plethysmograph,1,0.0
flows,1,0.0
POSSIBLE,1,0.0
DEFINITE,1,0.0
conducts,1,0.0
28-day,1,0.0
1021,1,0.0
1012,1,0.0
25-74,1,0.0
persistently,1,0.0
resembled,1,0.0
Event,1,0.0
handles,1,0.0
diseasesauthors,1,0.0
atypical,1,0.0
vaccine-preventable,1,0.0
Topic,1,0.0
immunosuppressiveimmunomodulating,1,0.0
immunocompetent,1,0.0
neuromuscular,1,0.0
quantifies,1,0.0
scan-derived,1,0.0
atlas-guided,1,0.0
atlas-quantified,1,0.0
atlas-defined,1,0.0
application-dependent,1,0.0
bronchus-associated,1,0.0
Atlas-to-scan,1,0.0
probabilistic,1,0.0
employs,1,0.0
ARIC,1,0.0
patented,1,0.0
promptly,1,0.0
spasticity,1,0.0
Acupuncture,1,0.0
CXCL13,1,0.0
CCL19,1,0.0
homeostatic,1,0.0
iBALTs,1,0.0
330000,1,0.0
Augsburg,1,0.0
Timely,1,0.0
rapid-turnaround,1,0.0
flexor,1,0.0
extensor,1,0.0
wrist,1,0.0
Twenty-four,1,0.0
brain-machine,1,0.0
MI-based,1,0.0
longer-term,1,0.0
cortically,1,0.0
7-8,1,0.0
352,1,0.0
facility-level,1,0.0
looking,1,0.0
declines,1,0.0
interstimulus,1,0.0
certainty,1,0.0
205,1,0.0
detectability,1,0.0
Basketball,1,0.0
2019-2020,1,0.0
test-based,1,0.0
low-level,1,0.0
BK,1,0.0
perindopril,1,0.0
faciliate,1,0.0
prelude,1,0.0
courseABSTRACT,1,0.0
conditioning-test,1,0.0
plastic,1,0.0
reexamine,1,0.0
exponentially,1,0.0
authories,1,0.0
disinfecting,1,0.0
equipments,1,0.0
infectuousness,1,0.0
besides,1,0.0
exploiting,1,0.0
matrices,1,0.0
unanimate,1,0.0
animate,1,0.0
organism,1,0.0
surfaces,1,0.0
researches,1,0.0
390000,1,0.0
circuits,1,0.0
6600000,1,0.0
5th,1,0.0
counting,1,0.0
multiorgan,1,0.0
post-COVID,1,0.0
unexpected,1,0.0
coagulopathy,1,0.0
injury-causing,1,0.0
repercussions,1,0.0
cytokinemia,1,0.0
Lower,1,0.0
Machine,1,0.0
vasculatures,1,0.0
interlinked,1,0.0
over-production,1,0.0
Prior,1,0.0
10-15,1,0.0
cardiogram,1,0.0
entrenching,1,0.0
amelioration,1,0.0
felt,1,0.0
sinuses,1,0.0
30-70,1,0.0
X-rays,1,0.0
placebo-controlled,1,0.0
blind,1,0.0
recalcitrant,1,0.0
underutilize,1,0.0
Vietnamese,1,0.0
confluence,1,0.0
civil,1,0.0
p0036,1,0.0
469,1,0.0
312,1,0.0
792,1,0.0
814,1,0.0
regionallyABSTRACT,1,0.0
Increasingly,1,0.0
evaluable,1,0.0
Wall,1,0.0
415,1,0.0
accompany,1,0.0
lifespan,1,0.0
90-day,1,0.0
anti-proinflammatory,1,0.0
rs17561,1,0.0
Purpose-,1,0.0
MALDI-TOF,1,0.0
time-of-flight,1,0.0
desorptionionization,1,0.0
matrix-assisted,1,0.0
genotyped,1,0.0
IL1B,1,0.0
rs1143627,1,0.0
rs3917345,1,0.0
rs1143623,1,0.0
IL1A,1,0.0
rs2071373,1,0.0
rs16347,1,0.0
THAWS,1,0.0
rs1304037,1,0.0
192,1,0.0
Interleukin-1B,1,0.0
Interleukin-1A,1,0.0
Conduct,1,0.0
DO,1,0.0
TLCO,1,0.0
KNOW,1,0.0
notified,1,0.0
mutate,1,0.0
Alteplase,1,0.0
Unclear-Onset,1,0.0
irregular,1,0.0
polyphasic,1,0.0
monophasic,1,0.0
non-ST,1,0.0
FDPS,1,0.0
100--109,1,0.0
But,1,0.0
heart-disease,1,0.0
Apart,1,0.0
169,1,0.0
normality,1,0.0
assesses,1,0.0
2010-11,1,0.0
circulate,1,0.0
moving,1,0.0
reversed,1,0.0
sting,1,0.0
slopes,1,0.0
bee,1,0.0
envenomated,1,0.0
Reflecting,1,0.0
enrolling,1,0.0
advise,1,0.0
displaying,1,0.0
projections,1,0.0
ensemble,1,0.0
Mathematical,1,0.0
accrual,1,0.0
prioritizing,1,0.0
anti-infectious,1,0.0
pre-treatment,1,0.0
EDP,1,0.0
normalisation,1,0.0
precipitate,1,0.0
0025,1,0.0
4-6,1,0.0
082,1,0.0
8th-10th,1,0.0
Frank,1,0.0
Y,1,0.0
36-55,1,0.0
AH3N2-related,1,0.0
1210,1,0.0
Multivariate,1,0.0
standardised,1,0.0
Sanitaire,1,0.0
Veille,1,0.0
Institut,1,0.0
-065,1,0.0
rho,1,0.0
weights,1,0.0
Acceptability,1,0.0
Eighty,1,0.0
Acceptable,1,0.0
judgments,1,0.0
Health-related,1,0.0
104--110,1,0.0
seldom,1,0.0
exceed,1,0.0
2004-14,1,0.0
Inhaled,1,0.0
Modification,1,0.0
nitinol,1,0.0
Check™,1,0.0
IgMIgG,1,0.0
IgM-IgG,1,0.0
61-90,1,0.0
31-60,1,0.0
patient-specific,1,0.0
post-symptom,1,0.0
timepoints,1,0.0
bodys,1,0.0
devising,1,0.0
raced,1,0.0
cage,1,0.0
spherical,1,0.0
1-4,1,0.0
membrane-,1,0.0
PLAATO,1,0.0
Transcatheter,1,0.0
embolization,1,0.0
forecasting,1,0.0
virologists,1,0.0
dispersed,1,0.0
actively,1,0.0
remainder,1,0.0
cross-section,1,0.0
stations,1,0.0
anecdotal,1,0.0
Check,1,0.0
5-7,1,0.0
1984,1,0.0
AH1N1v-associated,1,0.0
genomics,1,0.0
predisposition,1,0.0
conferring,1,0.0
amyloid,1,0.0
surprisingly,1,0.0
∼5,1,0.0
∼18-50,1,0.0
Nontraumatic,1,0.0
totally,1,0.0
morbidities,1,0.0
apparatus,1,0.0
8-9,1,0.0
Provocation,1,0.0
longevity,1,0.0
Assessing,1,0.0
abulia,1,0.0
ganglion,1,0.0
standards,1,0.0
unfamiliar,1,0.0
flight,1,0.0
asthmogenic,1,0.0
secondly,1,0.0
incapacitation,1,0.0
Firstly,1,0.0
incompatible,1,0.0
re-infection,1,0.0
sequentially,1,0.0
Pooling,1,0.0
DNA-centric,1,0.0
under-recognised,1,0.0
1777,1,0.0
4327,1,0.0
1209,1,0.0
3876,1,0.0
1890,1,0.0
5957,1,0.0
1441,1,0.0
4720,1,0.0
3725,1,0.0
echo-cardiography,1,0.0
radiographs,1,0.0
under-recognition,1,0.0
aids,1,0.0
Lowns,1,0.0
deteriorating,1,0.0
Measurement,1,0.0
hand-held,1,0.0
office,1,0.0
Aimed,1,0.0
droppings,1,0.0
soiled,1,0.0
waterbodies,1,0.0
birds,1,0.0
migratory,1,0.0
Wild,1,0.0
CO₂,1,0.0
NYHA,1,0.0
degenerative,1,0.0
12000,1,0.0
swimming,1,0.0
atenolol,1,0.0
ISIS,1,0.0
MIAMI,1,0.0
Göteborg,1,0.0
27000,1,0.0
beta-blockers,1,0.0
bradyarrhythmias,1,0.0
AV,1,0.0
conversion,1,0.0
Units,1,0.0
irritants,1,0.0
disinfectants,1,0.0
athletes,1,0.0
autosomal,1,0.0
salt--was,1,0.0
diet--primarily,1,0.0
drains,1,0.0
DCs,1,0.0
dendritic,1,0.0
regimes,1,0.0
weapon,1,0.0
evoke,1,0.0
equipped,1,0.0
Basic,1,0.0
leukoencephalopathy,1,0.0
arteriopathy,1,0.0
transform,1,0.0
prospects,1,0.0
regards,1,0.0
subtending,1,0.0
voluntary,1,0.0
Foix-Chavany-Marie,1,0.0
opercular,1,0.0
explicate,1,0.0
interdisciplinary,1,0.0
insurers,1,0.0
15-50,1,0.0
cut-off,1,0.0
receiver-operator,1,0.0
329,1,0.0
366,1,0.0
428,1,0.0
443,1,0.0
lingual,1,0.0
subtended,1,0.0
Qualitative,1,0.0
Plateau,1,0.0
pulsing,1,0.0
exponential,1,0.0
offline,1,0.0
Optison,1,0.0
harmonic,1,0.0
Thirty-four,1,0.0
catalytic,1,0.0
immunoenzymometric,1,0.0
lend,1,0.0
pharyngeal,1,0.0
mastication,1,0.0
multivariable,1,0.0
tnine,1,0.0
viral-induced,1,0.0
add-on,1,0.0
arthralgia,1,0.0
angioedema,1,0.0
rashes,1,0.0
zafirlukast,1,0.0
Cysteiny,1,0.0
controller,1,0.0
Inflammation,1,0.0
accentuate,1,0.0
six--with,1,0.0
syndrome--two,1,0.0
pleuritis,1,0.0
opercula,1,0.0
pains,1,0.0
sedimentation,1,0.0
erythrocyte,1,0.0
febrility,1,0.0
rest--10--between,1,0.0
frustrate,1,0.0
patients--24--were,1,0.0
cent--were,1,0.0
patients--24,1,0.0
patients--48,1,0.0
257,1,0.0
well-localized,1,0.0
0081,1,0.0
1001-1146,1,0.0
unresolved,1,0.0
web-based,1,0.0
975,1,0.0
proteome,1,0.0
target-based,1,0.0
blacks,1,0.0
optimisation,1,0.0
non-hERG,1,0.0
526,1,0.0
Ten,1,0.0
categorised,1,0.0
cardiotoxicity,1,0.0
mutagenicity,1,0.0
servers,1,0.0
financial,1,0.0
protomers,1,0.0
3-chymotrypsin-like,1,0.0
returns,1,0.0
stock,1,0.0
INFR,1,0.0
connectedness,1,0.0
time-varying,1,0.0
economy,1,0.0
PAIMS,1,0.0
accordance,1,0.0
646,1,0.0
r-TPA,1,0.0
preference,1,0.0
Models,1,0.0
oligomers,1,0.0
1100,1,0.0
quantity,1,0.0
1217-1436,1,0.0
1322,1,0.0
0300,1,0.0
6799,1,0.0
ischemiareperfusion,1,0.0
dependence,1,0.0
Controversy,1,0.0
individualised,1,0.0
feeding,1,0.0
rejection,1,0.0
malignancy,1,0.0
microbial,1,0.0
Ultimately,1,0.0
allosteric,1,0.0
drug-resistant,1,0.0
trace,1,0.0
50-fold,1,0.0
abundance,1,0.0
off-target,1,0.0
melt,1,0.0
Delay,1,0.0
GISSI-Avoidable,1,0.0
decisive,1,0.0
httpssars3dcom,1,0.0
download,1,0.0
protein-ligand,1,0.0
low-flow,1,0.0
Smaller,1,0.0
jugular,1,0.0
Alicante,1,0.0
Electronic,1,0.0
idiopathic,1,0.0
rarity,1,0.0
trachea,1,0.0
mediastinal,1,0.0
compression,1,0.0
mediastinum,1,0.0
Fibrous,1,0.0
Through,1,0.0
twelve,1,0.0
Castellón,1,0.0
y,1,0.0
Miocardio,1,0.0
0954,1,0.0
agudo,1,0.0
Infarto,1,0.0
Registro,1,0.0
Proyecto,1,0.0
PRIMVAC,1,0.0
sub-group,1,0.0
quantitate,1,0.0
aortocoronary,1,0.0
Exercise,1,0.0
practicing,1,0.0
Mild,1,0.0
massage,1,0.0
mailed,1,0.0
Virus-like,1,0.0
prayers,1,0.0
200809,1,0.0
2001-2002,1,0.0
Nutrition,1,0.0
undoubtedly,1,0.0
trade-offs,1,0.0
timeliness,1,0.0
overestimating,1,0.0
aligned,1,0.0
unimmunised,1,0.0
imputing,1,0.0
Half,1,0.0
58–63,1,0.0
22–39,1,0.0
Age-adjusted,1,0.0
VLPs,1,0.0
unbiased,1,0.0
TND,1,0.0
Ontario,1,0.0
pro-B-type,1,0.0
afterload,1,0.0
insect,1,0.0
baculovirus,1,0.0
purification,1,0.0
redirecting,1,0.0
capsid,1,0.0
mimicking,1,0.0
biopharmaceuticals,1,0.0
rubs,1,0.0
Parental,1,0.0
double-lumen,1,0.0
culprit,1,0.0
defend,1,0.0
189091,1,0.0
Pfeiffer,1,0.0
1918-1920,1,0.0
1918-20,1,0.0
well-controlled,1,0.0
scored,1,0.0
0-100,1,0.0
instrument,1,0.0
Economic,1,0.0
177,1,0.0
reassessment,1,0.0
student-days¶,1,0.0
bacillus,1,0.0
109752,1,0.0
Stay,1,0.0
events§,1,0.0
competition,1,0.0
athletics,1,0.0
scheduled,1,0.0
completion,1,0.0
193,1,0.0
Utahs,1,0.0
1886,1,0.0
59552,1,0.0
2020-March,1,0.0
thesis,1,0.0
Virology,1,0.0
Fishers,1,0.0
re-construct,1,0.0
Parents,1,0.0
fibromuscular,1,0.0
Recovery,1,0.0
cardioplegia,1,0.0
tepid,1,0.0
retrograde,1,0.0
veins,1,0.0
saphenous,1,0.0
phosphokinase,1,0.0
advocated,1,0.0
postthrombolytic,1,0.0
postlytic,1,0.0
reductionism,1,0.0
postwar,1,0.0
Today,1,0.0
politicians,1,0.0
fill,1,0.0
archaeology,1,0.0
1950s,1,0.0
discipline,1,0.0
mankind,1,0.0
polypragmasy,1,0.0
chinine,1,0.0
Aggressive,1,0.0
school-building,1,0.0
bacteriology,1,0.0
2013-2014,1,0.0
37015,1,0.0
cause-specific,1,0.0
low-neck,1,0.0
ophthalmological,1,0.0
Peoples,1,0.0
Zhuang,1,0.0
Guangxi,1,0.0
162020,1,0.0
Ophthalmology,1,0.0
website,1,0.0
official,1,0.0
print,1,0.0
ahead,1,0.0
on-line,1,0.0
sinister,1,0.0
Virchow,1,0.0
checking,1,0.0
metastatic,1,0.0
audit,1,0.0
axillary,1,0.0
supraclavicular,1,0.0
lump,1,0.0
wait,1,0.0
axilla,1,0.0
papilloma,1,0.0
astonishing,1,0.0
passenger,1,0.0
test-and-travel,1,0.0
airline,1,0.0
inquiring,1,0.0
conjunctivitis-related,1,0.0
4326,1,0.0
-038,1,0.0
venovenous,1,0.0
broncholytic,1,0.0
acidosis,1,0.0
hypercapnia,1,0.0
supra-,1,0.0
craniectomy,1,0.0
consecutively,1,0.0
1-10,1,0.0
Extensive,1,0.0
prognostication,1,0.0
meaningful,1,0.0
Nearly,1,0.0
049,1,0.0
370,1,0.0
1-18,1,0.0
20-75,1,0.0
entailing,1,0.0
Upper,1,0.0
sensorimotor,1,0.0
Preclinical,1,0.0
433-437,1,0.0
Ophthalmol,1,0.0
J,1,0.0
2019Chin,1,0.0
1667±929,1,0.0
complained,1,0.0
Routine,1,0.0
observe,1,0.0
fluids,1,0.0
Romanian,1,0.0
Intracellular,1,0.0
glia,1,0.0
Acutely,1,0.0
myalgias,1,0.0
892,1,0.0
226,1,0.0
686,1,0.0
562,1,0.0
agitatedanxious,1,0.0
sadderdepressive,1,0.0
questionnaire-based,1,0.0
Sjögren,1,0.0
pupils,1,0.0
end-tidal,1,0.0
859,1,0.0
boarding,1,0.0
Amantadine,1,0.0
1998,1,0.0
reassortants,1,0.0
parotitis,1,0.0
Swine,1,0.0
196-514,1,0.0
108-185,1,0.0
073-118,1,0.0
Former,1,0.0
120-158,1,0.0
kappa,1,0.0
mitogen-activated,1,0.0
arachidonic,1,0.0
hypoxic-ischemic,1,0.0
Walking,1,0.0
Inspired,1,0.0
ranking,1,0.0
inferiority,1,0.0
wards,1,0.0
Reinforcement,1,0.0
COVID-19‒positive,1,0.0
line‒associated,1,0.0
232,1,0.0
918,1,0.0
10848,1,0.0
competing,1,0.0
March‒October,1,0.0
Hospital-acquired,1,0.0
under-diagnosed,1,0.0
069-106,1,0.0
strengthening,1,0.0
078-098,1,0.0
Stratifying,1,0.0
083-098,1,0.0
476181,1,0.0
RRs,1,0.0
Pertinent,1,0.0
inconsistently,1,0.0
Nut,1,0.0
2-5,1,0.0
MCA,1,0.0
obscure,1,0.0
vegetable,1,0.0
regenerating,1,0.0
repairing,1,0.0
incapable,1,0.0
longterm,1,0.0
synopsis,1,0.0
hoped,1,0.0
parenchyma,1,0.0
Any,1,0.0
conundrums,1,0.0
phenotype-specific,1,0.0
assigning,1,0.0
recognised,1,0.0
Personal,1,0.0
hostile,1,0.0
Skin,1,0.0
substance,1,0.0
irritative,1,0.0
jobs,1,0.0
high-profile,1,0.0
trimer,1,0.0
alters,1,0.0
bat,1,0.0
S-mediated,1,0.0
cathepsin,1,0.0
putative,1,0.0
S1,1,0.0
Stem,1,0.0
Preconditioning,1,0.0
particle,1,0.0
COVID-Net,1,0.0
monthsABSTRACT,1,0.0
termination,1,0.0
IVIG-treated,1,0.0
gkg,1,0.0
infusions,1,0.0
6-20,1,0.0
extending,1,0.0
school-aged,1,0.0
preschool-aged,1,0.0
Fractional,1,0.0
outperform,1,0.0
COVIDNet-CT,1,0.0
architectures,1,0.0
preconditioned,1,0.0
993,1,0.0
five-category,1,0.0
non-COVID-19,1,0.0
Tuberculosis,1,0.0
dynamically,1,0.0
vanishing,1,0.0
gradient,1,0.0
solve,1,0.0
proposes,1,0.0
generalisability,1,0.0
X-Ray,1,0.0
manipulations,1,0.0
furin,1,0.0
SARS-CoV-2-infected,1,0.0
sero-susceptibility,1,0.0
931-100,1,0.0
alternate,1,0.0
pH1N1-associated,1,0.0
866000,1,0.0
NSW,1,0.0
Hunter,1,0.0
anticonvulsant,1,0.0
Epileptic,1,0.0
antiepileptic,1,0.0
epileptiform,1,0.0
hemiparetic,1,0.0
RT-3DE,1,0.0
dyssynchrony,1,0.0
905-100,1,0.0
ORF1,1,0.0
968,1,0.0
RT-iiPCR,1,0.0
transcription-insulated,1,0.0
ab,1,0.0
orf,1,0.0
single-target,1,0.0
Fewer,1,0.0
Titres,1,0.0
≥40,1,0.0
pre-immunisation,1,0.0
ASydney51997,1,0.0
swH3N2,1,0.0
substitute,1,0.0
2707,1,0.0
trimeric,1,0.0
cardiomyocytes,1,0.0
Inc,1,0.0
NOW™,1,0.0
Point-of-care,1,0.0
0-40,1,0.0
Community-acquired,1,0.0
CAP,1,0.0
Reviewed,1,0.0
CABP,1,0.0
regenerative,1,0.0
exceptional,1,0.0
spawning,1,0.0
exciting,1,0.0
Transplanted,1,0.0
2562,1,0.0
equitable,1,0.0
rationales,1,0.0
labor,1,0.0
drifted,1,0.0
2014-2015,1,0.0
frontline,1,0.0
Saliva,1,0.0
nonsignificant,1,0.0
2985,1,0.0
2662,1,0.0
2824,1,0.0
2852,1,0.0
peri-operative,1,0.0
∼2789,1,0.0
105558,1,0.0
os,1,0.0
cerebellum,1,0.0
Types,1,0.0
stutter,1,0.0
dysarthria,1,0.0
dysprosody,1,0.0
Questions,1,0.0
euthyroid,1,0.0
rendered,1,0.0
iodine,1,0.0
radioactive,1,0.0
trinitrate,1,0.0
glyceryl,1,0.0
hyperthyroid,1,0.0
rampantly,1,0.0
normotensive,1,0.0
investigatedCurrently,1,0.0
non-dipping,1,0.0
evening,1,0.0
U-shaped,1,0.0
J-,1,0.0
120-14080-90,1,0.0
Optimal,1,0.0
channel,1,0.0
MOSES,1,0.0
cerebroprotective,1,0.0
aldosterone,1,0.0
reverting,1,0.0
mini,1,0.0
spend,1,0.0
light-to-moderate,1,0.0
neighborhoods,1,0.0
record-based,1,0.0
heath,1,0.0
Patient-clinician,1,0.0
31-40,1,0.0
51-64,1,0.0
BYamagata1688,1,0.0
6-8,1,0.0
H1-ATaiwan186,1,0.0
H3-AShanghai1688,1,0.0
199091,1,0.0
drinking,1,0.0
NIC,1,0.0
formulation,1,0.0
Interventions,1,0.0
correspondence,1,0.0
exertional,1,0.0
constrictive,1,0.0
degeneration,1,0.0
fibrotic,1,0.0
Pericarditis,1,0.0
virus-infected,1,0.0
non-neutralizing,1,0.0
RBD-binding,1,0.0
compiled,1,0.0
Towards,1,0.0
Recurrent,1,0.0
haemorrhagic,1,0.0
Racial,1,0.0
Monetarised,1,0.0
Soluble,1,0.0
replenishing,1,0.0
storing,1,0.0
avoiding,1,0.0
driven,1,0.0
reliant,1,0.0
Plans,1,0.0
Preparedness,1,0.0
devised,1,0.0
visualisation,1,0.0
discounted,1,0.0
disposal,1,0.0
alternatively,1,0.0
035-091,1,0.0
worthwhile,1,0.0
adopt,1,0.0
cheap,1,0.0
Epi-aortic,1,0.0
post-coronary,1,0.0
foremost,1,0.0
finite,1,0.0
pricing,1,0.0
Caution,1,0.0
528,1,0.0
ignoring,1,0.0
£187682,1,0.0
tumorigenicity,1,0.0
eliminate,1,0.0
Baseline,1,0.0
Greater,1,0.0
0015,1,0.0
128-1003,1,0.0
359,1,0.0
138-1159,1,0.0
fourfold,1,0.0
0026,1,0.0
races,1,0.0
2-13,1,0.0
interquartile,1,0.0
486,1,0.0
588,1,0.0
374,1,0.0
1134,1,0.0
0-1,1,0.0
modified-Rankin,1,0.0
pre-stroke,1,0.0
Demographics,1,0.0
tertiary-care,1,0.0
18-45,1,0.0
racial,1,0.0
102-1630,1,0.0
501,1,0.0
ngmL,1,0.0
587,1,0.0
quartile,1,0.0
cross-reactive,1,0.0
immunised,1,0.0
12514,1,0.0
Statistical,1,0.0
slight,1,0.0
nebulized,1,0.0
hyper-reactivity,1,0.0
Cambodian,1,0.0
KAPs,1,0.0
HPAI-related,1,0.0
salivary,1,0.0
741,1,0.0
Agreement,1,0.0
Percent,1,0.0
733,1,0.0
072,1,0.0
self-collected,1,0.0
distilled,1,0.0
shoulder,1,0.0
arms,1,0.0
faint,1,0.0
lightheaded,1,0.0
feeling,1,0.0
jaw,1,0.0
optimizing,1,0.0
Recognizing,1,0.0
friends,1,0.0
remind,1,0.0
Month,1,0.0
seconds,1,0.0
-057,1,0.0
Histamine,1,0.0
interacting,1,0.0
hamper,1,0.0
DoD,1,0.0
Defense,1,0.0
destination,1,0.0
agency,1,0.0
QI,1,0.0
Spirometry,1,0.0
sugar,1,0.0
purposes,1,0.0
Immediate,1,0.0
ultrasonography,1,0.0
MRA,1,0.0
Diabetes,1,0.0
772,1,0.0
ample,1,0.0
404,1,0.0
328,1,0.0
1721,1,0.0
First-ever,1,0.0
Valid,1,0.0
scepticism,1,0.0
Immunisations,1,0.0
forthcoming,1,0.0
18th,1,0.0
smallpox,1,0.0
neurohormonal,1,0.0
oxidant,1,0.0
subsystems,1,0.0
physics,1,0.0
20-59,1,0.0
persisted,1,0.0
Biosensor,1,0.0
Tech,1,0.0
Assure,1,0.0
JOYSBIO,1,0.0
CV-1,1,0.0
1141,1,0.0
undetected,1,0.0
pass,1,0.0
infectiousness,1,0.0
Antigen,1,0.0
weighting,1,0.0
inverted,1,0.0
0763,1,0.0
NDFOS,1,0.0
062-194,1,0.0
040-055,1,0.0
0539,1,0.0
071-191,1,0.0
133-362,1,0.0
112-241,1,0.0
164,1,0.0
110,1,0.0
427,1,0.0
11402,1,0.0
491,1,0.0
12023,1,0.0
VivaChek,1,0.0
Sensitivities,1,0.0
Next,1,0.0
kits,1,0.0
multidimensional,1,0.0
unidimensional,1,0.0
preferences,1,0.0
Tailoring,1,0.0
GRs,1,0.0
018,1,0.0
1846,1,0.0
2092,1,0.0
538,1,0.0
461,1,0.0
midpoint,1,0.0
kit,1,0.0
Suspected,1,0.0
ATGs,1,0.0
Odate,1,0.0
Enhanced,1,0.0
automaticity,1,0.0
skill,1,0.0
needless,1,0.0
RT-PCR-positive,1,0.0
high-prevalence,1,0.0
well-performing,1,0.0
81-97,1,0.0
grew,1,0.0
Corrected,1,0.0
ATG,1,0.0
overseas,1,0.0
Naval,1,0.0
Cairo,1,0.0
2531,1,0.0
χ249614,1,0.0
2220,1,0.0
3266,1,0.0
Z-9190,1,0.0
score21,1,0.0
310,1,0.0
660,1,0.0
P0012,1,0.0
χ26267,1,0.0
2348,1,0.0
P0003,1,0.0
χ28616,1,0.0
2992,1,0.0
χ224267,1,0.0
P0001and,1,0.0
Z-3928,1,0.0
score20,1,0.0
661,1,0.0
7613,1,0.0
754,1,0.0
aggravation,1,0.0
823,1,0.0
2773,1,0.0
glucocorticoids,1,0.0
3213,1,0.0
heredity,1,0.0
1840,1,0.0
536,1,0.0
specialty,1,0.0
coauthors,1,0.0
months-old,1,0.0
17-120,1,0.0
post-immunisation,1,0.0
nsp,1,0.0
protein-protein,1,0.0
Cleavage,1,0.0
Mpro,1,0.0
conformation,1,0.0
replicationtranscription,1,0.0
cleaved,1,0.0
stranded,1,0.0
Biochemical,1,0.0
Krichel,1,0.0
398,1,0.0
MERS,1,0.0
cognition,1,0.0
61--80min,1,0.0
141--16081--100,1,0.0
three-years,1,0.0
unfavourable,1,0.0
deeply,1,0.0
203,1,0.0
prehospitalization,1,0.0
Plzen,1,0.0
altogether,1,0.0
Elevated,1,0.0
6603,1,0.0
875,1,0.0
GINA,1,0.0
polyDL-lactide-co-glycolide,1,0.0
head-to-head,1,0.0
equine,1,0.0
low-airborne,1,0.0
horses,1,0.0
Equine,1,0.0
exhibits,1,0.0
Achieving,1,0.0
60-69,1,0.0
happen,1,0.0
2030,1,0.0
biodegradable,1,0.0
PLGA-based,1,0.0
localized,1,0.0
levelaccording,1,0.0
veterinarians,1,0.0
accentuated,1,0.0
Highly-pathogenic,1,0.0
Mediterranean,1,0.0
Eastern,1,0.0
reformulated,1,0.0
so-called,1,0.0
Forces,1,0.0
Armed,1,0.0
tens,1,0.0
veterinarian,1,0.0
64E,1,0.0
Healthy,1,0.0
short-termed,1,0.0
retained,1,0.0
posttransplantation,1,0.0
mainland,1,0.0
Tibet,1,0.0
autonomous,1,0.0
municipalities,1,0.0
third-level,1,0.0
multi-center,1,0.0
OA,1,0.0
dabigatran,1,0.0
conferences,1,0.0
Anticoagulants,1,0.0
Antithrombotic,1,0.0
ninth,1,0.0
standardization,1,0.0
bloodserum,1,0.0
adequacy,1,0.0
Detection,1,0.0
pro-,1,0.0
fails,1,0.0
cross-talk,1,0.0
stringency,1,0.0
re-consideration,1,0.0
vascularisation,1,0.0
attenuating,1,0.0
secreted,1,0.0
biomolecules,1,0.0
Sixty-seven-year-old,1,0.0
Possible,1,0.0
relate,1,0.0
adhesion,1,0.0
706,1,0.0
24275,1,0.0
NHIS,1,0.0
Interview,1,0.0
Regular,1,0.0
gum,1,0.0
periodontitis,1,0.0
antimicrobial,1,0.0
antimicrobials,1,0.0
Choice,1,0.0
obliterans,1,0.0
gram-negative,1,0.0
cytomegalovirus,1,0.0
Pretransplant,1,0.0
deglutition,1,0.0
pharyngolaryngeal,1,0.0
enjoyment,1,0.0
mealtime,1,0.0
salivation,1,0.0
biomechanics,1,0.0
swallow,1,0.0
Sensory,1,0.0
taste,1,0.0
smell,1,0.0
Persistent,1,0.0
183,1,0.0
131-257,1,0.0
married,1,0.0
560,1,0.0
hypertrophy,1,0.0
stores,1,0.0
iron,1,0.0
insulin,1,0.0
antioxidants,1,0.0
Hyperactivity,1,0.0
post-AMI,1,0.0
subforms,1,0.0
post-acute,1,0.0
hyperactive,1,0.0
psychodiagnostic,1,0.0
door-to-imaging,1,0.0
195,1,0.0
door-to-needle,1,0.0
logistically,1,0.0
leaving,1,0.0
048-097,1,0.0
069,1,0.0
043-092,1,0.0
104-293,1,0.0
174,1,0.0
151-293,1,0.0
211,1,0.0
137-277,1,0.0
explains,1,0.0
delineated,1,0.0
proof-of-principle,1,0.0
proton-pump,1,0.0
anticancer,1,0.0
tumor,1,0.0
Cancer,1,0.0
declare,1,0.0
prompting,1,0.0
3486,1,0.0
290000,1,0.0
quarantining,1,0.0
syndrome-related,1,0.0
reintroduction,1,0.0
exiting,1,0.0
elimination,1,0.0
ultrasound-virtual,1,0.0
esogastroscopy,1,0.0
aggravating,1,0.0
sphincter,1,0.0
microaspiration,1,0.0
oesofagus,1,0.0
neurogenic,1,0.0
vagal,1,0.0
constrictor,1,0.0
eso-bronchial,1,0.0
incriminated,1,0.0
imperfectly,1,0.0
intravascular,1,0.0
pinpointing,1,0.0
T1-weighted,1,0.0
perfectly,1,0.0
corticospinal,1,0.0
Damage,1,0.0
Image,1,0.0
Unlabelled,1,0.0
well-adopt,1,0.0
acceptor,1,0.0
Molecular,1,0.0
substrate-binding,1,0.0
allocates,1,0.0
expose,1,0.0
Quantum,1,0.0
QPLD,1,0.0
encodes,1,0.0
XP,1,0.0
ZINC,1,0.0
ADP-ribose-1,1,0.0
ADP-ribose,1,0.0
poly,1,0.0
mono,1,0.0
ADP-ribosylation,1,0.0
host-mediated,1,0.0
counteracting,1,0.0
ADP-ribosylhydrolase,1,0.0
Nsp3,1,0.0
protects,1,0.0
precipitated,1,0.0
GUSTO,1,0.0
exertion,1,0.0
transcriptase-polymerase,1,0.0
bottleneck,1,0.0
precipitous,1,0.0
Q-wave,1,0.0
pathogenesistransmission,1,0.0
droplet,1,0.0
WMF,1,0.0
mouth,1,0.0
sparsely,1,0.0
aerodigestive,1,0.0
alternatives,1,0.0
optimizations,1,0.0
Compounds,1,0.0
reporter,1,0.0
confinements,1,0.0
homologous,1,0.0
rekindled,1,0.0
on-going,1,0.0
re-emergence,1,0.0
high-volume,1,0.0
low-volume,1,0.0
bolus,1,0.0
50-60,1,0.0
hyposensitization,1,0.0
carency,1,0.0
qRT-PCR-based,1,0.0
stemming,1,0.0
supply-chain,1,0.0
workflow,1,0.0
PAMI,1,0.0
Air,1,0.0
contingency,1,0.0
likewise,1,0.0
VTM-8181,1,0.0
RP,1,0.0
VTM-4141,1,0.0
N3,1,0.0
VTM-3941,1,0.0
primerprobe-set,1,0.0
analytic,1,0.0
mixes,1,0.0
stresses,1,0.0
master,1,0.0
concentration-into,1,0.0
inoculation-with,1,0.0
heat-inactivation,1,0.0
extractionpurification,1,0.0
replaces,1,0.0
RNase,1,0.0
RP-control,1,0.0
primersprobe,1,0.0
CDCs,1,0.0
resource-limited,1,0.0
intracutaneous,1,0.0
radio-allergo-sorbent-test,1,0.0
excretions,1,0.0
naturally,1,0.0
Gross,1,0.0
0125,1,0.0
telemetry,1,0.0
vehicle,1,0.0
po,1,0.0
mgkgday,1,0.0
mofetil,1,0.0
mycophenolate,1,0.0
immunosuppressant,1,0.0
salt-loaded,1,0.0
end-organ,1,0.0
Stroke-prone,1,0.0
macrophagemicroglial,1,0.0
CEA,1,0.0
statins,1,0.0
coenzyme,1,0.0
3-hydroxy-3-methylglutaryl,1,0.0
adrenergic,1,0.0
paradox,1,0.0
balancing,1,0.0
procoagulant,1,0.0
vasodilatory,1,0.0
vasoconstrictory,1,0.0
untrained,1,0.0
absent,1,0.0
undetectable,1,0.0
conditioned,1,0.0
Bank,1,0.0
nisoldipine,1,0.0
anti-ischemic,1,0.0
beta-Blocker,1,0.0
exert,1,0.0
stunned,1,0.0
hibernating,1,0.0
antibody-antigen,1,0.0
topological,1,0.0
affinities,1,0.0
orders,1,0.0
PDB,1,0.0
attracted,1,0.0
brains,1,0.0
small-molecular,1,0.0
immunomodulatory,1,0.0
stroke-prone,1,0.0
predisposes,1,0.0
blunted,1,0.0
Salt,1,0.0
tubulointerstitial,1,0.0
mgmg,1,0.0
752,1,0.0
albumincreatinine,1,0.0
proteinuria,1,0.0
interrelation,1,0.0
Pathogenetic,1,0.0
precipitates,1,0.0
circle,1,0.0
bands,1,0.0
strategiesWe,1,0.0
10316,1,0.0
pregnancy-associated,1,0.0
deliveries,1,0.0
30100000,1,0.0
Pregnancy-associated,1,0.0
983,1,0.0
7422-572604,1,0.0
188369,1,0.0
483-87114,1,0.0
5291,1,0.0
0-395,1,0.0
0-311,1,0.0
22-75,1,0.0
≥50,1,0.0
Quant,1,0.0
IgGII,1,0.0
Cross,1,0.0
Red,1,0.0
Musashino,1,0.0
floating,1,0.0
gaseous,1,0.0
auxiliary,1,0.0
precondition,1,0.0
CFRs,1,0.0
deduced,1,0.0
CFROverall,1,0.0
arteriographic,1,0.0
AIIRD,1,0.0
analyse,1,0.0
AIIRDs,1,0.0
Broad,1,0.0
stopping,1,0.0
Long-acting,1,0.0
mildest,1,0.0
2-4,1,0.0
Undoubtedly,1,0.0
Selection,1,0.0
contemporaneous,1,0.0
clot-selective,1,0.0
gene-environment,1,0.0
hierarchies,1,0.0
ascent,1,0.0
brings,1,0.0
Increasing,1,0.0
Evaluating,1,0.0
Acquired,1,0.0
developmental,1,0.0
acquisition,1,0.0
Language,1,0.0
intelligence,1,0.0
compromises,1,0.0
psychologic,1,0.0
diminution,1,0.0
precoditions,1,0.0
-181-152,1,0.0
late-stage,1,0.0
PSD,1,0.0
principally,1,0.0
lifestyles,1,0.0
Aphasia,1,0.0
-574-608,1,0.0
513-824,1,0.0
707,1,0.0
348-621,1,0.0
503,1,0.0
379-679,1,0.0
300-651,1,0.0
three-month,1,0.0
506,1,0.0
3617,1,0.0
3152,1,0.0
4759,1,0.0
spline,1,0.0
201415,1,0.0
influenza-like-illness,1,0.0
medically-attended,1,0.0
multicentre,1,0.0
20089,1,0.0
anti-T2,1,0.0
single-centre,1,0.0
escalation,1,0.0
name,1,0.0
construed,1,0.0
Moscow,1,0.0
Pirogov,1,0.0
Chair,1,0.0
DDR,1,0.0
Leipzig,1,0.0
Marx,1,0.0
Internal,1,0.0
Clinic,1,0.0
substantiation,1,0.0
rules,1,0.0
incorporates,1,0.0
fared,1,0.0
psychosis,1,0.0
VANQWISH,1,0.0
Non-Q-Wave,1,0.0
adhesions,1,0.0
False,1,0.0
Telephone,1,0.0
registries,1,0.0
ablative,1,0.0
impairing,1,0.0
schizophrenia,1,0.0
neurosurgeries,1,0.0
Ablative,1,0.0
PMI,1,0.0
LOS,1,0.0
Government,1,0.0
50-54,1,0.0
1582,1,0.0
synthesized,1,0.0
alignment-free,1,0.0
deploying,1,0.0
biography,1,0.0
attributional,1,0.0
behavior-not,1,0.0
appears-unlike,1,0.0
conflicts,1,0.0
intermingled,1,0.0
65-69,1,0.0
35-39,1,0.0
non-SARS-CoV-2,1,0.0
non-normative,1,0.0
cohort-specific,1,0.0
35-44,1,0.0
coronary-prone,1,0.0
neighbourhood,1,0.0
35-69,1,0.0
case-referent,1,0.0
367255,1,0.0
5939234,1,0.0
span,1,0.0
vigilant,1,0.0
lengths,1,0.0
three-base,1,0.0
one-half,1,0.0
differentiating,1,0.0
vicious,1,0.0
ambivalent,1,0.0
subacute,1,0.0
CVR,1,0.0
tied,1,0.0
damaging,1,0.0
outperforming,1,0.0
compute,1,0.0
computationally,1,0.0
982,1,0.0
974,1,0.0
elected,1,0.0
periodicity,1,0.0
Random,1,0.0
t-test,1,0.0
unbalanced,1,0.0
Kappa-scores,1,0.0
F-measure,1,0.0
trees,1,0.0
machines,1,0.0
neighbor,1,0.0
k-nearest,1,0.0
fed,1,0.0
filter-based,1,0.0
Speech,1,0.0
or18,1,0.0
polyclinics,1,0.0
Subepithelial-layer,1,0.0
TLR-4,1,0.0
TLR-2,1,0.0
IL-1βIL-1F2,1,0.0
TNF-α,1,0.0
Agrippal,1,0.0
chronically,1,0.0
immunogenic,1,0.0
ventilator,1,0.0
arranging,1,0.0
Thickness,1,0.0
subepithelial-layer,1,0.0
coincide,1,0.0
TRL-2,1,0.0
gastrooesophageal,1,0.0
immunopathogenesis,1,0.0
Tfh-mediated,1,0.0
productions,1,0.0
cell-mediated,1,0.0
reactions,1,0.0
germinal,1,0.0
helper,1,0.0
follicular,1,0.0
High-affinity,1,0.0
recommends,1,0.0
TLR-7,1,0.0
TRL-4,1,0.0
notable,1,0.0
NI-resistant,1,0.0
2000-2001,1,0.0
B-associated,1,0.0
reasoning,1,0.0
deductive,1,0.0
resilience,1,0.0
Iranian,1,0.0
eleven,1,0.0
nonlinear,1,0.0
neuroepidemiological,1,0.0
Striking,1,0.0
Disruption,1,0.0
Wide-spread,1,0.0
TRL-7,1,0.0
deteriorates,1,0.0
258,1,0.0
19500,1,0.0
importations,1,0.0
InfluSim,1,0.0
deterministic,1,0.0
extend,1,0.0
Modeling,1,0.0
Neuraminidase,1,0.0
downgrade,1,0.0
hemodialysis,1,0.0
capability,1,0.0
25-year-old,1,0.0
post-bronchodilator,1,0.0
pine,1,0.0
indoors,1,0.0
propagules,1,0.0
Indoor,1,0.0
non-asthmatic,1,0.0
cultured,1,0.0
Penicillium,1,0.0
spores,1,0.0
Internet-based,1,0.0
momentum,1,0.0
creates,1,0.0
Bringing,1,0.0
Teams,1,0.0
disseminate,1,0.0
didactic,1,0.0
Barriers,1,0.0
by-pass,1,0.0
arteriogrpahy,1,0.0
permitting,1,0.0
disappeared,1,0.0
non-progressive,1,0.0
speculate,1,0.0
hemodynamics,1,0.0
non-progressing,1,0.0
599,1,0.0
stoke,1,0.0
Modifiable,1,0.0
architectural,1,0.0
construction,1,0.0
carotid-plaque,1,0.0
rhinorrhea,1,0.0
watery,1,0.0
profuse,1,0.0
bronchospastic,1,0.0
Inhalation,1,0.0
non-professional,1,0.0
42-year-old,1,0.0
Annually,1,0.0
octreotide,1,0.0
noteworthy,1,0.0
small-cell,1,0.0
characterise,1,0.0
Addressing,1,0.0
high-resolution,1,0.0
heightened,1,0.0
caps,1,0.0
thin,1,0.0
intraplaque,1,0.0
cores,1,0.0
modifier,1,0.0
damp,1,0.0
poverty,1,0.0
fuel,1,0.0
alleviation,1,0.0
perforators,1,0.0
dehydration,1,0.0
coma,1,0.0
laryngo-bronchial,1,0.0
institutionalization,1,0.0
disabled,1,0.0
15-30,1,0.0
700000,1,0.0
pathologies,1,0.0
nascent,1,0.0
laryngeal,1,0.0
rhinosinusitis,1,0.0
polypous,1,0.0
157,1,0.0
Altogether,1,0.0
rhino-,1,0.0
Congress,1,0.0
plethysmography,1,0.0
Modern,1,0.0
anesthesiologists,1,0.0
obstetricians,1,0.0
multimodality,1,0.0
34-year-old,1,0.0
interesting,1,0.0
mining,1,0.0
year-round,1,0.0
East-Southeast,1,0.0
seeded,1,0.0
Receipt,1,0.0
480,1,0.0
reflecting,1,0.0
coordinator,1,0.0
Hospitalisations,1,0.0
Preventable,1,0.0
Potentially,1,0.0
cardio-respiratory,1,0.0
mobilization,1,0.0
Facing,1,0.0
epizootic,1,0.0
deepening,1,0.0
kills,1,0.0
dietitian,1,0.0
collaborated,1,0.0
director,1,0.0
arrived,1,0.0
serving,1,0.0
funded,1,0.0
federally,1,0.0
physical-activity-related,1,0.0
Illinois,1,0.0
referrals,1,0.0
screenings,1,0.0
Division,1,0.0
appreciate,1,0.0
telephoning,1,0.0
arriving,1,0.0
lacrimation,1,0.0
subsided,1,0.0
expectoration,1,0.0
histamine-PC20,1,0.0
nicotine,1,0.0
emboli,1,0.0
pressure-lowering,1,0.0
TIAs,1,0.0
crescendo,1,0.0
assists,1,0.0
30-60,1,0.0
focal,1,0.0
Transient,1,0.0
dimension,1,0.0
assumption,1,0.0
varying,1,0.0
098,1,0.0
078,1,0.0
081,1,0.0
Admission,1,0.0
co-morbidity,1,0.0
Admissions,1,0.0
362065,1,0.0
Multivariable,1,0.0
bedsize,1,0.0
transfers,1,0.0
Interhospital,1,0.0
CS,1,0.0
Inpatient,1,0.0
Urgent,1,0.0
reassessed,1,0.0
archeo-epidemiologic,1,0.0
subnational,1,0.0
Lmin,1,0.0
Pranlukast,1,0.0
beclomethasone,1,0.0
microgramsday,1,0.0
orally,1,0.0
Co,1,0.0
Pharmaceutical,1,0.0
Ono,1,0.0
topographic,1,0.0
hyperdense,1,0.0
connectivity,1,0.0
islands,1,0.0
binomial,1,0.0
Portuguese,1,0.0
1920,1,0.0
fallwinter,1,0.0
northeast,1,0.0
southeastern,1,0.0
1919-were,1,0.0
influenza-July,1,0.0
Poisson,1,0.0
Influenza-related,1,0.0
1916-1922,1,0.0
respiratory-related,1,0.0
separately,1,0.0
Together,1,0.0
diasthesis,1,0.0
SITS-MOST,1,0.0
co-circulated,1,0.0
precursors,1,0.0
Mission11918,1,0.0
ABrevig,1,0.0
1911,1,0.0
circulated,1,0.0
deliver,1,0.0
infrastructure,1,0.0
investment,1,0.0
PROSIT,1,0.0
Safe,1,0.0
unfounded,1,0.0
mammals,1,0.0
fears,1,0.0
Chalela,1,0.0
coworkers,1,0.0
Claiborne-Johnston,1,0.0
Lancet,1,0.0
themed,1,0.0
press,1,0.0
traditionally,1,0.0
IgE-allergen,1,0.0
Cockroft,1,0.0
053,1,0.0
ancestor,1,0.0
precursor,1,0.0
physiologic,1,0.0
vigilance,1,0.0
exactly,1,0.0
villagers,1,0.0
piloted,1,0.0
Bangladesh,1,0.0
assumptions,1,0.0
Chemoprophylaxis,1,0.0
ion-channel,1,0.0
opportunistic,1,0.0
sewing,1,0.0
knitting,1,0.0
embroidery,1,0.0
reinforces,1,0.0
abort,1,0.0
Class,1,0.0
municipal,1,0.0
stool,1,0.0
non-enveloped,1,0.0
employees,1,0.0
protections,1,0.0
OSHA,1,0.0
Occupational,1,0.0
aligns,1,0.0
Agency,1,0.0
Protection,1,0.0
typing,1,0.0
endeavor,1,0.0
reevaluation,1,0.0
biannual,1,0.0
under-diagnosis,1,0.0
Performing,1,0.0
phone,1,0.0
v,1,0.0
160,1,0.0
ensuring,1,0.0
consists,1,0.0
smoked,1,0.0
Ethiopias,1,0.0
Ethiopia,1,0.0
Tertiary,1,0.0
inquire,1,0.0
check-ups,1,0.0
Secondary,1,0.0
breastfeed,1,0.0
advises,1,0.0
Starting,1,0.0
Breastfeeding,1,0.0
deal,1,0.0
lot,1,0.0
0-19,1,0.0
hypothyroidism,1,0.0
Subclinical,1,0.0
hospital-related,1,0.0
dollars,1,0.0
long-held,1,0.0
BPTs,1,0.0
Lipohyalinosis,1,0.0
12577,1,0.0
dyskinesias,1,0.0
agitation,1,0.0
40-y-old,1,0.0
reverse-transcription,1,0.0
paradoxical,1,0.0
HRQoL,1,0.0
campuses,1,0.0
Bates,1,0.0
all-campus,1,0.0
389,1,0.0
16623,1,0.0
t-tests,1,0.0
overemphasized,1,0.0
code-level,1,0.0
ArcGIS,1,0.0
tabulation,1,0.0
census,1,0.0
5-year,1,0.0
repository,1,0.0
Atheroma,1,0.0
Excluding,1,0.0
hyaline,1,0.0
lipohyalinosis,1,0.0
Classical,1,0.0
interventionist,1,0.0
conceive,1,0.0
look,1,0.0
598,1,0.0
retain,1,0.0
dissipation,1,0.0
absorbed,1,0.0
Usually,1,0.0
BDT,1,0.0
bronchodilation,1,0.0
undiagnosed,1,0.0
illustrates,1,0.0
Mycology,1,0.0
broncho,1,0.0
14741,1,0.0
16760,1,0.0
non-smoker,1,0.0
1910,1,0.0
fumigatus,1,0.0
absolute,1,0.0
His,1,0.0
impaction,1,0.0
high-attenuation,1,0.0
consolidation,1,0.0
patchy,1,0.0
High-resolution,1,0.0
opacification,1,0.0
dense,1,0.0
moreover,1,0.0
bullous,1,0.0
antilipidemic,1,0.0
assumed,1,0.0
lipoproteins,1,0.0
Histopathological,1,0.0
Pretreatment,1,0.0
peroxidation,1,0.0
glutaryl-Coenzyme-A,1,0.0
methyl,1,0.0
3-hydroxy-3,1,0.0
triglycerides,1,0.0
troponins,1,0.0
Rats,1,0.0
culture-based,1,0.0
linking,1,0.0
interferon-α2a,1,0.0
tangible,1,0.0
roots,1,0.0
tackling,1,0.0
joining,1,0.0
uncertainties,1,0.0
unpredictability,1,0.0
academia,1,0.0
heal,1,0.0
didnt,1,0.0
indicted,1,0.0
stuffiness,1,0.0
parkinsonism,1,0.0
unremarkable,1,0.0
PETCT,1,0.0
Th2,1,0.0
revise,1,0.0
IWK,1,0.0
Wave,1,0.0
Scotia,1,0.0
Nova,1,0.0
Windsor,1,0.0
entered,1,0.0
Intraaortic,1,0.0
mHla,1,0.0
wild-type,1,0.0
conformational,1,0.0
alum,1,0.0
astute,1,0.0
formulated,1,0.0
kDa,1,0.0
protein-aided,1,0.0
heptamer,1,0.0
cross-protective,1,0.0
sulfate,1,0.0
Magnesium,1,0.0
longstanding,1,0.0
expertise,1,0.0
leverage,1,0.0
multisectoral,1,0.0
Experience,1,0.0
prolongation,1,0.0
threats,1,0.0
Dramatic,1,0.0
human-transmissible,1,0.0
intermittently,1,0.0
ostium,1,0.0
obstructing,1,0.0
Transesophageal,1,0.0
cusp,1,0.0
aortography,1,0.0
48-year-old,1,0.0
inferiorlateral,1,0.0
depressions,1,0.0
definitively,1,0.0
Adults,1,0.0
Nurses,1,0.0
detectable,1,0.0
Loss,1,0.0
Household,1,0.0
same-household,1,0.0
Specimens,1,0.0
≥55,1,0.0
743,1,0.0
986,1,0.0
783180968,1,0.0
1943421452,1,0.0
Serologic,1,0.0
eradicate,1,0.0
reservoirs,1,0.0
limbic,1,0.0
description,1,0.0
midst,1,0.0
chemotherapy,1,0.0
ALL,1,0.0
leukaemia,1,0.0
ILIs,1,0.0
inundated,1,0.0
epicentre,1,0.0
64-year-olds,1,0.0
50-,1,0.0
logarithmically,1,0.0
tobacco-related,1,0.0
non-linear,1,0.0
membersvisitors,1,0.0
Glostrup,1,0.0
1914,1,0.0
re-occlusion,1,0.0
Investigational,1,0.0
parental,1,0.0
Immunosuppressive,1,0.0
recipient,1,0.0
10-yr-old,1,0.0
hypermetabolic,1,0.0
hypermetabolism,1,0.0
extralimbic,1,0.0
Contact,1,0.0
recentclose,1,0.0
slower,1,0.0
Evolving,1,0.0
forego,1,0.0
medical-surgical,1,0.0
nevertheless,1,0.0
successes,1,0.0
operable,1,0.0
pre-operative,1,0.0
Academy,1,0.0
endorsed,1,0.0
dementias,1,0.0
Proclamation,1,0.0
converging,1,0.0
accelerate,1,0.0
anyone,1,0.0
Involvement,1,0.0
organizational,1,0.0
converge,1,0.0
convergent,1,0.0
doubles,1,0.0
Burden,1,0.0
-of,1,0.0
Years,1,0.0
Disability,1,0.0
rotated,1,0.0
ILIH1N1,1,0.0
eosinophil-driven,1,0.0
visualized,1,0.0
Sixty-three,1,0.0
OSCTC,1,0.0
aggravate,1,0.0
syndrome-induced,1,0.0
tremendously,1,0.0
vasodilation,1,0.0
1-7,1,0.0
opposes,1,0.0
Renin-Angiotensin-Aldosterone,1,0.0
angiotencin,1,0.0
corona,1,0.0
industry-wide,1,0.0
approached,1,0.0
Investigation,1,0.0
Potency,1,0.0
readmissions,1,0.0
ganglia,1,0.0
mineralizing,1,0.0
Older,1,0.0
sensitizing,1,0.0
fibrocystic,1,0.0
NSABSTRACT,1,0.0
14-day,1,0.0
-026,1,0.0
019,1,0.0
-031,1,0.0
-056,1,0.0
urges,1,0.0
struggling,1,0.0
Year,1,0.0
non-related,1,0.0
Adjustment,1,0.0
1075,1,0.0
Faroe,1,0.0
No-reflow,1,0.0
categorically,1,0.0
corrective,1,0.0
inoperable,1,0.0
augmentation,1,0.0
disastolic,1,0.0
fulfilling,1,0.0
confirmatory,1,0.0
Specificity,1,0.0
evasion,1,0.0
Nose,1,0.0
NVRL,1,0.0
AN1v,1,0.0
AH1v,1,0.0
MMSE,1,0.0
State,1,0.0
Mini-Mental,1,0.0
defeat,1,0.0
forestall,1,0.0
leap,1,0.0
quantum,1,0.0
dose-response,1,0.0
non-specific,1,0.0
hypovolemic,1,0.0
neuroprotectants,1,0.0
2490,1,0.0
populated,1,0.0
motivates,1,0.0
preoccupation,1,0.0
peaks,1,0.0
Beside,1,0.0
noticed,1,0.0
asthmaticus,1,0.0
522,1,0.0
32933,1,0.0
aggressively,1,0.0
tend,1,0.0
land,1,0.0
physiotherapy,1,0.0
comprises,1,0.0
40-99,1,0.0
29713100000,1,0.0
disability-adjusted,1,0.0
1654100000,1,0.0
Myanmar,1,0.0
non-pharmacological,1,0.0
leave,1,0.0
legacy,1,0.0
todays,1,0.0
nonmetropolitan,1,0.0
preregistered,1,0.0
compromised,1,0.0
opposite,1,0.0
PCWP,1,0.0
LVEDP,1,0.0
CHF,1,0.0
diuretics,1,0.0
self-smoking,1,0.0
bedroom,1,0.0
carpet,1,0.0
aluminum-framed,1,0.0
ferroconcrete,1,0.0
apartment,1,0.0
remitted,1,0.0
IUml,1,0.0
interacted,1,0.0
251,1,0.0
249,1,0.0
retes,1,0.0
Relapse,1,0.0
208,1,0.0
281,1,0.0
865,1,0.0
sheets,1,0.0
reap,1,0.0
low-density,1,0.0
Moderated,1,0.0
off-site,1,0.0
OSCTCs,1,0.0
348,1,0.0
springboard,1,0.0
--,1,0.0
hemolysis,1,0.0
ng,1,0.0
myoglobinemia,1,0.0
time-course,1,0.0
radioimmunoassay,1,0.0
ageusia,1,0.0
suspicious,1,0.0
strategic,1,0.0
twenties,1,0.0
story,1,0.0
lived,1,0.0
impacted,1,0.0
obscured,1,0.0
unregistered,1,0.0
Denmark,1,0.0
asserted,1,0.0
closer,1,0.0
restrictive,1,0.0
excessively,1,0.0
progressively,1,0.0
virtually,1,0.0
complicates,1,0.0
similarly,1,0.0
pulsed,1,0.0
Levels,1,0.0
380-53,1,0.0
Wehn,1,0.0
right-brain,1,0.0
Decidability,1,0.0
Executability,1,0.0
performs,1,0.0
implementability,1,0.0
prime,1,0.0
reaching,1,0.0
non-mirror,1,0.0
mirror,1,0.0
two-handed,1,0.0
left-brain,1,0.0
disturbed,1,0.0
hands,1,0.0
195-47,1,0.0
Left-brain,1,0.0
aged-matched,1,0.0
non-dominant,1,0.0
executed,1,0.0
representation,1,0.0
Radioimmunoassay,1,0.0
41-6,1,0.0
thereafter,1,0.0
8-12,1,0.0
determinations,1,0.0
Serial,1,0.0
4-chamber,1,0.0
apical,1,0.0
regurgitation,1,0.0
labored,1,0.0
inhibits,1,0.0
dysregulate,1,0.0
≤6,1,0.0
≤4,1,0.0
Stepwise,1,0.0
Bivariate,1,0.0
composite,1,0.0
1451,1,0.0
sex-related,1,0.0
mucolytic,1,0.0
expiration,1,0.0
recurring,1,0.0
replicate,1,0.0
hypersecretion,1,0.0
proceedings,1,0.0
beta-adrenergic,1,0.0
blockade,1,0.0
cholinergic,1,0.0
bronchiale,1,0.0
facets,1,0.0
pathologic,1,0.0
Allergic,1,0.0
Colleges,1,0.0
going,1,0.0
dysregulates,1,0.0
depletion,1,0.0
climacteric,1,0.0
IFITM3,1,0.0
aforementioned,1,0.0
forth,1,0.0
log-cubic,1,0.0
98,1,0.0
logarithm,1,0.0
147,1,0.0
lidocaine,1,0.0
IAV-induced,1,0.0
conversely,1,0.0
knockdown,1,0.0
ISG15,1,0.0
interferon-stimulated,1,0.0
3-fold,1,0.0
STAT1,1,0.0
phosphorylation,1,0.0
abolished,1,0.0
Consistent,1,0.0
coactivator,1,0.0
lately,1,0.0
repressor,1,0.0
dose-dependent,1,0.0
albeit,1,0.0
2-fold,1,0.0
6-fold,1,0.0
remedies,1,0.0
vested,1,0.0
debaters,1,0.0
airport,1,0.0
abstracted,1,0.0
redundant,1,0.0
eliminates,1,0.0
simplifies,1,0.0
11-item,1,0.0
abridged,1,0.0
15-item,1,0.0
meta-regression,1,0.0
44-94,1,0.0
tendencies,1,0.0
μgg,1,0.0
-007,1,0.0
-066,1,0.0
square,1,0.0
004,1,0.0
1187,1,0.0
package,1,0.0
metafor,1,0.0
mixed-effect,1,0.0
well-discussed,1,0.0
CD001187,1,0.0
Art,1,0.0
Reviews,1,0.0
Systematic,1,0.0
suppressed,1,0.0
182,1,0.0
jump,1,0.0
selectivity,1,0.0
v1,1,0.0
gRNA,1,0.0
positive-sense,1,0.0
templates,1,0.0
intermediates,1,0.0
negative-sense,1,0.0
hallmark,1,0.0
Carrageenan,1,0.0
lambda,1,0.0
Iota,1,0.0
Cambridge,1,0.0
Biosoft,1,0.0
CalcuSyn,1,0.0
sulfated,1,0.0
antagonistic,1,0.0
CC50EC50,1,0.0
TI,1,0.0
Diego,1,0.0
v902,1,0.0
Prism,1,0.0
GraphPad,1,0.0
dose-response-inhibition,1,0.0
CC50,1,0.0
polysaccharides,1,0.0
non-sulfated,1,0.0
connective,1,0.0
Similarly,1,0.0
JAK,1,0.0
Taking,1,0.0
rales,1,0.0
Room,1,0.0
coronariography,1,0.0
attitude,1,0.0
postal,1,0.0
981,1,0.0
542,1,0.0
551,1,0.0
Hajj,1,0.0
departing,1,0.0
ancestry,1,0.0
693,1,0.0
lineal,1,0.0
3014,1,0.0
GC3,1,0.0
584,1,0.0
4291,1,0.0
GC,1,0.0
rich,1,0.0
ended,1,0.0
codons,1,0.0
over-preferred,1,0.0
snapshot,1,0.0
sixty,1,0.0
cardiomegaly,1,0.0
z,1,0.0
costimulatory,1,0.0
repressed,1,0.0
anti-CD-20,1,0.0
B-cells,1,0.0
activating,1,0.0
B-cell,1,0.0
IL-17,1,0.0
TNF,1,0.0
Necrosis,1,0.0
calcineurin,1,0.0
antimetabolites,1,0.0
ARD,1,0.0
Autoimmune,1,0.0
conflictual,1,0.0
X1,1,0.0
recall,1,0.0
narrations,1,0.0
sentences,1,0.0
recollection,1,0.0
impression,1,0.0
Polygraphic,1,0.0
publics,1,0.0
833,1,0.0
364,1,0.0
X3,1,0.0
X2,1,0.0
mRNAs,1,0.0
sgRNAs,1,0.0
discontinuous,1,0.0
annealing,1,0.0
dealt,1,0.0
Roys,1,0.0
extraneous,1,0.0
dsmCRIPSR,1,0.0
2312,1,0.0
7353,1,0.0
G614D164,1,0.0
D614,1,0.0
G614,1,0.0
1345,1,0.0
crRNA--1,1,0.0
crRNAs,1,0.0
acarabose,1,0.0
dsmCRISPR,1,0.0
CRISPRCas12a,1,0.0
mismatches,1,0.0
evade,1,0.0
encoding,1,0.0
2325,1,0.0
reoperation,1,0.0
incision,1,0.0
leg,1,0.0
Postoperative,1,0.0
2125,1,0.0
versions,1,0.0
triflusal,1,0.0
1525,1,0.0
Vmax,1,0.0
port,1,0.0
continent,1,0.0
sweeping,1,0.0
historians,1,0.0
Latin,1,0.0
Vmax50,1,0.0
measuring,1,0.0
Secondly,1,0.0
firstly,1,0.0
responders,1,0.0
intersect,1,0.0
helium-oxygen,1,0.0
British,1,0.0
988,1,0.0
989,1,0.0
cat,1,0.0
desirable,1,0.0
Surrogate,1,0.0
specified,1,0.0
post-menopausal,1,0.0
hormonal,1,0.0
powered,1,0.0
Appropriately,1,0.0
simvastatin,1,0.0
1425,1,0.0
1625,1,0.0
semi-quantitative,1,0.0
1974-1975,1,0.0
1332,1,0.0
routes,1,0.0
WvGS,1,0.0
masks,1,0.0
wearing,1,0.0
institutions,1,0.0
Nigeria,1,0.0
Lagos,1,0.0
null,1,0.0
actually,1,0.0
Guidelines,1,0.0
1979-1980,1,0.0
Males,1,0.0
synchronous,1,0.0
abroad,1,0.0
1413,1,0.0
1908,1,0.0
1968-1980,1,0.0
amitriptyline,1,0.0
toxiclethal,1,0.0
unassociated,1,0.0
RNAs,1,0.0
untranslated,1,0.0
RT-ddPCR,1,0.0
377,1,0.0
302,1,0.0
immunopathological,1,0.0
occult,1,0.0
carriers,1,0.0
BioNTechs,1,0.0
Pfizer,1,0.0
demanded,1,0.0
desperately,1,0.0
casirimabimdevimab,1,0.0
bamlanivimab,1,0.0
transition,1,0.0
laceration,1,0.0
contusion,1,0.0
diaphragm,1,0.0
sustaining,1,0.0
452,1,0.0
Emergence,1,0.0
excreted,1,0.0
Samples,1,0.0
hematology-oncology,1,0.0
virologic,1,0.0
miss,1,0.0
ordinances,1,0.0
mask,1,0.0
lock-down,1,0.0
Afterwards,1,0.0
COVID-19IMPORTANCE,1,0.0
915,1,0.0
810,1,0.0
Ventilation,1,0.0
hemoglobin,1,0.0
executive,1,0.0
Battery,1,0.0
Frontal,1,0.0
256,1,0.0
175,1,0.0
Velocity,1,0.0
Gait,1,0.0
062,1,0.0
Stride,1,0.0
065,1,0.0
-036,1,0.0
009,1,0.0
Balance,1,0.0
Berg,1,0.0
046,1,0.0
-024,1,0.0
upper-limb,1,0.0
-004,1,0.0
035,1,0.0
Score,1,0.0
Paresis,1,0.0
Block,1,0.0
Box,1,0.0
-001,1,0.0
028,1,0.0
PRESPERO,1,0.0
CRD42016037106,1,0.0
cover,1,0.0
Balbc,1,0.0
pancytopenia,1,0.0
397,1,0.0
malaise,1,0.0
farmer,1,0.0
43-year-old,1,0.0
lymphohistiocytosis,1,0.0
hemophagocytic,1,0.0
thrombocytopenia,1,0.0
equip,1,0.0
epitope-based,1,0.0
in-comparison,1,0.0
immunize,1,0.0
immunoinformatics,1,0.0
matching,1,0.0
MHC-II,1,0.0
MHC-I,1,0.0
cross-reacted,1,0.0
PFAMQMAYRFNG,1,0.0
FSQILPDPSKPSKRS,1,0.0
IRGDEVRQIAPGQTGKIADYNYKLPD,1,0.0
LQSYGFQPT,1,0.0
TEIYQASTPCNGVEG,1,0.0
QTGKIADYNYK,1,0.0
custommune,1,0.0
Peg,1,0.0
9-Hole,1,0.0
PEDro,1,0.0
arrhythmogenic,1,0.0
p001,1,0.0
216,1,0.0
363,1,0.0
hazard,1,0.0
Event-free,1,0.0
R229,1,0.0
R254,1,0.0
p0002,1,0.0
Subsequent,1,0.0
bouts,1,0.0
reinfarctions,1,0.0
Preoperative,1,0.0
Improvements,1,0.0
orthopedic,1,0.0
modifiers,1,0.0
Lingering,1,0.0
analgesic,1,0.0
anesthetic,1,0.0
nation-wide,1,0.0
nitrates,1,0.0
stasis,1,0.0
favoured,1,0.0
expenditures,1,0.0
postloads,1,0.0
whatever,1,0.0
cleared,1,0.0
Library,1,0.0
occured,1,0.0
01-30,1,0.0
feline,1,0.0
Neutralization,1,0.0
protein-based,1,0.0
Seroprevalence,1,0.0
housed,1,0.0
seroprevalence,1,0.0
companion,1,0.0
Continual,1,0.0
H3,1,0.0
Subsequently,1,0.0
Sporadic,1,0.0
reopening,1,0.0
District,1,0.0
Song,1,0.0
Thung,1,0.0
proxies,1,0.0
gerontology,1,0.0
instance,1,0.0
advisable,1,0.0
Comparative,1,0.0
T25-100,1,0.0
614,1,0.0
SEM,1,0.0
070,1,0.0
triglyceride,1,0.0
Validity,1,0.0
mmolL,1,0.0
anti-COVID-19,1,0.0
Rasch,1,0.0
SS-QOL,1,0.0
stroke-specific,1,0.0
limbs,1,0.0
migraines,1,0.0
occipital,1,0.0
Horner,1,0.0
hemicranial,1,0.0
laterocervical,1,0.0
Dissections,1,0.0
infarctionABSTRACT,1,0.0
Fourteen,1,0.0
079,1,0.0
-090,1,0.0
isotope,1,0.0
acquisitions,1,0.0
edge,1,0.0
slices,1,0.0
coronal,1,0.0
sized,1,0.0
conceptions,1,0.0
coincided,1,0.0
mortalities,1,0.0
character,1,0.0
continuation,1,0.0
470,1,0.0
contralateral,1,0.0
R292K,1,0.0
regionally,1,0.0
invading,1,0.0
embolize,1,0.0
Invasive,1,0.0
Immunosuppression,1,0.0
first-wave,1,0.0
swallowing,1,0.0
Swallowing,1,0.0
transmit,1,0.0
proliferate,1,0.0
dual-receptor,1,0.0
motif,1,0.0
restenosis,1,0.0
PEIPKGRG,1,0.0
homology,1,0.0
similarity,1,0.0
phylogenetic,1,0.0
alignment,1,0.0
Sequence,1,0.0
locality,1,0.0
raising,1,0.0
chickens,1,0.0
Kunming,1,0.0
Improving,1,0.0
Examples,1,0.0
dated,1,0.0
sixteenth,1,0.0
aberrantly,1,0.0
Paired,1,0.0
COVID-positive,1,0.0
Indian,1,0.0
Fc,1,0.0
pertaining,1,0.0
incompletely,1,0.0
Pregnancy-induced,1,0.0
outweighs,1,0.0
weapons,1,0.0
disproportionate,1,0.0
immuno-stimulation,1,0.0
hyperinflammatory,1,0.0
main-group,1,0.0
Signs,1,0.0
etoposide,1,0.0
mgday,1,0.0
acetate,1,0.0
Hemophagocytosis,1,0.0
Epstein-Barr,1,0.0
5013-6083,1,0.0
NK,1,0.0
μgL,1,0.0
81404,1,0.0
ferritin,1,0.0
rechecked,1,0.0
10-22,1,0.0
burial,1,0.0
postulate,1,0.0
twentieth,1,0.0
reactivation,1,0.0
latency,1,0.0
travelled,1,0.0
adolescent,1,0.0
non-Q,1,0.0
parsimonious,1,0.0
circumstantial,1,0.0
cullers,1,0.0
non-familial,1,0.0
preponderance,1,0.0
broncho-obstructive,1,0.0
checkups,1,0.0
asphyxia,1,0.0
nonasthmatic,1,0.0
Cronbach,1,0.0
00007,1,0.0
Aas,1,0.0
version,1,0.0
sanatorium,1,0.0
outlook,1,0.0
rationed,1,0.0
riding,1,0.0
bicycle-ergometric,1,0.0
disproven,1,0.0
fresh,1,0.0
218,1,0.0
copy,1,0.0
two-vessel,1,0.0
single-vessel,1,0.0
dyssynergic,1,0.0
Model,1,0.0
Hazards,1,0.0
Proportional,1,0.0
Survival,1,0.0
TOP-SNAb,1,0.0
FDA-EUA,1,0.0
0-7,1,0.0
TOP-TAb,1,0.0
fluidics,1,0.0
manipulation,1,0.0
liquid,1,0.0
pre-dispensed,1,0.0
cartridges,1,0.0
Disposable,1,0.0
Cy5-Streptavidin-polysacharide,1,0.0
quartz,1,0.0
RBD-coated,1,0.0
biosensor,1,0.0
testing-on-a-probe,1,0.0
progeny,1,0.0
disseminated,1,0.0
Foundation,1,0.0
three-vessel,1,0.0
frames,1,0.0
cycles,1,0.0
664,1,0.0
chromogranin,1,0.0
BNP,1,0.0
B-type,1,0.0
CRP,1,0.0
cTnI,1,0.0
MM,1,0.0
multi-marker,1,0.0
skipped,1,0.0
Saturday,1,0.0
consult,1,0.0
Cough,1,0.0
ACalifornia72009,1,0.0
digitized,1,0.0
fortnightly,1,0.0
727,1,0.0
Influenza-like,1,0.0
Woven,1,0.0
introduces,1,0.0
hyperkinesis,1,0.0
compensatory,1,0.0
wall-motion,1,0.0
Echocardiographic,1,0.0
microcomputer,1,0.0
off-line,1,0.0
developmentHigh-quality,1,0.0
Czech,1,0.0
arrhythmiaThe,1,0.0
cardiology,1,0.0
vague,1,0.0
Though,1,0.0
fairly,1,0.0
thrombohemorrhagic,1,0.0
30-fold,1,0.0
SpO2,1,0.0
1473,1,0.0
SARS-COV-2,1,0.0
Coinfection,1,0.0
serves,1,0.0
navigable,1,0.0
balloon-mounted,1,0.0
convalescents,1,0.0
Modifications,1,0.0
Multimodal,1,0.0
whenever,1,0.0
clarifying,1,0.0
chart,1,0.0
contradictions,1,0.0
clearer,1,0.0
publishing,1,0.0
stricter,1,0.0
581,1,0.0
Process,1,0.0
pinpoint,1,0.0
SARS-CoV-2-reactive,1,0.0
untreatable,1,0.0
substances,1,0.0
suckling,1,0.0
understated,1,0.0
prolific,1,0.0
opportune,1,0.0
utmost,1,0.0
emphasises,1,0.0
ambiguities,1,0.0
substantiated,1,0.0
valued,1,0.0
se,1,0.0
faced,1,0.0
tapped,1,0.0
bipolar,1,0.0
uniqueness,1,0.0
abundantly,1,0.0
nutritive,1,0.0
Essential,1,0.0
enddiastolic,1,0.0
Tomography,1,0.0
Emission,1,0.0
Photon,1,0.0
Single,1,0.0
Gated,1,0.0
Transluminal,1,0.0
CgA,1,0.0
48h,1,0.0
Inflammatory,1,0.0
semaphorin3EplexinD1,1,0.0
hemicraniectomy,1,0.0
Complex,1,0.0
antithrombotics,1,0.0
glycemic,1,0.0
neurodiagnostics,1,0.0
neuropathology,1,0.0
neurointensivist,1,0.0
thrombolytics,1,0.0
swelling,1,0.0
Features,1,0.0
neurocritical,1,0.0
semaphorin,1,0.0
sympton-free,1,0.0
hyperresponsivenss,1,0.0
mediates,1,0.0
plexinD1,1,0.0
binds,1,0.0
Ubiquitously,1,0.0
axonal,1,0.0
Semaphorins,1,0.0
viremia,1,0.0
coinciding,1,0.0
contractions,1,0.0
abortion,1,0.0
sufferers,1,0.0
invariably,1,0.0
ramping,1,0.0
TA,1,0.0
latex,1,0.0
latex-induced,1,0.0
Latex,1,0.0
nonoccupational,1,0.0
o,1,0.0
als,1,0.0
Workup,1,0.0
sensation,1,0.0
possibleto,1,0.0
workdays,1,0.0
work-aggravated,1,0.0
thunderstorm,1,0.0
mechanics,1,0.0
well-being,1,0.0
sense,1,0.0
symptom-free,1,0.0
sympathomimetics,1,0.0
Preventive,1,0.0
O2,1,0.0
alveolar-arterial,1,0.0
widened,1,0.0
maldistribution,1,0.0
exaggerate,1,0.0
Tentacious,1,0.0
Exacerbations,1,0.0
Rapidly,1,0.0
morphologic,1,0.0
Seegene,1,0.0
planimetrically,1,0.0
serially,1,0.0
Serum,1,0.0
resemble,1,0.0
bronchi,1,0.0
alveoli,1,0.0
immortalized,1,0.0
220,1,0.0
Elitech,1,0.0
GeneFinder,1,0.0
927,1,0.0
Findings,1,0.0
al,1,0.0
I216T,1,0.0
S162N,1,0.0
subclade,1,0.0
6B1,1,0.0
belonged,1,0.0
AH1N1pdm09-positive,1,0.0
26-73,1,0.0
44-77,1,0.0
Sentinel,1,0.0
EPO,1,0.0
erythropoietin,1,0.0
Sobel,1,0.0
099,1,0.0
279,1,0.0
inter-patient,1,0.0
508,1,0.0
respirators,1,0.0
N95,1,0.0
FFP2,1,0.0
precautions,1,0.0
discussions,1,0.0
Insufficient,1,0.0
40th,1,0.0
downward,1,0.0
distortion,1,0.0
translates,1,0.0
genetics,1,0.0
accordingly,1,0.0
contributory,1,0.0
AHR,1,0.0
T2LOW,1,0.0
T2HIGH,1,0.0
multi-faceted,1,0.0
rough,1,0.0
imprecise,1,0.0
falling,1,0.0
graphs,1,0.0
plotted,1,0.0
096,1,0.0
diaries,1,0.0
puffs,1,0.0
Twelve-lead,1,0.0
SARS-CoV-2-positive,1,0.0
educating,1,0.0
146,1,0.0
historically,1,0.0
exhibition,1,0.0
counties,1,0.0
Educational,1,0.0
correlational,1,0.0
threaten,1,0.0
IAVs,1,0.0
threatens,1,0.0
caseload,1,0.0
Paediatricians,1,0.0
Anxious,1,0.0
NPI,1,0.0
underdeveloped,1,0.0
Robustness,1,0.0
intranasal,1,0.0
NAb,1,0.0
marmosets,1,0.0
NAbs,1,0.0
teratogenic,1,0.0
fetotoxicity,1,0.0
embryo-,1,0.0
acutechronic,1,0.0
β-propiolactone-inactivated,1,0.0
husbandry,1,0.0
typesubtype,1,0.0
n35,1,0.0
Caledonia2099-like,1,0.0
nonsynonymous,1,0.0
one-step,1,0.0
analytically,1,0.0
Genomic,1,0.0
SENTINEL,1,0.0
confines,1,0.0
intensiv,1,0.0
fifty,1,0.0
Costs,1,0.0
200304,1,0.0
BJiangsu102003-like,1,0.0
ANew,1,0.0
n420,1,0.0
Kong3302001-like,1,0.0
AWyoming32003-like,1,0.0
0-3,1,0.0
youngest,1,0.0
15-25,1,0.0
895,1,0.0
26-45,1,0.0
688,1,0.0
MDCK,1,0.0
DIFA,1,0.0
parainfluenzavirus,1,0.0
durability,1,0.0
high-quality,1,0.0
multitude,1,0.0
misinformation,1,0.0
messaging,1,0.0
elites,1,0.0
corrupt,1,0.0
centered,1,0.0
organizes,1,0.0
COVID-denialist,1,0.0
styles,1,0.0
rhetorical,1,0.0
salient,1,0.0
user-generated,1,0.0
disinformation,1,0.0
hurdle,1,0.0
Lymphangio-MRI,1,0.0
intra-,1,0.0
atheroembolic,1,0.0
well-recognised,1,0.0
motivate,1,0.0
spirit,1,0.0
listening,1,0.0
Reflective,1,0.0
weigh,1,0.0
agenda,1,0.0
motivational,1,0.0
overlaps,1,0.0
persuasive,1,0.0
contrast-enhancing,1,0.0
urged,1,0.0
asymmetric,1,0.0
upheaval,1,0.0
bears,1,0.0
morphine,1,0.0
dolantine,1,0.0
injections,1,0.0
narcotics,1,0.0
grown,1,0.0
retail,1,0.0
non-medical,1,0.0
B117s,1,0.0
export,1,0.0
practices†,1,0.0
congregate,1,0.0
PPE,1,0.0
Residents,1,0.0
facility-based,1,0.0
Genetic,1,0.0
12-day,1,0.0
lapses,1,0.0
259,1,0.0
MDH,1,0.0
Facility-wide,1,0.0
48711,1,0.0
3950,1,0.0
Assay,1,0.0
Francisco,1,0.0
Snakebites,1,0.0
Bay,1,0.0
correctable,1,0.0
pertain,1,0.0
authorisation,1,0.0
procurement,1,0.0
Rosen,1,0.0
considers,1,0.0
grapple,1,0.0
socialised,1,0.0
orchestrated,1,0.0
set-up,1,0.0
sweets,1,0.0
desserts,1,0.0
cuisines,1,0.0
deemed,1,0.0
Pinyin,1,0.0
Gancao,1,0.0
Licorice,1,0.0
concoctions,1,0.0
wellbeing,1,0.0
Medicines,1,0.0
roll-out,1,0.0
Preventions,1,0.0
suited,1,0.0
4960,1,0.0
5360,1,0.0
Emotional,1,0.0
folklore,1,0.0
originates,1,0.0
arthritis,1,0.0
ideally,1,0.0
cross,1,0.0
radiology,1,0.0
paramedics,1,0.0
dispatchers,1,0.0
dialogue,1,0.0
optimise,1,0.0
Delivery,1,0.0
3-45,1,0.0
differing,1,0.0
RA,1,0.0
rheumatoid,1,0.0
frightening,1,0.0
prescribe,1,0.0
neuroinflammation,1,0.0
ischaemia-induced,1,0.0
Lacunar,1,0.0
disease-a,1,0.0
small-vessel,1,0.0
nightmares,1,0.0
dire,1,0.0
Intense,1,0.0
sweats,1,0.0
racing,1,0.0
108120,1,0.0
111120,1,0.0
925,1,0.0
EURASPIRE,1,0.0
Inconsistent,1,0.0
system-of-care,1,0.0
ECC,1,0.0
CPR,1,0.0
AHA,1,0.0
diabetologists,1,0.0
cooperation,1,0.0
cardiodiabetic,1,0.0
Wouldnt,1,0.0
noninsulin-diabetes,1,0.0
explosive,1,0.0
unwarranted,1,0.0
coordinated,1,0.0
248,1,0.0
P2,1,0.0
B1526,1,0.0
B1429,1,0.0
B1427,1,0.0
229,1,0.0
perfect,1,0.0
007,1,0.0
387,1,0.0
1567,1,0.0
4049,1,0.0
benefiting,1,0.0
35-year-old,1,0.0
RdRpHel,1,0.0
proteases,1,0.0
easyMAG®,1,0.0
NucliSENS®,1,0.0
bead-based,1,0.0
PHASIFY™,1,0.0
liquid-based,1,0.0
manpower-saving,1,0.0
cost-,1,0.0
popularity,1,0.0
over-mortality,1,0.0
bigger,1,0.0
destruction,1,0.0
cleavability,1,0.0
drowsiness,1,0.0
systems-based,1,0.0
virulent,1,0.0
debilitating,1,0.0
HCT,1,0.0
recess,1,0.0
costophrenic,1,0.0
loculated,1,0.0
Her,1,0.0
ventriculopleural,1,0.0
hydrocephalus,1,0.0
meningitis,1,0.0
builds,1,0.0
willing,1,0.0
counseling,1,0.0
interviewing,1,0.0
leak,1,0.0
disrupt,1,0.0
implies,1,0.0
pericytes,1,0.0
astrocytes,1,0.0
adjacent,1,0.0
solutes,1,0.0
transporters,1,0.0
efflux,1,0.0
influx,1,0.0
junction,1,0.0
charcteristics,1,0.0
obstacle,1,0.0
blood-brain,1,0.0
90-95,1,0.0
severities,1,0.0
immunotherapy,1,0.0
omalizumab,1,0.0
Avoidance,1,0.0
mild-to-moderate,1,0.0
nonallergic,1,0.0
polyps,1,0.0
hypersensitive,1,0.0
significances,1,0.0
Ovid,1,0.0
glial-expressed,1,0.0
receptorstargets,1,0.0
manipulated,1,0.0
eliminated,1,0.0
Making,1,0.0
Trail,1,0.0
Modalities,1,0.0
Symbol-Digit,1,0.0
Stroke-Canadian,1,0.0
Disorders,1,0.0
reserve,1,0.0
contrast-enhanced,1,0.0
dobutamine,1,0.0
originating,1,0.0
VTs,1,0.0
halfway,1,0.0
pharmacologically,1,0.0
Epicardial,1,0.0
radiofrequency,1,0.0
irrigated,1,0.0
electrophysiological,1,0.0
55-year-old,1,0.0
gathering,1,0.0
core,1,0.0
neighborhood,1,0.0
Targeting,1,0.0
integrity,1,0.0
glial,1,0.0
allergies,1,0.0
approximates,1,0.0
Aeroallergen,1,0.0
brainstem-,1,0.0
071,1,0.0
040,1,0.0
LVPW,1,0.0
converted,1,0.0
anteroseptal,1,0.0
antileukotriene,1,0.0
MgSO4,1,0.0
bromide,1,0.0
cornerstone,1,0.0
2-agonists,1,0.0
compressive,1,0.0
dolichoectasia,1,0.0
Color,1,0.0
Vertebrobasilar,1,0.0
001-098,1,0.0
Subjects,1,0.0
H1N1pdm-vaccinated,1,0.0
monovalent,1,0.0
try,1,0.0
kinin,1,0.0
SARS-,1,0.0
activates,1,0.0
symptomatology,1,0.0
Soon,1,0.0
006,1,0.0
numerical,1,0.0
cortisolaemia,1,0.0
relates,1,0.0
hyperglycaemia,1,0.0
heterogenity,1,0.0
metabolism,1,0.0
carbohydrate,1,0.0
stressor,1,0.0
rat,1,0.0
glutarylation,1,0.0
succinylation,1,0.0
malonylation,1,0.0
Researchers,1,0.0
Invalidism,1,0.0
treatment-it,1,0.0
intensities,1,0.0
requirement,1,0.0
Difference,1,0.0
swabsaliva,1,0.0
contents,1,0.0
distributions,1,0.0
restored,1,0.0
024,1,0.0
transducers,1,0.0
open-chest,1,0.0
061,1,0.0
029,1,0.0
2530,1,0.0
23-2430,1,0.0
Exploratory,1,0.0
non-participants,1,0.0
pre-clinically,1,0.0
paramagnetic,1,0.0
super,1,0.0
radiolabelled,1,0.0
concert,1,0.0
Imaging,1,0.0
post-infarct,1,0.0
trialled,1,0.0
self-isolate,1,0.0
DMPs,1,0.0
DMP-,1,0.0
documentations,1,0.0
Concerns,1,0.0
legally,1,0.0
German,1,0.0
re-employed,1,0.0
isocyanate,1,0.0
durations,1,0.0
Asymptomatic,1,0.0
job,1,0.0
6-54,1,0.0
Koreas,1,0.0
economies,1,0.0
re-opening,1,0.0
firmly,1,0.0
student,1,0.0
nightclubs,1,0.0
diminished,1,0.0
Motivational,1,0.0
retention,1,0.0
Patient-centered,1,0.0
derive,1,0.0
mentoring,1,0.0
raise,1,0.0
postregistration,1,0.0
reiterates,1,0.0
articulating,1,0.0
illuminating,1,0.0
curricula,1,0.0
Median,1,0.0
evaluates,1,0.0
midline,1,0.0
viewpoint,1,0.0
vertical,1,0.0
themes,1,0.0
n266,1,0.0
n171,1,0.0
placements,1,0.0
n153,1,0.0
DipHE,1,0.0
Questionnaires,1,0.0
rationale,1,0.0
acted,1,0.0
logistics,1,0.0
functionally,1,0.0
lysis,1,0.0
RBD-Ferritin,1,0.0
threatened,1,0.0
physiologically,1,0.0
nighttime,1,0.0
daytime,1,0.0
Nocturnal,1,0.0
choroidal,1,0.0
PCA,1,0.0
amnesia,1,0.0
amnesic,1,0.0
neurotoxicity,1,0.0
side-effects,1,0.0
RBD-mi3,1,0.0
counteracted,1,0.0
recanalizationreperfusion,1,0.0
Tissue-type,1,0.0
sepsis-like,1,0.0
Wheezing,1,0.0
convulsions,1,0.0
7-16,1,0.0
Sepsis-like,1,0.0
≤16,1,0.0
401,1,0.0
16-year,1,0.0
24-mer,1,0.0
60-mer,1,0.0
sect,1,0.0
corroborating,1,0.0
hotspots,1,0.0
transmissions,1,0.0
technology-based,1,0.0
Arrays,1,0.0
nation,1,0.0
troubled,1,0.0
viruss,1,0.0
unparalleled,1,0.0
blocker,1,0.0
competitive,1,0.0
scale-up,1,0.0
blocked,1,0.0
RBD-I53-50,1,0.0
monomeric,1,0.0
authentic,1,0.0
120-fold,1,0.0
8-,1,0.0
antisera,1,0.0
Adjuvant,1,0.0
AddaVax,1,0.0
SpyTag-SpyCatcher,1,0.0
conjugation,1,0.0
covalent,1,0.0
120-mer,1,0.0
seamlessly,1,0.0
neuromyopathies,1,0.0
Electrocardiographic,1,0.0
wit,1,0.0
A2,1,0.0
phospholipase,1,0.0
lipoprotein-associated,1,0.0
profiling,1,0.0
excitotoxicity,1,0.0
Markers,1,0.0
simplistic,1,0.0
Major,1,0.0
uniform,1,0.0
disappointing,1,0.0
discrepancy,1,0.0
747,1,0.0
908,1,0.0
percentages,1,0.0
fulfil,1,0.0
seventy,1,0.0
checked,1,0.0
filled,1,0.0
again,1,0.0
Medium,1,0.0
Low,1,0.0
Rate,1,0.0
Expiratory,1,0.0
north,1,0.0
Babol,1,0.0
ultimate,1,0.0
cause-effect,1,0.0
sMMPi,1,0.0
beings,1,0.0
pre-pandemic,1,0.0
optimistically,1,0.0
implicating,1,0.0
obviated,1,0.0
auspicious,1,0.0
fast,1,0.0
trustworthy,1,0.0
relying,1,0.0
Instrumental,1,0.0
fighting,1,0.0
unsustainable,1,0.0
That,1,0.0
MMP-1,1,0.0
vaccinees,1,0.0
inoculation,1,0.0
inoculated,1,0.0
306,1,0.0
Kong873,1,0.0
Arbor166,1,0.0
BAnn,1,0.0
cold-adapted,1,0.0
recombining,1,0.0
cold-recombinant,1,0.0
-7,1,0.0
town,1,0.0
Jones,1,0.0
informs,1,0.0
disseminating,1,0.0
facilitys,1,0.0
intern,1,0.0
amongst,1,0.0
Kalafong,1,0.0
Initially,1,0.0
president,1,0.0
disaster,1,0.0
advancements,1,0.0
Promising,1,0.0
posted,1,0.0
descriptions,1,0.0
accepting,1,0.0
whilst,1,0.0
expert-review,1,0.0
clearinghouse,1,0.0
ECGs,1,0.0
electrocardiograms,1,0.0
hot-spot,1,0.0
recently-infarcted,1,0.0
cold-spot,1,0.0
still-viable,1,0.0
doulbe-radionuclide,1,0.0
obtainable,1,0.0
scintigram,1,0.0
swept,1,0.0
restricting,1,0.0
interwoven,1,0.0
DWI,1,0.0
T3,1,0.0
fare,1,0.0
tightly,1,0.0
T1,1,0.0
Closure,1,0.0
drug-drug,1,0.0
AUSSR,1,0.0
ATexas,1,0.0
Houston,1,0.0
Fort,1,0.0
hyperacute,1,0.0
Magnetic,1,0.0
human-human,1,0.0
inter-provider,1,0.0
permit,1,0.0
Spike-variants,1,0.0
SARS-CoV-2-Spike,1,0.0
exogenously,1,0.0
COVID-19-positive,1,0.0
C19-S-I-IFA,1,0.0
proof-of-concept,1,0.0
SARS-CoV-Spike,1,0.0
currentprevious,1,0.0
Success,1,0.0
Relying,1,0.0
tolerability,1,0.0
intraparenchymal,1,0.0
deceased,1,0.0
2307,1,0.0
2408,1,0.0
unscheduled,1,0.0
188,1,0.0
peak-flow,1,0.0
formal,1,0.0
respirologists,1,0.0
diuretic,1,0.0
thiazide-type,1,0.0
thing,1,0.0
metaregression,1,0.0
strongest,1,0.0
ISH,1,0.0
WHOInternational,1,0.0
unambiguously,1,0.0
SYST-China,1,0.0
SYST-Eur,1,0.0
SHEP,1,0.0
informative,1,0.0
person-years,1,0.0
collective,1,0.0
Collaborative,1,0.0
VII,1,0.0
VI,1,0.0
1993,1,0.0
021004,1,0.0
024004,1,0.0
040009,1,0.0
surrounded,1,0.0
first-time,1,0.0
lifelong,1,0.0
Frequently,1,0.0
section,1,0.0
peinfarction,1,0.0
lumen,1,0.0
fracture,1,0.0
supposition,1,0.0
abscess,1,0.0
occluding,1,0.0
Fresh,1,0.0
Fibrin,1,0.0
1305,1,0.0
unblocked,1,0.0
Ruptured,1,0.0
canalization,1,0.0
educated,1,0.0
Between-group,1,0.0
6329,1,0.0
8822,1,0.0
9652,1,0.0
workschool,1,0.0
1309,1,0.0
1207,1,0.0
attribute,1,0.0
epidemiologists,1,0.0
SARS‐CoV‐2,1,0.0
litersmin,1,0.0
expenses,1,0.0
US104,1,0.0
hemodynamically,1,0.0
percutaneously,1,0.0
femoral,1,0.0
Need,1,0.0
unsuitable,1,0.0
dilated,1,0.0
1-vessel,1,0.0
asystole,1,0.0
regained,1,0.0
cannulas,1,0.0
earnings,1,0.0
20Fr,1,0.0
Wedge,1,0.0
Ligation,1,0.0
triphosphate,1,0.0
needle,1,0.0
ligating,1,0.0
effected,1,0.0
Experimentally,1,0.0
centrifugal,1,0.0
attacks--were,1,0.0
cases--that,1,0.0
US164,1,0.0
unanswered,1,0.0
COVID‐19,1,0.0
hypoperfused,1,0.0
topics,1,0.0
al1,1,0.0
Carli,1,0.0
COVID‐19”,1,0.0
“Is,1,0.0
letter,1,0.0
carefully,1,0.0
restoring,1,0.0
underestimate,1,0.0
uptakes,1,0.0
salvageable,1,0.0
exogenous,1,0.0
conditioning,1,0.0
imagings,1,0.0
fasting,1,0.0
deoxyglucose,1,0.0
F-18,1,0.0
ergometer,1,0.0
symptom-limited,1,0.0
ECT,1,0.0
Case,1,0.0
non-taking,1,0.0
exposing,1,0.0
marrow-derived,1,0.0
arteririography,1,0.0
catherization,1,0.0
frequencies,1,0.0
Egyptian,1,0.0
potentiate,1,0.0
nucleoside-modified,1,0.0
SARS-CoV-2-spike-encoding,1,0.0
recapitulates,1,0.0
amenable,1,0.0
added,1,0.0
messenger,1,0.0
230,1,0.0
burnout,1,0.0
immunohistochemistry,1,0.0
zymography,1,0.0
gelatin,1,0.0
thoracotomy,1,0.0
tracheotomy,1,0.0
analgesia,1,0.0
instruments,1,0.0
methological,1,0.0
widely-used,1,0.0
infiltration,1,0.0
und,1,0.0
rea-ltime,1,0.0
post-recanalization,1,0.0
suite,1,0.0
neuro-interventional,1,0.0
Association-American,1,0.0
agile,1,0.0
Estimating,1,0.0
introducing,1,0.0
opening,1,0.0
cardioverter-defibrillator,1,0.0
implantable,1,0.0
ajmaline,1,0.0
V1,1,0.0
aborted,1,0.0
37-year-old,1,0.0
initiatives,1,0.0
venues,1,0.0
teleconferences,1,0.0
cocreation,1,0.0
ecosystem,1,0.0
coalitions,1,0.0
2nd,1,0.0
mobilize,1,0.0
TÜBİTAK,1,0.0
Council,1,0.0
Technological,1,0.0
Scientific,1,0.0
competences,1,0.0
cocreation-based,1,0.0
science-based,1,0.0
constituted,1,0.0
plexus,1,0.0
interruption,1,0.0
tenets,1,0.0
Tissue,1,0.0
Life-table,1,0.0
lacteal,1,0.0
VITT,1,0.0
anti-PF4,1,0.0
Reference,1,0.0
cavernous,1,0.0
D-dimer,1,0.0
PF4,1,0.0
high-titre,1,0.0
5-day,1,0.0
10-16,1,0.0
non-tobacco,1,0.0
gland,1,0.0
extra-respiratory,1,0.0
confound,1,0.0
Extra-respiratory,1,0.0
virus-induced,1,0.0
inimitable,1,0.0
precocious,1,0.0
victims,1,0.0
gets,1,0.0
evacuation,1,0.0
Bahia,1,0.0
Reconcavo,1,0.0
jararaca,1,0.0
Bothrops,1,0.0
appearing,1,0.0
20122013,1,0.0
Operation,1,0.0
062-089,1,0.0
operative,1,0.0
ventriculogram,1,0.0
Sixty-two,1,0.0
premier,1,0.0
collapse,1,0.0
nonmechanical,1,0.0
hypereosinophilic,1,0.0
polyposis,1,0.0
dermatitis,1,0.0
anaphylaxis,1,0.0
074-100,1,0.0
Full,1,0.0
20142015,1,0.0
075-102,1,0.0
065-092,1,0.0
077,1,0.0
non-vaccination,1,0.0
two-dose,1,0.0
one-,1,0.0
Receiving,1,0.0
Generalized,1,0.0
guardians,1,0.0
7945,1,0.0
distributed,1,0.0
ICD,1,0.0
borne,1,0.0
break,1,0.0
22-27,1,0.0
resurgence,1,0.0
Beijings,1,0.0
expanded,1,0.0
Xinfadi,1,0.0
Non-pharmaceutical,1,0.0
conspicuous,1,0.0
discernible,1,0.0
Functional,1,0.0
Stratified,1,0.0
weaknessnumbness,1,0.0
13-18,1,0.0
Pooled,1,0.0
biocompatibility,1,0.0
moderators,1,0.0
Random-effects,1,0.0
1989-90,1,0.0
Washington,1,0.0
hydrochloride,1,0.0
1991-92,1,0.0
Outbreaks,1,0.0
contrasted,1,0.0
bronchopulmonary,1,0.0
difficult-to-control,1,0.0
mistaken,1,0.0
innovations,1,0.0
consequently,1,0.0
enlist,1,0.0
prepandemic,1,0.0
inhibitor-1,1,0.0
Endogenous,1,0.0
necessarily,1,0.0
Commercial,1,0.0
empirical,1,0.0
≥160,1,0.0
870,1,0.0
764,1,0.0
Performed,1,0.0
microneutralization,1,0.0
1099,1,0.0
ImmunoDiagnostics,1,0.0
hazardous,1,0.0
EDI,1,0.0
heart-lung,1,0.0
Small,1,0.0
mL,1,0.0
bodyweight,1,0.0
kilogram,1,0.0
tidal,1,0.0
cmH2O,1,0.0
Inspiratory,1,0.0
miniaturized,1,0.0
Support,1,0.0
misdiagnosed,1,0.0
waiver,1,0.0
assuming,1,0.0
ICTUSCARE,1,0.0
surprised,1,0.0
anamnestic,1,0.0
half-standardized,1,0.0
adopting,1,0.0
moderate-to-severe,1,0.0
remediation,1,0.0
Inner-City,1,0.0
Goal,1,0.0
502,1,0.0
LDL-cholesterol,1,0.0
298,1,0.0
Peripheral,1,0.0
approximation,1,0.0
Internationally,1,0.0
€43129,1,0.0
€3047,1,0.0
14933,1,0.0
116017,1,0.0
biologics,1,0.0
cascade,1,0.0
beta2-adrenoceptor,1,0.0
lab,1,0.0
immune-assays,1,0.0
Serology,1,0.0
crescendo-course,1,0.0
orand,1,0.0
determines,1,0.0
certified,1,0.0
readiness,1,0.0
operational,1,0.0
fail,1,0.0
978,1,0.0
coroners,1,0.0
certifying,1,0.0
Failure,1,0.0
overestimate,1,0.0
15-64,1,0.0
overestimated,1,0.0
enquiry,1,0.0
1983,1,0.0
localisation,1,0.0
two-year,1,0.0
self-administered,1,0.0
seven-item,1,0.0
Childhood,1,0.0
troublesome,1,0.0
rated,1,0.0
breathlessness,1,0.0
consulted,1,0.0
furthermore,1,0.0
prodromi,1,0.0
enzymatically,1,0.0
SCD,1,0.0
umbrella,1,0.0
N450-F456,1,0.0
five-fold,1,0.0
theranostics,1,0.0
subpopulations,1,0.0
regress,1,0.0
narrowings,1,0.0
1540,1,0.0
1823,1,0.0
ulceration,1,0.0
flap-like,1,0.0
intraluminal,1,0.0
long-segment,1,0.0
Analysis,1,0.0
quite,1,0.0
postnatal,1,0.0
prenatal,1,0.0
evidences,1,0.0
Outdoor,1,0.0
nonmalignant,1,0.0
HSPC,1,0.0
TEE,1,0.0
transesophagical,1,0.0
morbimortality,1,0.0
Lymphocyte,1,0.0
n59,1,0.0
n70,1,0.0
Hubei,1,0.0
individualize,1,0.0
TLR,1,0.0
retinoic,1,0.0
outlier,1,0.0
Overcrowding,1,0.0
crowding,1,0.0
flies,1,0.0
dishes,1,0.0
dirty,1,0.0
army,1,0.0
War,1,0.0
Virginia,1,0.0
Humphreys,1,0.0
Camp,1,0.0
Brewer,1,0.0
Why,1,0.0
acid-inducible,1,0.0
unmet,1,0.0
adjunctive,1,0.0
Theranostics,1,0.0
transcriptomics,1,0.0
proteomics,1,0.0
superinfections,1,0.0
Steroids,1,0.0
Anti-inflammatory,1,0.0
NF-κB,1,0.0
kappa-light-chain-enhancer,1,0.0
RIG-I,1,0.0
ambulate,1,0.0
task-oriented,1,0.0
nonambulatory,1,0.0
bilayered,1,0.0
proximity,1,0.0
phospholipids,1,0.0
chains,1,0.0
acyl,1,0.0
hydrophobic,1,0.0
prefusion,1,0.0
globular,1,0.0
relaxation,1,0.0
NMR,1,0.0
15N,1,0.0
micelles,1,0.0
inserted,1,0.0
polar,1,0.0
wedge-shaped,1,0.0
solution,1,0.0
transforms,1,0.0
membranes,1,0.0
deploys,1,0.0
viral-cell,1,0.0
catalyze,1,0.0
rearrange,1,0.0
Spike,1,0.0
proteolysis,1,0.0
renin,1,0.0
nitroxide,1,0.0
displace,1,0.0
anticipating,1,0.0
creatinine-kinase,1,0.0
elaborate,1,0.0
multi-organ,1,0.0
RRT-requiring,1,0.0
H1N1-infected,1,0.0
818,1,0.0
inotropics,1,0.0
transferase,1,0.0
alanine,1,0.0
doubling,1,0.0
3-week,1,0.0
Seventy-five,1,0.0
705,1,0.0
Ca2,1,0.0
Salivary,1,0.0
prophylactically,1,0.0
Favorable,1,0.0
relieving,1,0.0
modestly,1,0.0
furosemide,1,0.0
bilayer,1,0.0
protrudes,1,0.0
helix,1,0.0
Polar,1,0.0
ions,1,0.0
stood,1,0.0
Calculations,1,0.0
β-sheet,1,0.0
overcrowding,1,0.0
Fold,1,0.0
Nail,1,0.0
Weighted,1,0.0
Nius,1,0.0
Tian,1,0.0
sixteen,1,0.0
traits,1,0.0
MRI-based,1,0.0
Areas,1,0.0
imaging-based,1,0.0
only-based,1,0.0
administrative,1,0.0
time-consuming,1,0.0
front,1,0.0
Plan,1,0.0
abilities,1,0.0
pre-assessment,1,0.0
tailor-made,1,0.0
Alternatively,1,0.0
concomitantly,1,0.0
kinesthetic,1,0.0
cursor,1,0.0
visuomotor,1,0.0
Participants,1,0.0
healthy-controls,1,0.0
Microcirculation,1,0.0
video,1,0.0
microcirculatory,1,0.0
049-088,1,0.0
embryonic,1,0.0
cardialgia,1,0.0
promoted,1,0.0
hypnosuggestive,1,0.0
Mini-Mult,1,0.0
psychotherapy,1,0.0
confers,1,0.0
026-070,1,0.0
043,1,0.0
028-072,1,0.0
Subgroup,1,0.0
050-090,1,0.0
got,1,0.0
067,1,0.0
053-082,1,0.0
6079,1,0.0
5678,1,0.0
incongruent,1,0.0
interleukin,1,0.0
Continuous,1,0.0
082-097,1,0.0
GOT,1,0.0
LDH,1,0.0
CPK,1,0.0
visual-dominant,1,0.0
kinesthetic-,1,0.0
ameliorate,1,0.0
30100,1,0.0
supply-demand,1,0.0
1996,1,0.0
458,1,0.0
368,1,0.0
sharp,1,0.0
1976,1,0.0
Fifty-four,1,0.0
Sixty-seven,1,0.0
caucasians,1,0.0
certificates,1,0.0
1981-82,1,0.0
1977,1,0.0
ischemia-reperfusion,1,0.0
cardiac-penetrating,1,0.0
hints,1,0.0
exploratory,1,0.0
standby,1,0.0
intracardiac,1,0.0
intraoperative,1,0.0
extracardiac,1,0.0
save,1,0.0
traumatic,1,0.0
gunshot,1,0.0
transmediastinal,1,0.0
chronotropic,1,0.0
bradycardic,1,0.0
sectors,1,0.0
Arabic,1,0.0
Priority,1,0.0
disruption,1,0.0
Preparation,1,0.0
distribute,1,0.0
manufacture,1,0.0
defer,1,0.0
nonimmune,1,0.0
466,1,0.0
776,1,0.0
railed,1,0.0
Asthmatics,1,0.0
Emirates,1,0.0
ivabradine,1,0.0
Arab,1,0.0
Al-Ain,1,0.0
attendees,1,0.0
LTC4,1,0.0
lavage,1,0.0
age-matched,1,0.0
oleic,1,0.0
Context—,1,0.0
mechano-chronotropic,1,0.0
399,1,0.0
563,1,0.0
immune-mediated,1,0.0
waned,1,0.0
Caucasian,1,0.0
WHtR,1,0.0
DHODH,1,0.0
dihydroorotate,1,0.0
TMPRSS2,1,0.0
host-targeted,1,0.0
residue,1,0.0
Amino,1,0.0
oseltamivir-resistance,1,0.0
ATianjinningheSWL492009H1,1,0.0
Ca,1,0.0
D239N,1,0.0
ATianjinjinnanSWL412011H1,1,0.0
ATianjinhedongSWL442011H1,1,0.0
Sa,1,0.0
K180T,1,0.0
S179N,1,0.0
10-3,1,0.0
740,1,0.0
10-4,1,0.0
739,1,0.0
0-06,1,0.0
06-17,1,0.0
07-26,1,0.0
ACalifornia072009H1N1,1,0.0
Identity,1,0.0
PB1,1,0.0
medicinal,1,0.0
chemistry,1,0.0
nucleoside,1,0.0
health-promoting,1,0.0
confounds,1,0.0
temporality,1,0.0
anxietydepression,1,0.0
pitfalls,1,0.0
nebulizers,1,0.0
inhalers,1,0.0
metered,1,0.0
beta-agonists,1,0.0
plugging,1,0.0
80-85,1,0.0
Near-fatal,1,0.0
emphasised,1,0.0
analogues,1,0.0
Relenza,1,0.0
1999,1,0.0
post-influenza,1,0.0
disturbing,1,0.0
danger,1,0.0
Mouse,1,0.0
PLpro,1,0.0
papain-like,1,0.0
3CLpro,1,0.0
3C-like,1,0.0
ribavirin,1,0.0
splicing,1,0.0
infectiondeath,1,0.0
220523,1,0.0
Elliott,1,0.0
bifrontal,1,0.0
paroxysmal,1,0.0
52-year-old,1,0.0
streamlined,1,0.0
prescribes,1,0.0
fix,1,0.0
law,1,0.0
pledge,1,0.0
noting,1,0.0
unwieldy,1,0.0
navigate,1,0.0
exported,1,0.0
Isolated,1,0.0
license,1,0.0
Pledge,1,0.0
Chrétien,1,0.0
Jean,1,0.0
enacted,1,0.0
ST-T,1,0.0
indefinitely,1,0.0
contiguous,1,0.0
nadir,1,0.0
notching,1,0.0
universally,1,0.0
mesial,1,0.0
orbitofrontal,1,0.0
421,1,0.0
tri-assortment,1,0.0
2010-March,1,0.0
9301346,1,0.0
691,1,0.0
2009-March,1,0.0
1921269,1,0.0
12693068,1,0.0
12089,1,0.0
254,1,0.0
3068,1,0.0
Totally,1,0.0
Northeast,1,0.0
hypercoagulable,1,0.0
rapid-eye-movement,1,0.0
rarer,1,0.0
investigating,1,0.0
rotation,1,0.0
subaxial,1,0.0
atlantoaxial,1,0.0
happens,1,0.0
hunters,1,0.0
bow,1,0.0
Pediatric,1,0.0
hypometabolism,1,0.0
medial,1,0.0
Biological,1,0.0
self-degradative,1,0.0
organelles,1,0.0
attempting,1,0.0
uncommonly,1,0.0
m,1,0.0
4000,1,0.0
60-year-old,1,0.0
pre-hospital,1,0.0
notably,1,0.0
noncardiac,1,0.0
lipid-lowering,1,0.0
-blockers,1,0.0
doubts,1,0.0
nobody,1,0.0
Often,1,0.0
trekking,1,0.0
alternans,1,0.0
baroreflex,1,0.0
nonresolution,1,0.0
transitory,1,0.0
unsuitability,1,0.0
GISSI-2,1,0.0
Others,1,0.0
prereperfusion,1,0.0
prethrombolytic,1,0.0
Heterogeneity,1,0.0
Consolidated,1,0.0
high-altitude,1,0.0
Himalayas,1,0.0
Relevant,1,0.0
elementary,1,0.0
waist-height,1,0.0
WC,1,0.0
circumference,1,0.0
waist,1,0.0
BROCA,1,0.0
sex-specific,1,0.0
adiposity,1,0.0
decide,1,0.0
Challenges,1,0.0
gatherings,1,0.0
4-32,1,0.0
2-7,1,0.0
not-withstanding,1,0.0
4-10,1,0.0
24-49,1,0.0
39-86,1,0.0
5-28,1,0.0
VSDs,1,0.0
inotropes,1,0.0
defects--VSDs,1,0.0
70-year-old,1,0.0
STE,1,0.0
sickness,1,0.0
mountain,1,0.0
Finland,1,0.0
quadrivalent,1,0.0
degraded,1,0.0
conducive,1,0.0
snake,1,0.0
EPCs,1,0.0
shape,1,0.0
artifacts,1,0.0
constrained,1,0.0
SS-OCT,1,0.0
OCT,1,0.0
swept-source,1,0.0
whole-brain,1,0.0
observing,1,0.0
capturing,1,0.0
contemplating,1,0.0
enzyme-2,1,0.0
autophagy-mediated,1,0.0
allergen-driven,1,0.0
autophagic,1,0.0
overactive,1,0.0
plethora,1,0.0
immunometabolic,1,0.0
starvation,1,0.0
Principal,1,0.0
renovation,1,0.0
recycling,1,0.0
lysosome,1,0.0
venom,1,0.0
participates,1,0.0
attentions,1,0.0
unravel,1,0.0
analyzedCCC,1,0.0
regressions,1,0.0
pro-brain,1,0.0
Gensini,1,0.0
sub-groups,1,0.0
non-CCC,1,0.0
1339,1,0.0
323,1,0.0
patientsA,1,0.0
debatable,1,0.0
linkages,1,0.0
urge,1,0.0
S-protein,1,0.0
collated,1,0.0
extrinsic,1,0.0
ACE2-S-protein,1,0.0
bioactive,1,0.0
phytochemicals,1,0.0
micro-RNAs,1,0.0
modifications,1,0.0
disruptors,1,0.0
endocrine,1,0.0
toxicants,1,0.0
gateway,1,0.0
ESC,1,0.0
tetracycline,1,0.0
doxcycline,1,0.0
taught,1,0.0
maleate,1,0.0
ergometrine,1,0.0
8th,1,0.0
gestation,1,0.0
casting,1,0.0
IMPORTANCE,1,0.0
caution,1,0.0
E6,1,0.0
Vero,1,0.0
anti-basigin,1,0.0
polyclonal,1,0.0
coli,1,0.0
Escherichia,1,0.0
plasmon,1,0.0
chromatography,1,0.0
recombinantly,1,0.0
RH5-basigin,1,0.0
claim,1,0.0
RH5,1,0.0
homolog,1,0.0
reticulocyte,1,0.0
parasites,1,0.0
erythrocytes,1,0.0
malaria,1,0.0
falciparum,1,0.0
thrombin-antithrombin,1,0.0
plasmin-alpha,1,0.0
2-plasmin,1,0.0
VOCs,1,0.0
hemiplegia,1,0.0
occurrences,1,0.0
228,1,0.0
1979,1,0.0
Kent,1,0.0
Theta,1,0.0
VOIs,1,0.0
Countries,1,0.0
GAMMA,1,0.0
BETA,1,0.0
ALPHA,1,0.0
mutated,1,0.0
Knowledge,1,0.0
filter,1,0.0
keywords,1,0.0
library,1,0.0
Willey,1,0.0
NATURE,1,0.0
EMBASE,1,0.0
Dublin,1,0.0
VOI,1,0.0
VOC,1,0.0
enormously,1,0.0
SARS-coronavirus,1,0.0
Plasmodium,1,0.0
invade,1,0.0
administer,1,0.0
episodic,1,0.0
multiply,1,0.0
maynei,1,0.0
Euroglyphus,1,0.0
farinae,1,0.0
robustness,1,0.0
normalize,1,0.0
intrathoracic,1,0.0
mucoviscidosis,1,0.0
untypical,1,0.0
Instead,1,0.0
hypercontractility,1,0.0
cytopathologists,1,0.0
upholstered,1,0.0
prioritisation,1,0.0
summarised,1,0.0
drastically,1,0.0
Extraordinary,1,0.0
radically,1,0.0
productive,1,0.0
pharmacists,1,0.0
information-sharing,1,0.0
Acting,1,0.0
overusing,1,0.0
underusing,1,0.0
carpets,1,0.0
furniture,1,0.0
spray,1,0.0
G11083T,1,0.0
8-18,1,0.0
Immunization,1,0.0
proof,1,0.0
varicella,1,0.0
rubella,1,0.0
risen,1,0.0
launched,1,0.0
Reduced,1,0.0
traveled,1,0.0
C14805T,1,0.0
G26144T,1,0.0
phylogenetically,1,0.0
hot,1,0.0
close-contact,1,0.0
connections,1,0.0
nonimmunological,1,0.0
permeability,1,0.0
Der,1,0.0
mastocytes,1,0.0
proliferative,1,0.0
Sensitized,1,0.0
HDMs,1,0.0
atmosphere,1,0.0
humid,1,0.0
20-bed,1,0.0
allocated,1,0.0
four-month,1,0.0
monocyte,1,0.0
Immunofluorescence,1,0.0
1969-1983,1,0.0
Lifestyle,1,0.0
off-pump,1,0.0
on-pump,1,0.0
death-related,1,0.0
blood-pool,1,0.0
Radionuclide,1,0.0
localize,1,0.0
nontransmural,1,0.0
scintigraphic,1,0.0
bathyphase,1,0.0
parenchymatous,1,0.0
acrophase,1,0.0
transcripts,1,0.0
Cosinor,1,0.0
supernatants,1,0.0
One-Step,1,0.0
Monocytes,1,0.0
q-RTPCR,1,0.0
actor,1,0.0
parainfluenza,1,0.0
Reddy,1,0.0
Ray,1,0.0
impressions,1,0.0
drift-variant,1,0.0
randomised,1,0.0
antigonists,1,0.0
long-chain,1,0.0
nonanchoring,1,0.0
locks,1,0.0
G496-V503,1,0.0
anchor,1,0.0
Y473-F490,1,0.0
anchor-locker,1,0.0
SASA,1,0.0
solvent-accessible,1,0.0
calculation,1,0.0
hinders,1,0.0
nonsteroidal,1,0.0
Victoria75,1,0.0
sensitisation,1,0.0
destined,1,0.0
Treating,1,0.0
age-appropriate,1,0.0
topical,1,0.0
1970s,1,0.0
wheezy,1,0.0
incur,1,0.0
verified,1,0.0
employment,1,0.0
Simultaneous,1,0.0
RCT,1,0.0
childrens,1,0.0
remedial,1,0.0
Nurse,1,0.0
sedation,1,0.0
naso-pharyngeal,1,0.0
diarrhea,1,0.0
83-year-old,1,0.0
clarified,1,0.0
trending,1,0.0
graph,1,0.0
color-coded,1,0.0
Tracker,1,0.0
Clot,1,0.0
blocking,1,0.0
Chief,1,0.0
bases,1,0.0
Foster,1,0.0
argues,1,0.0
generalization,1,0.0
rehabilitative,1,0.0
nerve,1,0.0
vagus,1,0.0
bursts,1,0.0
arm,1,0.0
after-care,1,0.0
arrangements,1,0.0
therapists,1,0.0
hypercontractile,1,0.0
mid-apical,1,0.0
immunotherapies,1,0.0
356,1,0.0
ameliorated,1,0.0
Disease-19,1,0.0
Coronavirus-2,1,0.0
ICTV,1,0.0
Taxonomy,1,0.0
Committee,1,0.0
attracts,1,0.0
maturity,1,0.0
facts,1,0.0
724,1,0.0
vectorcardiographic,1,0.0
272,1,0.0
ballooning,1,0.0
1458,1,0.0
healed,1,0.0
infiltrate,1,0.0
interstitium,1,0.0
Abundant,1,0.0
myocytes,1,0.0
coagulative,1,0.0
subepicardial,1,0.0
maneuvers,1,0.0
pulseless,1,0.0
Shortly,1,0.0
alerting,1,0.0
snack,1,0.0
tet-notch4,1,0.0
1-2,1,0.0
antiparasitic,1,0.0
antifungal,1,0.0
photodynamic,1,0.0
TorontoABSTRACT,1,0.0
consistently,1,0.0
paradoxus,1,0.0
pulsus,1,0.0
Pulse,1,0.0
spirometer,1,0.0
015,1,0.0
charts,1,0.0
enumerated,1,0.0
downtown,1,0.0
MRI-guided,1,0.0
known-onset,1,0.0
manuscripts,1,0.0
above-matched,1,0.0
Papers,1,0.0
cross-referenced,1,0.0
1966,1,0.0
administering,1,0.0
14-296,1,0.0
accounts,1,0.0
Wake-up,1,0.0
Cardiology,1,0.0
non-photodynamic,1,0.0
non-photoactivated,1,0.0
micromolar,1,0.0
30-50,1,0.0
1516,1,0.0
1616,1,0.0
Testing,1,0.0
swabbing,1,0.0
archives,1,0.0
anomalies,1,0.0
publicly,1,0.0
nucleotides,1,0.0
2821103,1,0.0
Motivated,1,0.0
Asian,1,0.0
Less-frequent,1,0.0
021,1,0.0
mutates,1,0.0
thrive,1,0.0
timescale,1,0.0
adept,1,0.0
333,1,0.0
CmaxEC90,1,0.0
CmaxEC50,1,0.0
201,1,0.0
IHUMI-3,1,0.0
MOI,1,0.0
multiplicity,1,0.0
86-year-old,1,0.0
Rarely,1,0.0
cortisone,1,0.0
Chen,1,0.0
Keller,1,0.0
Fayad,1,0.0
W-Z,1,0.0
Zhu,1,0.0
Laflamme,1,0.0
Mani,1,0.0
Kattman,1,0.0
Briley-Saebo,1,0.0
Giovannone,1,0.0
Kaplan,1,0.0
Bystrup,1,0.0
therapy-Adler,1,0.0
two-stage,1,0.0
Immunohistochemistry,1,0.0
Dox-cells,1,0.0
Mice,1,0.0
uninduced,1,0.0
embryoid,1,0.0
Tet-notch4,1,0.0
reasoned,1,0.0
fate,1,0.0
respecified,1,0.0
Flk1,1,0.0
ESCs,1,0.0
sequence-based,1,0.0
barcoded,1,0.0
parenteral,1,0.0
anastomoses,1,0.0
normalcy,1,0.0
PFR,1,0.0
kriyas--and,1,0.0
meditation,1,0.0
Pranayama,1,0.0
practices--yogasanas,1,0.0
570,1,0.0
misdiagnoses,1,0.0
topographical,1,0.0
sensibility,1,0.0
harder,1,0.0
SCA,1,0.0
population-scale,1,0.0
PICA,1,0.0
AICA,1,0.0
Cerebellum,1,0.0
Cerebellar,1,0.0
scalable,1,0.0
near-patient,1,0.0
multiplexed,1,0.0
barcodes,1,0.0
sample-specific,1,0.0
decentralized,1,0.0
Stage,1,0.0
938,1,0.0
milieu,1,0.0
Combination,1,0.0
Students,1,0.0
Up,1,0.0
Diabetic,1,0.0
ruling,1,0.0
noninflammatory,1,0.0
non-iatrogenic,1,0.0
non-traumatic,1,0.0
Dissection,1,0.0
Jordanian,1,0.0
peers,1,0.0
practise,1,0.0
enjoyed,1,0.0
well-received,1,0.0
Host-directed,1,0.0
notes,1,0.0
journal,1,0.0
reflective,1,0.0
junior,1,0.0
open-ended,1,0.0
adaptability,1,0.0
Feasibility,1,0.0
bilingual,1,0.0
Jordan,1,0.0
girls,1,0.0
English-language,1,0.0
Sustained,1,0.0
anti-infection,1,0.0
Adolescent,1,0.0
G2P2,1,0.0
complain,1,0.0
Resistance,1,0.0
maximized,1,0.0
746,1,0.0
liberation,1,0.0
post-exposure,1,0.0
weight-dependent,1,0.0
Apgar,1,0.0
amniotic,1,0.0
3200,1,0.0
gestational,1,0.0
newborn,1,0.0
activate,1,0.0
miRNA,1,0.0
recapitulated,1,0.0
Social,1,0.0
ncHi,1,0.0
nonencapsulated,1,0.0
Hib,1,0.0
elevating,1,0.0
endocytosis,1,0.0
rationality,1,0.0
Metformin,1,0.0
self-protective,1,0.0
Triple,1,0.0
mildmoderate,1,0.0
Bauhins,1,0.0
grounds,1,0.0
10-dose,1,0.0
dead-space,1,0.0
mark,1,0.0
Flutrade,1,0.0
ergonomic,1,0.0
wastage,1,0.0
dose-capacity,1,0.0
syringes,1,0.0
stretched,1,0.0
begin,1,0.0
stockpiling,1,0.0
microflora,1,0.0
Extrapolations,1,0.0
intoxication,1,0.0
endogenic,1,0.0
intestines,1,0.0
dysbacteriosis,1,0.0
duodenal,1,0.0
duodenography,1,0.0
manometry,1,0.0
endoscopy,1,0.0
digestion,1,0.0
extrapulmonary,1,0.0
exogenic,1,0.0
vials,1,0.0
accrue,1,0.0
SOC,1,0.0
hierarchical,1,0.0
Tocilizumab,1,0.0
proxalutamide,1,0.0
nitazoxanide,1,0.0
sarilumab,1,0.0
tofacitinib,1,0.0
colony,1,0.0
granulocyte,1,0.0
colchicine,1,0.0
imatinib,1,0.0
102950,1,0.0
grouped,1,0.0
Odds,1,0.0
platelet-rich,1,0.0
CrIs,1,0.0
equal-tailed,1,0.0
Outcome,1,0.0
Obesity,1,0.0
OC43,1,0.0
valinomycin,1,0.0
heavy,1,0.0
HCoVs,1,0.0
ruled,1,0.0
P-selectin,1,0.0
prompts,1,0.0
member,1,0.0
